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I. INTRODUCTION 
 The role of the endometrium in reproduction  
The endometrium is the inner mucous lining of the mammalian uterus which has been of main 
interest in research of female reproduction over the last decades. During the 1970’s it has been 
established that the endometrium influences the action of the corpus luteum (CL) via a local or 
a systemic uteroovarian pathway (Johnson et al., 2003) several studies unraveled the role of 
prostaglandin F2-alpha (PGF2a) as luteolysin in this process (McCracken, 1973). Further on, in 
the 1980’s it was discovered that the presence of significant amounts of PGF2a in the blood and 
uterine lumen during the estrous cycle, pregnancy and pseudopregnancy provoked by estrogen 
injections, is a result of its retrograde transfer in the area of the mesometrium (Koziorowski, 
1988, Krzymowski, 1982). However, the physiological functions of the uterus were found to 
depend upon proper integration of endocrine and paracrine signals by the different cell types 
and tissue layers (Bigsby, 1991, Cunha et al., 1985). To date it is known that the endometrium 
plays an important morphological, functional and regulatory role during the sexual cycle: 
transport of sperm, uterine clearance (horse and pig), preparation for pregnancy, i.e., uterine 
secretions for support of conceptus growth and development, and preparation for conceptus 
implantation. 
 Morphological changes of the endometrium throughout the estrous cycle 
During the sexual cycle, the ovarian cycle and the uterine cycle run in parallel and their interplay 
is mainly regulated by the ovarian steroid hormones estradiol (E2) and progesterone (P4). The 
ovarian cycle is responsible for follicular development, rupture of the follicle and development 
and regression of the corpus luteum (CL) whereas the uterine cycle is characterized by the 
morphological and functional changes of the endometrium (Loeffler et al., 2013). These 
changes start after puberty in sexually mature females and are influenced by numerous factors 
including nutrition, environment, lactation stage, age and individual genetic background. Non-
seasonal polyestrous mammals (cat, cow and pig) cycle several times throughout a year whereas 
seasonal polyestrous mammals (horse, sheep, goat and doe) only show regularly returning 
estrous cycles in specific phases during the year, e.g., mares are so called “long-day breeders” 
with ovulatory activity being related to days with ‘long’ daylight. Goats and sheep only cycle 
when day times are short and therefore are called “short-day breeders”. Typical characteristics 
of the estrous cycle as length of cycle, hormonal regulation, reproductive behavior and the 
anatomy of participating female reproductive organs show similarities but also extreme 
differences between mammalian species. According to the steroid hormone concentrations the 
estrous cycle is divided into four main phases: preestrus (late luteal phase, early estrus or 
follicular phase), estrus (ovulatory phase), metestrus (early luteal phase) and diestrus (mid 
luteal phase).  
 Morphological changes of the equine endometrium throughout the estrous cycle 
During estrus the mitotic activity of the luminal epithelial (LE) cells is extremely high, the 
nuclei are enlarged and oval-shaped and the LE appears cylindrical. At this time during the 
cycle, high E2 concentration and low P4 concentration contribute to the increasing uterine wall 
edema. The edematization eases the tissue and therefore proliferative glands appear less packed. 
At this time in cycle the connective tissue is enriched with body liquid and clearly vascularized. 
Secretory products as well as cell debris are commonly found in the lumen of the glands during 
this time in the cycle. The increased secretory activity together with infiltration of the luminal 
epithelium by granulocytes and macrophages is important for uterine clearance after breeding 
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(Tunon, 1995). In addition, uterine granulocytes show tendency of arranging in groups close to 
the lumen and single erythrocytes are found in the Stratum compactum (Schoon et al., 1992). 
Gerstenberg and coworkers (Gerstenberg, 1999) observed a sudden marked and highly 
significant increase in the proliferation rate of the epithelial cells within the secretory portions 
of the endometrial glands between day 3 and day 7 after ovulation. In addition, Vogel and 
Humke (Vogel et al., 1973) found that equine uterine glands are changing their shape and size 
throughout the cycle. At estrus, uterine glands are transforming from an elongated to a coiled 
shape and the end of the glands becomes aciniformed. During the luteal phase the number of 
secretory endometrial cells rapidly declines and only few are present (Aurich, 2011). Following 
estrus, the edematization of the endometrium decreases and the density of the uterine glands 
increases (Soede et al., 2011). According to Vogel and Humke (Vogel et al., 1973), the glands 
become more and more aciniformed and start to build clusters during postestrum and elongate 
during interestrum. Unfortunately, in this population there is no exact time definition given for 
the phase ‘postestrum’ and ‘interestrum’. At diestrus the uterine cells show cubical orientation. 
According to Riegel (Riegel J., 2002) the height of the equine epithelium is at maximum during 
this time of the estrous cycle. During late luteal phase, the proliferation rate in all types of cells 
(luminal epithelium, gland neck epithelium, superficial stroma, deep gland epithelium and deep 
stroma) and the superficial strata (luminal epithelium and stratum compactum) decreases to 
basal values (Gerstenberg, 1999). 
 Morphological changes of the porcine endometrium throughout the estrous 
cycle 
During the estrous cycle the porcine endometrium exhibits distinct morphological changes in 
foldings at the luminal side. At estrus primary folds are high while during diestrus there are 
additionally secondary and tertiary folds developed. However, the height of the foldings clearly 
decreases during this process but increases again at preestrus (Fabian, 1960). In addition, the 
changes in the height of the luminal epithelia throughout the estrous cycle have been reported 
differently in literature. A maximum height was reported by Corner (Corner, 1921) and 
Steinbach (Steinbach et al., 1970) on day 4 and by Mehlhorn (Mehlhorn et al., 1975) on day 5 
of the estrous cycle. Fabian (Fabian, 1960) observed a maximum height of the luminal epithelia 
not before day 7 / 8. However, a change in height from 50-62 µm at metestrus compared to 34-
41 µm at estrus was found by Sidler (Sidler et al., 1986). A minimum height of 12-16 µm on 
day 12 of the reproductive cycle was shown by latter group and verified by Corner (Corner, 
1921) and Fabian (Fabian, 1960). In contrast, other research groups (Mehlhorn et al., 1975, 
Prehn, 1963) observed a minimum height around day 17 of the cycle. Stroband (Stroband et al., 
1986) did not detect significant local changes in the height at all. This extreme divergence could 
be explained by the disagreement in the onset of the estrous cycle and methodical differences 
in tissue preparation. At estrus the luminal epithelial cells are highly prismatic and change their 
shape to iso-prismatic during the luteal phase. The columnar cells are irregularly arranged and 
their nuclei are situated at different levels in the cells, giving the epithelium a stratified 
appearance. Mitotic cells are increased during this time. Following estrus the number of mitotic 
cells among the luminal secretory cells decreases. Besides the cells of the luminal epithelium, 
the small secretory cells in the glandular epithelium show mitotic activity around day 5 and the 
presence of clear secretory vesicles continues up to day 16 during the estrous cycle (Stroband 
et al., 1986). In addition to secretory cells, Kaeoket (Kaeoket et al., 2001) observed different 
types of cells of the immune system (e.g. lymphocytes, neutrophils, eosinophils and 
macrophages) in the connective tissue of subepithelial and glandular layers of the porcine 
endometrium at different stages of the estrous cycle. According to the latter, highest number of 
lymphocytes in the surface and glandular epithelia is at early diestrus. In addition, macrophages 
were only found at preestrus and estrus, except for a few cells in the glandular epithelium at 
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early diestrus. The edematization of the stroma decreases after estrus, remains unidentified 
during diestrus and starts again at the beginning of estrus. 
 Anatomy and physiology of the uterus and the endometrium 
 Uterus 
The uterus, as the major female hormone-responsive reproductive organ is divided into the body 
(corpus uteri), the uterine tubes (cornua uteri) and the cervix. At one end, the cervix opens into 
the vagina while the other end is connected to one or both uterine tubes/horns depending on the 
species. The development of the uterus starts from the paired paramesonephric ducts during 
early fetal life and their degree of fusion is variable for different types of uteri amongst species. 
Women and higher primates exhibit a single completely fused uterus (uterus simplex) with a 
connection between the isthmus and the uterine body but no uterine horns. Lagomorphs, some 
rodents and marsupials possess two uteri (uterus duplex). These species exhibit two large horns, 
two cervices but no uterine body. In mammals like horse, swine (Figure I-1) and ruminants, the 
fusion of the paired paramesonephric ducts is only partial with a homogenous uterine body but 
the uterus remains paired and develops two uterine horns (uterus biscornis) (Loeffler et al., 
2013). The equine uterine tubes reach a length of about 18-30 cm whereas the fusion in the sow 
is very short and results in even longer uterine horns that can reach a length up to 60-90 cm. 
Figure I-1: Graphical illustration of the reproductive tract of the mare (A) and sow (B). 1-uterine tubes, 2-fallopian 
tubes, 3-ovary, 4-cervix, 5-vagina, 6-uterine body. Graphic copied from ‘Embryologie der Haustiere’ (Rüsse, 
1998) and edited using CorelDrawX7 software. 
Besides the different types of uteri, mammals are additionally separated into groups regarding 
different types of placentation (the formation of the placenta which requires close synchrony 
between the state of uterine receptivity and the stage of embryonic development) and different 
types of developed placentae. Most domestic animals (except carnivores) exhibit a non-invasive 
placentation which means that epithelial cells are remained intact on the uterine lumen surface, 
no induction of endometrial stromal cell decidualization occurs and the trophoblast does not 
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invade maternal tissue but rather expands to cover a large maternal surface (Croy et al., 2009). 
The different types of placenta development are divided i) regarding the degree of rearranging 
the layers in between the maternal and fetal vascular system, ii) interdigitation between 
maternal and fetal tissues and iii) based on placental shape and distribution of contact sites 
between fetal membranes and endometrium. In domestic animals, the number of maternal 
layers in the placental barrier results in two main placental classes: the epitheliochorial and the 
endotheliochorial placenta. Ruminants, pigs and horses develop an epitheliochorial placenta 
and carnivores establish the endotheliochorial (attachment of the chorion to the maternal 
endothelial vessels) placenta type (Hyttel et al., 2010). In addition, the mare and the sow exhibit 
a Semiplacenta diffusa (surface of the allantochorion is involved in formation of the placenta) 
while the porcine chorioallantonic surface area is increased by foldings and therefore referred 
to as being ‘folded’, the equine placenta is referred to as being villous because chorion villi a 
gathered in numerous microcotyledones (Hyttel et al., 2010). 
 Endometrium 
The uterine wall is arranged in three layers: the perimetrium (overlay of serosa–exterior), the 
myometrium (smooth musculature–medial) and the endometrium (mucosa–interior). The basic 
composition of the endometrial tissue is similar between mammalian groups and consists of the 
luminal epithelium (LE) which provides a defensive barrier and is also the site of embryo 
attachment, glandular epithelium (GE) which secretes paracrine and autocrine factors, stroma 
cells which regulate growth, morphogenesis, cytodifferentiation, and function of the 
epithelium, blood vessels (BV or endothelial cells) and a variety of immune cells such as 
macrophages, lymphocytes, and mast cells (Spencer et al., 1995a). However, there are 
differences between species in shape and constitution of the endometrium.  
The equine endometrium is arranged in 12-15 longitudinal folds which are supported by 
collagenous connective tissue cores (Morel, 2008). It comprises a single-layered cylindrical LE 
(with fractionally ciliated respiratory cells) which is attached to a basal lamina and the Lamina 
propria. Furthermore, the Lamina propria differentiates into a subepithelial narrow Stratum 
compactum (Str. comp.) and a wide Stratum spongiosum (Str. spong.). Whereas the Str. comp. 
shows high density of spindle-shaped stroma cells, the Str. spong. mainly exhibits blood vessels 
and arborescent, tubular uterine glands (Kenney, 1978). Equine uterine glands develop from 
the endometrial mucosa, penetrate into the submucosa and become more and more coiled during 
the cycle. They secrete material into the lumen of the uterus.  
In direction towards the lumen, the porcine endometrium is folded and anatomically 
differentiated into a simple luminal epithelium and the subjacent Lamina propria. As in other 
domesticated mammals, the porcine LE is highly prismatic and single-layered. It is called 
Epithelium simplex columnare (Leiser et al., 1988). In the area of more apical parts of the 
uterine glands and around the openings of the glands in the porcine LE ciliated cells are 
common and found (Stroband et al., 1986). Branched tubular uterine glands are embedded in 
the Lamina propria which consists of squamous connective tissue. The amount of uterine glands 
is higher in the deep endometrial stroma (Kaeoket et al., 2001). 
 Endocrine/paracrine hormone actions on the uterus during the 
estrous cycle 
In general, female mammals share the same endocrine regulatory system including the release 
of the gonadotropin releasing hormone (GnRH) from the hypothalamus in pulses and the 
secretion of the pituitary follicle stimulating hormone (FSH) and the luteinizing hormone (LH). 
This system elapses hierarchically starting with the hypothalamus on the top, the pituitary gland 
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in the middle, the ovaries on the basis. Their communication occurs through a very complex 
network and is finalized by characteristic actions of the ovarian steroid hormones on the uterus. 
Regular estrous cycles, as well as establishment and maintenance of pregnancy, require 
integration of both endocrine and paracrine signals from the ovary, conceptus, and uterus itself. 
Within the uterus, different cell types communicate with one another in a classical paracrine 
manner (Spencer et al., 1995a).  
 Steroid hormone metabolism and synthesis 
Steroid hormones have influences on metabolism, inflammation, immune functions, salt and 
water balance, development of sexual characteristics and the ability to withstand illness and 
injury. Their synthesis is derived from cholesterol in the adrenal gland and their actions on the 
uterus are mainly mediated through their respective receptors which show species-specific 
expression in the uterus and interact in a complex pattern. 
 Progesterone (P4)  
Progesterone plays a crucial role in the expression of genes needed for several functions 
regarding female mammalian reproduction at the level of the endometrium; regulation of the 
endometrial luteolytic mechanism, anti-luteolytic effects of interferon-tau (IFNτ) and 
maintenance of pregnancy (Spencer, 2004). During its biosynthesis the rate determining step is 
exhibited by the transport of cholesterol from the outer to the inner mitochondrial membrane. 
This transport is regulated by the enzyme steroidogenic acute regulatory protein (StAR) which 
shows the affinity to bind cholesterol (Tuckey et al., 2002). At the inner mitochondrial 
membrane the side chain between the 20th and the 22nd carbon atom of cholesterol is cleaved 
and pregnenolone is synthesized. The enzyme performing this reaction is cytochrome P450scc 
which is located in mitochondria and controlled by the anterior pituitary hormones. 
Pregnenolone can further be converted to i) progesterone or to ii) 17-hydroxypregnenolone 
which is converted  into estradiol.  
Under the influence of P4, the amount of endometrial glandular structures greatly increases and 
become more tortuous. Throughout the estrous cycle P4 concentration rises to a peak at diestrus. 
For example, in mares P4 concentration is highest around day 8 during the cycle and decreases 
rapidly afterwards, whereas in the pig P4 concentration is highest on day 12. Thus, 
determination of P4 concentration in peripheral blood plasma is a common and confident way 
to analyze estrous cycle manners which are species dependent.  
In all mammalian uteri the progesterone receptor (PGR) is expressed in the endometrial 
epithelium and stroma during the early luteal phase, allowing direct regulation of a number of 
genes by progesterone via activation of the PGR (Spencer, 2004). During this time in cycle P4 
from the newly formed CL which is along with the luteinized granulosa cells in the ovary the 
main source of progesterone, stimulates accumulation of phospholipids in LE and superficial 
ductal glandular epithelium (sGE) that can liberate arachidonic acid for synthesis and secretion 
of PGF2a. During following diestrus, progesterone levels further increase and act via PGR to 
block the expression of estrogen receptor alpha (ERa) and oxytocin receptor (OXTR) in the 
endometrial LE and sGE (McCracken, 1980). This interactive network has especially been 
studied and analyzed in the ovine uterus. Progesterone signaling through its nuclear 
transcription factor is essential for normal uterine function. Although deregulation of the 
receptor of progesterone (PGR)-mediated signaling is known to underscore uterine dysfunction 
and a number of endometrial pathologies, the early molecular mechanisms of this deregulation 
are unclear. Paradoxically, progesterone is involved first in suppressing and then inducing the 
development of the endometrial luteolytic mechanism during the estrous cycle. The timing of 
PGR down-regulation in the LE and superficial GE by progesterone appears to determine when 
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the luteolytic mechanism develop in the endometrium. Thereby the expression of ESR1 and 
OXTR in the LE and sGE increase which causes by the induction of oxytocin increasingly 
PGF2a release (Spencer, 2004). This hypothesis is strongly supported by the finding that 
exogenous progesterone administration during metestrus decreased the interestrus interval in 
sheep and cattle (Garrett et al., 1988, Woody et al., 1967). 
 Estradiol-17ß (E2) 
Estradiol is a member of the estrogen family which comprises the main key steroid hormones 
in female reproduction and which has several functions during the estrous cycle; suppressing 
the secretion of FSH in a negative feedback mechanism and aiding that way during the selection 
of the dominant follicle, preventing multifollicular development in the mid-late follicular phase 
in monoovulatory species (e.g. horse), and triggering of the LH surge by initiating a positive 
feedback mechanism when its concentration rises to a critical level. It is further known that E2 
secreted by the ovary induces proliferation of endometrial cells in human (Jabbour et al., 2006), 
rodents (Zhang et al., 2006) and sheep (Johnson et al., 1997). Additionally, it also induces the 
expression of growth factors throughout the estrous cycle in the bovine endometrium and 
promotes the proliferation of bovine endometrial epithelial cells by stimulating the production 
of a variety of growth factors in stromal cells (Arai et al., 2013, Xiao et al., 1998). E2 stimulates 
the edematization of the mucosa inducing the LH surge and increasing blood circulation and 
has an influence on the contraction of smooth musculature. In rodents and humans, estrogens 
produced from the developing follicles stimulate endometrial growth (Groothuis et al., 2007).  
The synthesis of estradiol is carried out by the interplay of theca cells and granulosa cells in the 
ovary. Therefore, the luteinizing hormone binds its receptor on the surface of the theca cells 
and stimulates the production of androgens. Then the androgens (androstendion, testosterone 
and dehydroepiandrosteron) are transported to the adjacent granulosa cells and are aromatized 
to estrogens which is triggered by the binding of the follicle stimulating hormone to its 
receptors. The aromatization of estrogens as well as synthesis of androgens is stimulated by the 
second messenger cyclic adenosinmonophosphat (cAMP). Some estrogens are also produced 
in smaller amounts by other tissues such as the liver, adrenal glands and fat cells (Nelson et al., 
2001). 
Furthermore, estrogen is known to stimulate the expression of several steroid hormone 
receptors in the uterus. The highly regulated uterine estrogen receptor alpha (ESR1), 
progesterone receptor (PGR), and oxytocin receptor (OXTR) expression is caused by estrogen 
levels that peak from an ovulatory Graafian follicle at the time of estrus (Spencer et al., 1995a). 
It has been shown that PGR mRNA and protein have relatively high endometrial levels during 
estrus (Hartt, 2005) in sheep and horse. Throughout the estrous cycle, E2 concentration is 
highest during the estrus phase and decreased during the luteal phase.  
 Prostaglandin metabolism and synthesis 
Prostaglandins (PG) are a group of local paracrine mediators that are traditionally synthesized 
from an intermediate arachidonic acid (AA) released from plasma membrane phospholipids 
(Figure I-2). 
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Figure I-2: Cyclooxygenase pathway of prostaglandin synthesis showing main steps and main enzymes. 
Arachidonic acid is first created from phospholipids via phospholipase A2 (PLA2) and then enzymatically 
catalyzed by the enzyme cyclooxygenase-2 (COX-2), also known as prostaglandin-endoperoxide synthase 2 
(PTGS2) and oxygenated to yield endoperoxide-containing prostaglandin G2 (PGG2). The enzyme also reduces 
hydroperoxyl in PGG2 to hydroxyl to form PGH2 via a separate peroxidase. A cell specific isomerase catalyzes 
the reaction of PGH2 to different PG’s and Tromboxane A2. PGG2-prostaglandin G2, PGH2-prostaglandin H2, 
PGE2-prostaglandin E2, PGF2a-prostaglandin F2 alpha, TXA2-thromboxane A2. Illustration was created using 
CorelDraw X7 software. 
Systematic studies of these substances have begun in the 1930’s and revealed plenty of different 
types of prostaglandins with different functions; actions in the central nervous system, 
inflammation, pain, immunity, vascular homeostasis and reproduction (Narumiya et al., 1999). 
According to the literature the F and E types of prostaglandins are implicated in many aspects 
of reproductive function (Narumiya et al., '99). In connection with the topic of this study the 
metabolism and synthesis of prostaglandin F2a (PGF2a) and prostaglandin E2 (PGE2) are of 
major interest. PGF2a is involved in many physiological functions including contraction of 
uterine, bronchial, vascular and arterial smooth muscles (Watanabe, 2002), regulation of ocular 
pressure (Crawford et al., 1987), renal filtration (Weber, 1980), stimulation of hair growth 
(Sasaki et al., 2005) and regulation of the ovarian cycle through the induction of luteolysis 
(McCracken J., 1999). The onset of luteolysis (in some species) is known to be induced in the 
late luteal phase when oxytocin (OXT) is released in high-frequency bursts from the posterior 
pituitary. Pituitary OXT, supplemented with additional OXT released from the corpus luteum 
e.g. in sheep, then acts to stimulate the release of luteolytic pulses of PGF2a by the uterus 
(Boerboom et al., 2004). In addition E2 was found to stimulate the synthesis of PGF2a by the 
uterus in the guinea pig (Blatchley et al., 1971), the rat (Castracane et al., 1975) and in sheep 
(Caldwell et al., 1972) and further on it became apparent in studies of the sheep uterus that E2 
together with P4 controls the release of PGF2a by regulation of the endometrial oxytocin 
receptor (McCracken J., 1999).  
OXTR is a typical member of the rhodopsin-type (class I) G protein coupled receptor family 
and is differentially expressed in various tissues. In the uterus or hypothalamus, OXTR 
regulation correlates with the pattern of sex steroids, in particular estradiol (Goff, 2004). The 
complex interaction between sex hormones and their endometrial receptors in the pulsatile 
release of endometrial PGF2a has been summarized by Spencer and coworkers (Spencer, 2004) 
in the sheep but is still not completely clarified yet. 
In domestic animals, the endometrium also secretes prostaglandin E2 (PGE2) which in contrast 
to PGF2a is known to have luteoprotective effects. Uterine PGE2 production increases in early 
pregnancy (in sheep and pigs) and its infusion can protect the corpus luteum from the luteolytic 
effect of endogenous and exogenous PGF2a (McCracken J., 1999). PGE2 mediates its effect 
I - INTRODUCTION 
8 
by binding to either of four subtypes of G-protein-coupled receptors (PTGER1-4), also known 
as EP1-4), which are encoded by four individual genes (Narumiya et al., 1999). In addition, 
uterine blood vessels are relaxed by estrogens, PGE2, nitrogen oxide (NO), LH, numerous 
cytokines and constricted by progesterone, PGF2a, OXT, noradrenalin and the central 
sympathetic nervous system (Krzymowski et al., 2008). The most intensive blood flow in the 
uterine artery was noted by several research groups (Ford et al., 1979, Ford et al., 1977) in the 
follicular phase, before and at the time of ovulation. Blood flow in the uterus also depends on 
the phase of the cycle. The rhythmic changes in uterine blood flow during the cycle in each 
species appear to be temporally associated with the daily estrogen/progesterone ratios observed 
in systemic blood. The higher the E2/P4 ratio is, the greater is the quantity of blood flowing 
through the uterine vascular bed (Ford, 1982).  
 Endocrine regulation of the equine estrous cycle 
The average equine estrous cycle is about 22 days (D) in length and the four different phases 
are divided into estrus (ovulatory phase-around D0), early luteal phase, mid luteal phase 
(diestrus–around D8) and late luteal phase (reviewed in (Aurich, 2011)) (Figure I-3). As the 
mare is a monotocous animal, only one follicle is selected as dominant follicle and therefore 
only one follicle ovulates during an estrous cycle. The pre-ovulatory follicle continues growing 
from selection onwards, until reaching a diameter of 44-55 mm two days before ovulation 
(Ginther et al., '08). 
 Estrus and early luteal phase 
Throughout the equine estrous cycle, ovulatory phase starts around day 16 and ceases after a 
period of 5-7 days. The ovulatory process of the equine follicle involves a specific and unique 
pattern of gene regulation in theca and mural granulose cells which includes differences in the 
expression of a variety of factors (Sayasith et al., '07). As in ruminants, the high level of LH 
during this stage primarily stimulates the further development of the dominant follicle, which 
produces high amounts of estradiol responsible for the LH surge in a positive feedback loop 
preceeding ovulation. Progesterone levels immediately start to increase in the course of the 
formation of the new CL, while estradiol decreases to basal levels (da Costa et al., '05) following 
ovulation.  
 Diestrus and late luteal phase 
The CL is a temporary endocrine gland which mainly produces progesterone and does not 
appear at the outer surface of the ovaries. It is pear–shaped and the thinner end shows the fossa 
ovarii. In the event of fertilization it persists until day 150 and is called corpus luteum 
graviditatis. During normal estrous cycle the CL is degenerated and called corpus luteum 
albicans. The structures of the equine CL are formed by luteal (small and large luteal cells) and 
non-luteal cells. As in other domesticated animals, CL function is under the control of LH and 
P4. Functional luteolysis in the mare starts around day 14 after ovulation (Zavy et al., '78) while 
blood concentration of P4 decreases and overlaps with a decreasing P450scc expression. 
Structural luteolysis develops later and more slowly (Ginther et al., '05, '07). In the connection 
with the theme of luteolysis oxytocin plays an important role by stimulating the pulsatile release 
of prostaglandin F2a from the endometrium (Aurich, '11) which causes regression of the CL 
during late luteal phase. In turn, endometrial PGF2a stimulates secretion of oxytocin from the 
CL and hypothalamus, creating a positive feedback loop that increases the magnitude of the 
PGF2a spike. In the mare, oxytocin has been proven to be produced by hypothalamic neurons 
and secreted from the posterior pituitary but also in the endometrium (Aurich, '11). So far, 
expression of a number of genes involved in prostaglandin synthesis and signaling has been 
investigated during the estrous cycle and early pregnancy (Boerboom et al., 2004, Merkl et al., 
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2010). In cyclic mares increased capacity of prostaglandin production during the late luteal 
phase has been observed, e.g., increased expression of prostaglandin-endoperoxide synthase 2 
(PTGS2), also known as cyclooxygenase 2 (COX2), in uterine epithelial cells on day 15 of the 
cycle, whereas the increase of endometrial PTGS2 expression is inhibited in pregnant mares 
(Boerboom et al., 2004) 
Figure I-3: Summary of the endocrine hormone signaling throughout the equine estrous cycle. Cycle length shown 
is 21 days. E2-estradiol, P4-progesterone, LH-luteinizing hormone, FSH-follicle stimulating hormone, PGF2a-
prostaglandin F2 alpha. Graphic was edited by the use of CorelDraw X7 software. 
 Endocrine regulation of the porcine estrous cycle 
The estrous cycle in gilts spans an ordinary period of 21 days (D) but can vary in its length from 
18 to 24 days. The pig is polytocous and may therefore ovulate 15 to 30 follicles in one estrous 
phase depending on age, breed, nutritional status and other factors. During the estrous cycle 
functional changes of the female genitals are periodically repeated, which constitute 
requirements for individual fertility. According to the changes in steroid hormone 
concentrations and corresponding endometrial changes, the porcine estrous cycle can be 
divided into four stages; preestrus, estrus (around D0), metestrus and diestrus (around D12) 
(Figure I-4).  
 Estrus and metestrus 
FSH is involved in the maintenance of a pool of medium sized follicles, but these follicles need 
to be selected by LH for final maturation and ovulation. The selection process of follicles 
continues during a large part of the follicular phase, but seems finalized on the first day of 
estrus, which is defined as the period of time when the female is receptive to the male and will 
stand for mating. The length of the period of estrus varies among species and is defined as the 
period around ovulation in which sows show receptive behavior. In comparison to the mare the 
estrus phase in the pig is much shorter. In the presence of a boar, estrus lasts 40–60 h on average, 
but varies from less than 24 h to more than 96 h for individual sows (Soede et al., 2011). During 
estrus, spontaneous ovulation takes place which varies from about 1–3 h in spontaneously 
ovulating sows and up to 6 h in induced sows (Soede, 1997). Ovulation appears at 
approximately two-thirds of the estrus period about 30±3 h (mean±SD) after the LH surge. 
During this period, estrogen production from the pre-ovulatory follicles reaches its maximum, 
which induces the preovulatory LH surge (and a small FSH surge) via positive feedback causing 
an immediate decrease in peripheral concentrations of 17β-estradiol. The LH surge also initiates 
the follicular changes that result in ovulation and luteinization of the follicle wall, triggering 
progesterone production (Soede et al., 2011). After rupture of preovulatory follicles at 
ovulation, extensive remodeling and reorganization of tissue take place, resulting in the 
formation of fully functional corpora lutea in the mid-luteal phase (Soede et al., 2011). 
I - INTRODUCTION 
10 
 Luteal phase and luteolysis 
The developing corpora lutea (pl. corpus luteum) produce increasing quantities of P4 that reach 
peak values by days 10-12 after ovulation also suppressing secretion of gonadotropins and 
independent of LH input from the pituitary (Peltoniemi et al., 1995). In non-pregnant pigs, 
luteolysis occurs around day 15 after ovulation, and is caused by uterine prostaglandin F2 alpha 
(PGF2a) which is taken to the CL by the narrow contact between the Vena uterine and the 
Ateria ovarica. Other than in cattle, uterine prostaglandin secretion increases earlier than day 
15, but it is only by days 12–13 that corpora lutea of pigs become sensitive to prostaglandins. 
In case of pregnancy, the conceptus secretes estrogens between days 10 and 15 which show 
anti-luteolytic effects by redirecting PGF2a secretion (Waclawik, 2011) and are debated 
together with prolactin as pregnancy recognition signal in pigs. Other than that, the action of 
oxytocin in controlling PGF2a secretion has not been defined in the pig yet. In pigs, luteal OXT 
may not be responsible for initiation of luteolysis, but is more likely involved in the control of 
pulsatile release of PGF2a, especially the height and frequency of the peaks of this hormone 
during luteolysis (Kotwika et al., 1999). In addition, OXT stimulates the synthesis and secretion 
of PGE2 (PG which has the opposite action to PGF2a on the CL) by endometrial luminal 
epithelial (LE) cells only during early pregnancy but not on the corresponding days of the 
estrous cycle (Waclawik et al., 2010).  
 
Figure I-4: Summary of the endocrine hormone signaling throughout the porcine estrous cycle. Cycle length 
shown is 21 days. E2-estradiol, P4-progesteron, LH-luteinizing hormone, FSH-follicle stimulating hormone, 
PGF2a-prostaglandin F2 alpha. Graphic was established using CoralDrawX7 software. 
 Approaches for the study of transcriptome changes 
Since most physiological processes are associated with complex changes in RNA expression 
profiles, transcriptome analysis is a powerful strategy for a holistic description of cellular 
changes at the molecular level. A number of analytical approaches, such as DNA microarrays 
and RNA sequencing (RNA-Seq) have been developed for systematic analyses of mammalian 
transcriptomes (Bauersachs et al., 2012). Microarrays have been used in two main ways: i) 
comparison of data established from healthy and diseased tissue with the aim to study changes 
in gene expression, to state characteristics of diseases and to identify novel therapeutic ways 
and ii) to study the actions of hormones, cytokines and drugs etc. on tissues of interest. With 
the development of microarray technology, global approaches have been pursued to identify 
gene expression changes in the endometrium involved in the regulation of the reproductive 
cycle. The tremendous number of studies of gene expression changes in the endometrium (of 
different domestic mammalian species) during the estrous cycle (Bauersachs et al., 2005, Forde 
et al., 2011, Mitko, 2008) and in comparison of the estrous cycle and early pregnancy 
(Hakhuyan et al., 2009, Klein, 2010, Krzymowski, 2004, Merkl et al., 2010, Samborski et al., 
2013) that were published within a short time frame elucidates scientific importance. Results 
of these studies demonstrate clearly that the morphological and functional changes of the 
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endometrium throughout the estrous cycle still have to be further investigated (reviewed in 
(Krzymowski et al., 2008)), which was the objective of this study.  
 Scientific importance and aim of the present study 
Infertility is a serious problem with common aspects in several species. The reasons for 
subfertility or infertility principally relate to events prior to insemination (impaired oocyte 
and/or follicle development) or after insemination (failure of the fertilized oocyte to undergo 
normal development, increased early embryo mortality and inadequate physiological 
development of the uterine endometrium, i.e. reduced receptivity). In addition, subfertility or 
infertility is a major problem resulting in economic losses in livestock breeding and food 
industry. Overcoming these problems requires a better understanding of the biochemical and 
cellular processes that drive the coordinated physiological regulation of ovarian, oocyte, 
embryo and uterine function at this important time. Reproductive success depends on the 
functionality of biological processes: maturation and selection of gametes, fertilization, pre-and 
post-implantation embryonic development, fetal growth regulation, birth and early postnatal 
development of offspring. Altogether, these processes are based on a functional and faultless 
reproductive cycle. The challenge is to understand the complexity of key mechanisms that are 
characteristic for successful reproduction in domestic animals and to use that knowledge to 
enhance fertility and reproductive health or to establish acceptable methods for control of 
fertility, as there is only limited scientific knowledge. 
The scientific aim of this thesis was to analyze gene expression changes in equine and porcine 
endometrium and to understand the interaction of the variety of differentially expressed genes 
in relation to common and species-specific characteristics in distinct events during the estrous 
cycle. 
In addition, similarly and inversely correlated gene expression profiles in equine and porcine 
endometrium during the estrous cycle were analyzed. This comparison was performed to 
understand the interaction and relation of identified common and species-specific gene 
expression changes throughout the reproductive cycle between equine and porcine 
endometrium. A comparison of these genes to gene expression changes in bovine endometrium 
throughout the cycle (Mitko, 2008) was performed to get additional insights into the complex 
regulation of the reproductive cycle among species. 
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II. MATERIALS AND METHODS 
 Materials 
 Chemicals 
Name Company 
2-Propanol  Merck 
Agarose LE Metaphor  
Boric acid Roth 
Bromphenol blue Serva 
Chloroform  Merck 
DNA low ladder (N3233) New England Biolabs 
Eosin – Phloxin Merck 
Ethanol (30-96%) BfB and Roth 
Ethidium bromide (10 mg/ml) Roth 
Ethylene diaminetetraacetate (EDTA) Merck 
Equine chorionic gonadotropin (Intergonan) MSD Animal Health Innovation GmbH 
Heparin sodium salt SIGMA 
Histofluid Superior 
Human chorionic gonadotropin (Ovogest) MSD Animal Health Innovation GmbH 
Hydrochloric acid (HCl) Roth 
Mayer’s Hemalaun AppliChem  
Nuclease-free Water Millipore 
RNAlater  Life Technologies GmbH 
Saccharose Merck 
Sodium acetate  Merck 
Sodium hydroxide  Riedel-de-Haen 
Tris (tris(hydroxymethyl)aminomethane) (Tris Base) Roth  
TRIzol® Reagent  Invitrogen 
Urea Roth 
Xylol SAV LP  
Table II-I:Used chemicals (name and company) in this study. 
 Buffers 
Name Composition 
1% acidic alcohol: 1 ml concentrated HCl  
 + 400 ml 70 % Ethanol 
2.5x HSE – Buffer: 2.4 g Urea  
 + 5 g Saccharose  
 + 1 ml 0.5 M EDTA (pH 8.0)  
 + 1 ml 1 % Bromphenol blue  
 + 10 ml H20 
1x PBS + Heparin (10 units/ml): 0.024 g Heparin 
 + 0.5 ml PBS  
10x TBE – Buffer: 108 g Tris Base  
 + 55 g Boric acid  
 + 40 ml 0.5 M EDTA (pH 8.0)  
 + 1l H2O 
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TE – Buffer (pH 7.2):  5 ml Tris – HCl (1 mol/l, pH 7.2) 
 + 1 ml EDTA (0.5 mol/l, pH 8.0)  
 + 500 ml H20 
TE – Buffer (pH 8.0): 5 ml Tris – HCl (1 mol/l, pH 8.0) 
 +1 ml EDTA (0.5 mol/l, pH 8.0)  
 + 500 ml H20 
Table II-II: Buffers used in this study (composition and pH-value). 
 Kits 
Name Company 
DNA 1000 Assay Agilent Technologies 
Gene expression Hybridization kit Agilent Technologies 
Quick Amp Labeling (One-color) kit Agilent Technologies 
Low Input Quick Amp Labeling (One-color) Agilent Technologies 
RNA 6000 Nano Assay Agilent Technologies 
RNA Spike–in (One–color) Agilent Technologies 
RNeasy Mini (50 colums) Qiagen 
Sprint RT Complete-Double PrePrimed  Clontech 
FastStart SYBR Green Master Roche 
Table II-III: All Kits used in this study (Name and company). 
 Oligonucleotides (primer for qPCR) 
Gene 
Symbol 1 
Entrez 
Gene ID 2 
Target Accession number 3 Primersequences 4 
(1st – forward, 2nd – reverse) 
Equus caballus 
ABCA1 100054241 ENSECAT00000011043 GCCCGCCTGAAAGGGCTCTC     
CCCCACAAAGGCCAACGCCA  
ACTB 100033878 NM_001081838 TGATATCGCCGCGCTCGTGG     
ATGCCCACCATCACGCCCTG  
ANXA3 100059394 ENSECAT00000019790 ATCTGGGTTGGACACCGGGGG     
GTGCGTTCGACCGCTCAGTCA  
CDH16 100052822 ENSECAT00000010631 CGGTGCTTGTGGAGGCCCAG     
GCGGGGTGTGCAGAGGTGTC  
CDK4 100051005 ENSECAT00000027031 CCCGGACCGATCCCGAGTGTA     
GTCCCATAGGCGCCGACACC  
COL1A1 100033877 ENSECAT00000020087 AAGGCGATGCTGGTCCCCCTG     
AGCCTCACCACGATCGCCACT  
CXCR4 100050974 ENSECAT00000003720 CGGCTGGAGAGCGAGCGGTTA     
ATTCTCCTCCCGGAAGCAGGGC  
ERGIC1 100069822 ENSECAT00000007756 CGTGCCCACGGTGTACGAGG     
AGGCTGCCGTCTCTCCGTGT  
ERP29 100057258 ENSECAT00000000362 CCAAGGGCGCCCCTCTGGATA     
TCCCCACCTCTGCCACCAAGAG  
GADPH 100033897 ENSECAT00000023721 GCAATGCCTCCTGCACCACCA     
TCCCAGAGGGGCCATCCACG  
H3F3A 100054462 XM_001489242 CCAGAGCGCAGCTATTGGTGCT     
CTCCACGTATGCGGCGTGCTAG  
INHBA 100034076 BM735205 GTGGGCAAAGTGGGGGAGAACG  
   GCCAGACTTCTGCACGCTCCA 
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MCM7 100053690 ENSECAT00000021201 CTGCACCGTCATTGCCGCAG  
   TGTCTGACGTGGCTGCCGAC  
PGRMC1 100058718 DN509190 TTCCGGAGCCCTCCCTAGCG  
   GCTGGTCCCCGCGCACTATC  
RN18S 100861557 AJ311673.1 GCGTGTGCCTACCCTACGCC  
   GCGACGGGCGGTGTGTACAA  
RPL7 100033932 CD535100 TGATCGCGCACGACGTGGAT  
   GGTGGTGCAGGTCTTCCTGTGG  
RPS27a 100052644 ENSECAT00000019995 GTGTTGAGACTTCGTGGTGGTGCT  
   GCACTCCCGACGAAGGCGAC  
SERPING1 100066476 ENSECAT00000011379 TCCCCATTCAGCATCGCCAGC  
   GGGTACGAGAGGACGCTCTCCA  
SNRPA 100050337 ENSECAT00000021045 TGGGTGATCTGGACCCTTTGGCAT  
   TTGTGCACCCCGTTTGCCCT  
SLC25A22  100147341 ENSECAT00000012473 GGGGGCCACGCTGCTCAG  
   GGTGCAGTCCAGGATCCCCGA 
SPP1 100053029 ENSECAT00000018317 TCCTAGCACCACAGACCGTGTCC  
   TGGCTTTCGTTGGACTGACTTGGG  
UBB 100033924 NM_001081862.1 CGTCTCAGGGGTGGCTGTTAGC  
   TGGGGCTAATGGCTGGAGTGCA  
Sus scrofa 
ABCA1 100152112 ENSSSCT00000005966 ACTCAGCAGCAGTTTGTGGCCC  
   TCCAGGCTGGGGTACTTGCCA  
ANXA7 100156638 ENSSSCT00000011272 TCCCCGGCTCCATCTTGCCA  
   TCCCCGGCTCCATCTTGCCA  
BAALC 100170128 NM_001129969 TTGAGCCCCGCTACTACGAGAGC  
   CACCATTGGCAGACACGCCATCT  
CCNE1 100523248 TC469751 GCCGAGGGAGAAGAAGGAAAGG
GA     A GGCTGATTGCCACACTGGCT  
CDK4 100144492 NM_001123097 GCCCAGTGCAGTCGGTGGT  
   GTGCTGCAGGGCTCGGAAGG  
COL1A1 397571 ENSSSCT00000019137 GTCCCAGCGCCAGAGTCCCT  
   CGGGGGCCAGTGTCTCCCTT  
CXCR4 396659 NM_213773 AACCTCTGCCCAGCACGCAC  
   GTCCACCCCGCTTTCCCTTGG  
FGFR1 100153248 XM_001928678 GGAATCGCCGAGCCCAGTGAG  
   GTGACCAGGCTCCACACCTCCA  
H3F3A 396970 NM_213930 CTTCCAGCGTCTGGTGCGGG  
   CTCCACGTATGCGGCGTGCT  
PGF 100156404 ENSSSCT00000002642 CGAGTGCAGACCTCTGCGGGA  
   GTGCCAGCAGGGAGGTAACTGAG
A  SERPING1 100144304 NM_001123194 TTCACCTGTGTCCACCAGGCCC  
   GGGCTGCTCCCATACAGGCTCT  
SNRPA 768109 NM_001077222 CACCAATGCCCTGCGCTCCA  
   GTCCCGCTCCACGAAGGTGC  
SPP1 397087 NM_214023 GAGGGCAGCACTGACAGCCG  
   GAAGGGCAGAGGCGAAGCCC  
TIMP-3 396775 ENSSSCT00000000163 CTCGGGCTTGTCGTGCTCCTG  
   GGCCCCTCCTTCACCAGCTTCT  
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UBB 396966 XM_001925271 TGTGGCGCAGGCAGTTTCGTG  
   GTCACTGGGCTCCACTTCCAGGG  
Table II-IV: Oligonucleotides for qPCR analysis.1 Official Gene Symbol, 2 Gene Identifier supplied by NCBI, 3 
Target Accession number supplied by databases (microarray), 4 reverse and forward primer sequences from 
PrimerBLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
 Equipment and consumables 
Name Company 
Benchtop microcentrifuge  Roth 
Bioanalyzer 2100  Agilent Technologies 
Camera (universal camera DP72) Olympus 
Centrifuge (GS-15R)  Beckmann 
Centrifuge 5417R Eppendorf 
Dialyzing membrane  Millipore 
Eppendorf reaction vials (0.5ml, 1.5ml and 2ml) Eppendorf 
Gasket slides Agilent Technologies 
Gibco BRL Horizontal Gel Invitrogen 
Glass coverslips Menzel 
Gloves (gentle Skin) Meditrade 
Gloves (nitrile)  Kimberly Clark 
High-speed stirrer (DIAX 900 )  Heidolph 
Hybridization chambers (stainless, G2534A)  Agilent Technologies 
Incubator Memmert 
Magnetic stirr plate (RCT)  IKA 
MicroAmo TMadhesive Film (48 – well fast optical) ABI Biosystems 
MicroAmo TMReaction Plate (48 – well optical) ABI Biosystems 
Microaray Scanner (G2505C) Agilent Technologies 
Microscope (BX41) Olympus 
Microtome (HM 360) Microm 
Microwave (8521) Privileg 
Nanodrop (1000) PEQLAB 
PCI – Gel Imager INTAS 
Pipette set  Gilson 
Pipette tip (10 ml) TPP 
Pipette tips (low – bind filtered) Biozym 
Pipetus – akku Hirschmann Laborgeräte 
Scalpel/dissecting instruments Specialized trade for veterinary equipment 
Shaker (Vibrax)  IKA 
StepOne TM (RT – PCR) ABI Biosystems 
Thermocycler T1 Biometra 
Thermomixer (5436) Eppendorf 
UV Crosslinker Spectrolinker 
Vials (5ml)  Sarstedt 
Vortexer (Vortex Genie2 Si) Scientific industries inc 
Water bath Bachofer 
Weighing machine (LA 1205) Sartorius 
Table II-V: Used equipment and consumables (Name and company). 
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 Software and databases 
Name Company and web address 
Bioanalyzer 2100 Expert B02.08  Agilent Technologies 
Bowtie http://bowtie-
bio.sourceforge.net/index.shtml 
DAVID (Database for Annotation, Visualization and Integrated 
Discovery)  
http://david.abcc.ncifcrf.gov/ 
Ensembl http://www.ensembl.org/index.ht
ml Feature extraction software 10.7.3.1  Agilent Technologies 
Geneplotter (graphics related functions of Bioconductor)  http://www.bioconductor.org/ 
KEGG (Kyoto Encyclopedia of Genes and Genomes) http://www.genome.jp/kegg/ 
LIMMA (linear models of microarray data)  http://www.bioconductor.org/ 
MeV (Multi experiment viewer, V4.7.1, V4.8.1) http://www.tm4.org/mev/ 
Microsoft Office 2013 Microsoft Corp. 
Nanodrop 1000 V3.7.1 PEQLAB 
NCBI (National centre of biotechnology information) BLAST 
(Basic local alignment search tool)  
http://blast.ncbi.nlm.nih.gov/Bla
st.cgi 
newCAST™ software  Visiopharm  
PrimerBLAST http://www.ncbi.nlm.nih.gov/too
ls/ primer-blast/ 
RefSeq (NCBI Reference Sequence Database) http://www.ncbi.nlm.nih.gov/ref
seq/ SAM (significance analysis of microarray (Mirosoft Excel add-
in))  
http://www.bioconductor.org/ 
Siggenes (SAM and Efron’s empirical Bayes approaches)  http://www.bioconductor.org/ 
StepOne TM V2.0 ABI Biosystems 
UCSC Genome Browser (University of California Santa Cruz) 
BLAT (Blast – like alignment tool) 
http://genome.ucsc.edu/cgi-
bin/hgBlat Vsn (Variance stabilization and calibration for microarray data)  http://www.bioconductor.org/ 
WikiPathways http://wikipathways.org/index.p
hp/ WikiPathways 
Table II-VI: Name, company and web address of all databases and saftware used in this study. 
 Methods 
 Housing of animals 
 Housing of mares 
The mares used for this study were provided from and housed in the facilities of the Bavarian 
principal and state stud of Schwaiganger, Germany.  
 Housing of sows 
Management of experimental animals was performed by Dr. Barbara Kessler und Christian 
Erdle (Chair for Molecular Animal Breeding and Biotechnology, LMU Munich, 
Oberschleissheim). After treatment, the animals were transferred to the experimental 
slaughterhouse in Grub, Germany. 
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 Sample collection  
 Collection of equine endometrial biopsy samples 
The collection of samples was performed in context of routine analysis of the mare’s fertility 
(evaluation of breeding fitness). Endometrial biopsy samples were collected from five normal 
cycling mares (M1, M2, M3, M4 and M5, Bavarian Warmblood). Follicular development and 
ovulation were monitored routinely by daily transrectal palpation and ultrasound examination. 
Mares were treated with 1500 IU human chorionic gonadotropin (hCG) i.v. to induce ovulation 
when mares developed an ovarian follicle of approximately 35 mm in diameter accompanied 
by prominent endometrial edema. Samples were obtained by transcervical biopsy and taken at 
five different days (D) (D0, D3, D8, D12, and D16) during the estrous cycle. No more than two 
biopsies were taken during the same cycle with an interval of at least 15 days. Samples were 
cut into six plane–parallel slices and every second slice was transferred into embedding 
capsules with their right cut surface facing downwards, covered with a foam sponge to avoid 
distortion of tissue samples, and fixed by immersion in 4 % buffered formaldehyde. The 
remaining pieces of the biopsy samples were immediately transferred into vials containing 4 ml 
RNAlater for mRNA expression analysis. The vials were cooled on ice and incubated overnight 
at 4°C. Samples were removed from RNAlater the day after and sample weight was recorded 
before storage at -80°C until further processing. Additionally, blood samples were collected in 
EDTA tubes from the jugular vein on each time point chosen to determine peripheral plasma 
progesterone concentrations. Blood samples were centrifuged at 2000 g, 4 ° C for 10 min. and 
plasma was decanted and stored at -20 ° C until assay. The collection of the biopsy and blood 
samples was performed by Dr. vet. med. M. Merkl. Sample collection procedures and 
progesterone assay protocol are recorded in the dissertation of Dr. vet. med. M. Merkl.  
 Collection of porcine endometrial biopsy samples 
All animals have been purchased from a fattening farm at the age of 6 month and are about a 
cross-breeding between the German landrace and the Piétrain. The collection of samples has 
been notified to the legal authorities. The animals were treated with a single injection (750 IU) 
of equine chorionic gonadotropin (eCG) and, 72 h later, a single injection with 750 IU of human 
chorionic gonadotropin (hCG) to synchronize ovulation (Samborski et al., 2013). The eCG 
stimulates follicular development due to its FSH-like activity, and hCG causes ovulation 
because of its LH-like activity (Youngs, 2001). Samples were obtained from six different 
normal cycling gilts on each of the five different days (D0, D3, D6, D12 and D18; in total n=30, 
S1101-S1130) during the estrous cycle. For precise biopsy sample collection on D0, the animals 
were treated 21 days ahead. Immediately after slaughtering the reproductive tract was removed 
from the animal. The uteri were bisected through the corpus and, starting from the corpus, the 
uterine tubes were opened longitudinally along the anti-mesometrial side. Three sets of 
endometrial biopsy samples were taken from each uterine tube (left and right): proximal (i.e. 
close to the ovaries = front), intermedial (middle) and distal (towards the corpus = back). The 
biopsy samples (altogether 90 for each uterine tube) were immediately transferred into vials 
containing 3 ml RNAlater for mRNA expression analysis. The vials were cooled on ice and 
incubated overnight at 4 ° C. Samples were removed from RNAlater and their weight was 
ascertained and stored at -80 ° C until further processing. Additionally, blood samples were 
collected in EDTA tubes from each animal to determine peripheral plasma progesterone 
concentrations. Blood samples were centrifuged at 4000 g, 4 ° C for 10 min. and plasma was 
decanted and stored at -20 ° C until assay. For additional characterization of cycle stages the 
number and size of corpora lutea and follicles in the ovary (left and right) were counted and 
documented in the ‘sample collecting protocol’ (see Supplemental Material-Table VIII-II) as 
well as shape and composition of the uteri. 
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 Determination of plasma progesterone concentrations 
 Equine blood samples 
Progesterone (P4) concentrations in peripheral blood plasma were measured by mini VIDAS® 
and VIDAS® Progesterone kits, a system based on the enzyme linked fluorescent assay (ELFA) 
technique. A detection limit of 0.25 ng/ml and a correlation coefficient of 0.89 related to 
radioimmunoassay (RIA) are certified for the assay by the manufacturer. The measurements 
were performed by Dr. vet. med.  M. Merkl for equine blood samples and procedures can be 
read in the dissertation of Dr. vet. med. M. Merkl. 
 Porcine blood samples 
For porcine blood samples the progesterone concentrations in peripheral blood plasma were 
measured with a system based on a sensitive enzyme immunoassay (EIA) for progesterone 
determination in unextracted bovine plasma using the secondary antibody technique (Prakash 
et al., 1987). The analysis was run in the laboratory of Prof. Susanne E. Ulbrich for porcine 
blood samples. 
 Quantitative Stereology 
For qualitative histological and quantitative stereological analyses, formalin-fixed slices of each 
biopsy samples were embedded in paraffin with their right cut surface facing downwards. 
Histological sections were cut at a nominal thickness of 3 μm with a rotary microtome, 
transferred onto glass slides and stained with hematoxylin & eosin (H&E). H&E stain is a very 
popular staining method in histology that tinges different structures in histological slices. It is 
divided into two single stain reactions: Hemalaun and eosin staining. Haematoxylin is a natural 
dye of the Logwood (Haematoxylum campechianum) and has to be concentrated to Haemalaun 
to develop its staining character. Haemalaun dyes acidic respectively basophile structures blue 
especially the nucleus with its DNA and the rough endoplasmic reticulum (rER) with its 
ribosomes. The second stain reaction is performed with Eosin, which is a synthetic dye that 
colors acidophilic respectively alkaline structures red, for example cell plasma proteins. 
Quantitative stereological analyses were carried out with the newCAST™ software.  
 H&E–Staining protocol 
Formalin–fixed slices had to be arranged in the same orientated direction during the cutting 
process with the microtome. The slices were put in an incubator at 37 ° C over night. To dissolve 
paraffin from tissue, the slices were transferred in xylene for 20 min. For removing of extra 
staining, the slices were processed through a descending alcohol line–up starting from 96 % to 
70 % of concentrated ethanol. Then the slices were washed in water and stained for 5 min. in 
Mayer’s Hemalaun. Afterwards, the slices were rinsed in the tap for 2 – 3 min. Before the 
second staining with Eosin–Phloxin the slices were put in an acidic alcohol solution (1%) for a 
couple of minutes. Acidic alcohol is used as differentiation solution in histology and cytology 
to remove excess stain and define nuclei. Adjacent eosin staining lasted until lightly tinged. 
Then, the slices were put through an ascending alcohol line–up starting from 70 % to 96 % of 
concentrated ethanol and afterwards put in distilled water for 5 min. The slices were dried out 
and covered with glass cover slips using Histofluid. 
 Tissue composition 
Slides were displayed on a monitor at a 400 x final magnification by a camera (universal 
camera) coupled to a microscope (standard laboratory microscope) and images were 
superimposed by an adjustable point counting grid. Approximately 2000 points were evaluated 
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per biopsy sample to determine volume densities of luminal epithelium (LE), glandular 
epithelium (GE), blood vessels (BV) and remaining tissue. This estimation was used to quantify 
cell and tissue morphology of all equine endometrial biopsy samples on all five days during the 
cycle. The volume densities (Vv) of the different tissue compartments were obtained by 
dividing the number of points hitting a compartment (P(compartment), e.g. points hitting blood 
vessels, P(blood vessels)) by the total number of points hitting the biopsy sample (P(sample)) 
considering the number of points in the counting grid used Vv 
(compartment/sample)=P(compartment)/P(sample)*points used in grid. 
 Isolation of total RNA 
Total RNA was isolated for microarray analysis and quantitative real-time RT-PCR (qPCR). 
For a meaningful analysis of obtained RNA expression data, it is necessary to perform isolation 
of RNA under standardized conditions. To prevent degradation of RNA by ubiquitous RNases, 
working areas were cleaned with ethanol anytime before use. Every step was performed using 
gloves and RNase-free equipment. 
All endometrial biopsy samples (25 equine samples and 90 porcine samples) were homogenized 
with Trizol–method according to the manufacturer’s instruction. TRIzol reagent contains 
phenol which dissolves hydrophobic protein areas and guanidine isothiocyanate which 
denaturates hydrophilic proteins, respectively. Afterwards, phase separation - into three 
different phases was induced by adding chloroform. The upper aqueous phase contains RNA, 
the interphase contains DNA agglutinated to denatured DNA-binding proteins (most likely 
histones) and the lower organic phase contains dissolved proteins and precipitated proteins at 
the bottom. This is a common method of total RNA extraction from cells and tissues based on 
the original publication of Chomczynski (Chomczynski et al., 2006). It takes slightly longer 
than column-based methods like RNAeasy but it has higher capacity and can yield more RNA. 
Along with lysis buffers containing chaotropic salts it is generally considered the method that 
gives the best quality of RNA with many tissue samples. In the next step the aqueous phase was 
then precipitated with isopropanol and samples were clarified with ethanol and diluted in 
RNase-free water.  
 Homogenization 
While handling TRIzol reagent, safety precautions had to be taken. According to their weight 
all samples were added to TRIzol reagent as follows: 1 ml of TRIzol per 50 to 100 mg sample 
weight. Using an applicator, the tissue sample was transferred to the reaction tube containing 
TRIzol and lysed with high-speed homogenizer for 60 s until the solution was homogenous. 
The homogenizer was cleaned and inspected for resting tissue each time of use. Cleaning was 
performed with 0.5 N NaOH solution and desalted water and the homogenizer was dried with 
a paper towel. NaOH solution destroys RNases and also RNA due to the alkaline environment. 
Samples were put on ice or stored at -20 ° C until further processing. 
 Phase separation 
Homogenized samples were thawed at RT for 10 minutes and shortly centrifuged. Chloroform 
was added for phase separation according to the volume of TRIzol used (0.2 ml CHCl3 per 1 
ml TRIzol) and the solution was mixed per hand for 15 seconds. Following incubation for 10 
min. at RT, the samples were centrifuged for 30 min. at 6 ° C and 25.000 g.  
 RNA-precipitation 
The corresponding amount of isopropanol was placed in 2 ml reaction vials (0.5 ml isopropanol-
per 1 ml TRIzol). After centrifugation the aqueous phase was transferred to the reaction vials 
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containing the appropriate amount of isopropanol and carefully mixed. The solution was 
incubated at RT for 10 min. and afterwards centrifuged for at least 30 min. with 25.000 g at 6 ° 
C. The supernatant was discarded. One ml of 75 % ethanol were added per 1 ml of original 
volume of TRIzol and centrifuged for 15 min. with 25.000 g at 6 ° C. Again the supernatant 
was discarded. After short centrifugation the remaining 75 %-EtOH was removed. The pellets 
were dried in the opened reaction vials close to the flame (Bunsen burner) and 100 µl of 
nuclease-free water was added for dissolving the purified RNA. The solution was put on ice for 
at least 30 min. Afterwards the samples were heated in a water bath at 58 ° C for 10 min and 
put back on ice. To remove any remaining contaminants from the Trizol isolation, an additional 
precipitation with sodium acetate (NaOAc) and isopropanol was performed. Therefore, 1 
volume of isopropanol and 1/10 volume of NaOAc (3M) were added to the RNA solution and 
incubated at RT for 10 min. The samples were centrifuged at 6 ° C and 25.000 g for another 10 
min. Then 500 µl 75 % EtOH were added to the pellet and again centrifuged at 6 ° C for 10 min 
with 25.000 g. The supernatant was decanted and the pellets were dried at flame. Afterwards, 
the pellets are dissolved in 100 µl water and put on ice for at least 30 min. Then the samples 
were heated for 10 min. at 58 ° C in a thermomixer and afterwards put back on ice.  
 Pooling of RNA isolated from porcine endometrial tissue samples 
Isolated RNA samples were pooled together; every three (front-middle-back) samples of the 
left uterine tube of one animal in the same amount of RNA. Concentration (ng/μl) was measured 
as described in 2.5.5. The three samples were added to a total volume proportional to RNA 
volume: 2 μl of the sample with lowest RNA concentration were put in an reaction tube as 
major component while the volume of remaining two RNA samples were calculated. Due to 
divergent P4 concentrations six animals have been excluded for further processing. 
Equation II-1: Volume of RNA isolated from procine tissue needed for pooling. If the volume was lower than 1 
μl, volumes were multiplied by factor 2 for accurate pipetting and total volume needed for further processing.  
Sample 
ID1 
Conc. 
RNA 
[ng/μl]2 
Volume 
RNA [μl]3 
Total 
Volume 
[μl]4 
Sample 
ID1 
Conc. 
RNA 
[ng/μl]2 
Volume 
RNA 
[μl]3 
Total 
Volume 
[μl]4 
D0S19-f 2166 0.4  D6S17-f 2147 1  
D0S19-m 725 1.1  D6S17-m 1406 1.5  
D0S19-b 402 2 3.5 D6S17-b 1069 2 4.5 
D0S20-f 1025 1.6 
 
D6S18-f 2048 0.9  
D0S20-m 990 1.6 
 
D6S18-m 1772 2  
D0S20-b 804 2 5.2 D6S18-b 2459 0.7 3.6 
D0S21-f 1139 2 
 
D12S2-f 1518 1.1  
D0S21-m 1318 1.7 
 
D12S2-m 1049 1.6  
D0S21-b 1171 1.9 5.7 D12S2-b 840 2 4.7 
D0S22-f 1202 2 
 
D12S3-f 879 2  
D0S22-m 1871 1.3 
 
D12S3-m 988 1.8  
D0S22-b 1839 1.3 4.6 D12S3-b 1221 1.4 5.2 
D0S24-f 629 2 
 
D12S5-f 1597 1.3  
D0S24-m 1499 0.8 
 
D12S5-m 1204 1.7  
D0S24-b 910 1.4 4.2 D12S5-b 1030 2 5 
D3S7-f 1471 2 
 
D12S6-f 1199 2  
D3S7-m 2614 1.1 
 
D12S6-m 1492 1.6  
concentration of main sample (ng/μl) = volume rate 
concentration of remaining sample (ng/μl) (same amount as μl added to tube) 
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D3S7-b 1465 2 5.1 D12S6-b 1455 1.6 5.3 
D3S8-f 1299 1.9 
 
D18S25-f 418 1.3  
D3S8-m 1258 2 
 
D18S25- 537 1  
D3S8-b 1251 2 5.9 D18S25-b 280 2 4.4 
D3S10-f 1140 2 
 
D18S26-f 639 2  
D3S10-m 1893 1.2 
 
D18S26- 713 1.8  
D3S10-b 1587 1.4 4.6 D18S26-b 701 1.8 5.6 
D3S12-f 1885 2 
 
D18S27-f 843 1.9  
D3S12-m 2191 1.7 
 
D18S27- 813 2  
D3S12-b 2467 1.5 5.2 D18S27-b 870 1.9 5.8 
D6S14-f 1574 1.3  D18S28-f 653 1  
D6S14-m 1021 2  D18S28- 341 2  
D6S14-b 1701 1.2 4.5 D18S28-b 348 2 5 
D6S15-f 1381 1.6 
 
D18S29-f 375 2  
D6S15-m 1444 1.6 
 
D18S29- 2063 0.4  
D6S15-b 1129 2 5.2 D18S29-b 718 1 3.4 
D6S16-f 1314 1.1 
 
D18S30-f 1184 0.7  
D6S16-m 724 2 
 
D18S30- 832 1  
D6S16-b 1364 1.1 4.2 D18S30-b 418 2 3.7 
Table II-VII: Concentrations and pooling of RNA isolated from remaining 72 porcine tissue samples.1 Sample 
identifier: D-day, S-sow, f-front, m-middle, b-back, 2 concentration meassured with Nanodrop 1000 UV-VIS, 3 
calculated volume of RNA pooled together 4 total volume of all porcine RNA samples.  
 Spectrophotometrical analysis of nucleic acids 
Quantity and purity of nucleic acids were measured with a NanoDrop 1000 UV-VIS 
Spectrophotometer and applicable Software (V3.7.1). The spectrophotometer measures the 
optical density of aqueous RNA/DNA solutions which can be influenced through attenuation, 
wavelength, chaotropic salts, phenol and proteins. Measurements are performed at different 
wavelength. Measurement at 260 nm is used for estimation of nucleic acid concentration (for 
RNA 1 OD= 40 ng/μl per 10 mm light path, for DNA 50 ng/μl). Two ratios of OD values are 
used for analysis of purity: 230/260-nm and 260/280-nm ratio. The 230/260 ratio indicates the 
presence of contaminants like chaotropic salts if lower than 2.1. Ratio 260/280-nm indicates 
contamination of RNA samples with DNA, proteins and phenol or of DNA samples with RNA, 
proteins and phenol, respectively. The 260/280-nm ratio for pure RNA is 2.0 and for DNA 1.8 
(at neutral pH). Before initializing the instrument, the sample loading area was cleaned with 
nuclease-free water. Once the instrument was initialized, a sample type (using the drop down 
menu) was selected. Afterwards, the instrument was blanked with the reference solution (TE–
buffer or nuclease-free water).  
2.5.5.1. RNA 
The sample loading area was cleaned each time between measurements with a laboratory wipe. 
1.5 μl of the RNA sample were measured each time. A baseline being flat at 0 is requested. If 
the baseline deviates from 0 and is not a flat horizontal line any longer, the instrument has to 
be reblanked with nuclease-free water and then the sample can be measured again. The software 
provides different menus for RNA analysis: ‘Nucleic acid’ (for concentration of total RNA) 
and ‘Microarray’ (for analysis of fluorescently labeled cRNA to determine the μg cRNA yield 
and Cyanine 3 dye concentration to determine label incorporation).  
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2.5.5.2. DNA 
Nucleic acid (ss-DNA) was used to measure the concentration of oligonucleotides (PCR 
primer) used for quantitative real- time PCR (qPCR). Due to the short nucleic sequences of 
oligonucleotides, the difference in weight between pyrimidine (thymine and cytosine) and 
purine (guanine and amine) bases must be considered. Therefore Dr. H. Blum developed a 
procedure by which at first only 85 % of recommended water volume by the company were 
added. The samples were then mixed on a vortexer and incubated for at least 24 hours in the 
fridge. Afterwards, the oligonucleotides were measured with a NanoDrop 1000 UV-VIS 
Spectrophotometer and applicable Software (V3.7.1). Considering the optical density, 
molecular weight and concentration (calculation by Dr. H. Blum) the volume of water to have 
a final concentration of 100 pmol/μl was added.  
 Microfluidics-based electrophoresis for sizing, quantification and quality 
control of nucleic acids 
Quality and quantity (DNA fragments) of total RNA and DNA was determined 
electrophoretically with an Agilent 2100 Bioanalyzer. 
2.5.6.1. Analysis of RNA samples 
Agilent RNA kits are designed for the analysis of total RNA (eukaryotic and prokaryotic) and 
mRNA samples. RNA samples are analyzed by using electrophoretic separation on micro-
fabricated fluidic chips and subsequently detected via laser-induced fluorescence measurement. 
RNA degradation is a gradual process reflected by a decrease in the 28S to 18S ribosomal RNA 
ratio and an increase in the baseline signal between the two ribosomal RNA peaks and the lower 
marker. The Bioanalyzer software automatically calculates the ratio of the 28S to 18S ribosomal 
RNA. Although ribosomal RNA ratios can be used for determining the level of sample 
degradation in gel electrophoresis, a more sophisticated analysis is performed by the Agilent 
2100 Bioanalyzer software to more accurately described sample integrity. The RNA integrity 
number (RIN) provided by the Bioanalyzer software is based on a combination of different 
features that contribute information about RNA integrity to provide a more robust universal 
measure (see www.agilent.de). The integrity number follows a numeric range from 1 to 10 with 
10 for optimal RNA integrity and 1 for complete degradation. Additionally, the Bioanalyzer 
2100 estimates the RNA concentration. The complete RNA 6000 Nano kit guide can be found 
in the online help of the 2100 expert software. Samples were diluted to a final concentration of 
250 ng/µl for best results. The RNA analysis was run according to the manufacturer’s 
instructions.  
2.5.6.2. Analysis of DNA samples 
For comparative quantitative real-time RT-PCR (qPCR) it is important to confirm that the PCR 
produced specific DNA fragments. Confirmation was performed in two steps i) analysis of PCR 
product size(s) and ii) sequence analysis. The Agilent 2100 Bioanalyzer DNA 1000 kit was 
used to get high resolution (down to 5 bp) over the entire size range of the obtained qPCR 
products. Furthermore, the analysis with the Agilent 2100 Bioanalyzer DNA 1000 assay 
provides accurate quantification of the DNA fragments amplified in the qPCR reactions that 
was needed for subsequent sequence analysis of the products. The analysis of the PCR products 
was performed according to the manufacturer’s instructions. 
 Agarose gel electrophoresis 
Agarose gel electrophoresis was also used to analyze nucleic acids according to their molecular 
weight. The nucleic acids, which are stained with ethidium bromide, are exposed to ultraviolet 
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light. According to fluorescence intensities, brightness of the fragments and comparison to the 
ladder, quantity and size of DNA fragments are determined. This method is less expensive than 
analyzing DNA with a Bioanalyzer but needs far more time effort. Agarose gel electrophoresis 
was used to analyze qPCR products derived from test series, which was performed to find 
optimal annealing temperatures for obtaining PCR products. A “small DNA” agarose was used 
(2 %/1x TBE) for PCR products with a size of 100–200 bp. One gram of “small DNA” agarose 
was added to 45 ml of H20 in an Erlenmeyer flask and dissolved by heating in a microwave. 
Evaporated water was refilled. With a magnetic stir bar (added before heating) on top of a 
magnetic stirrer, the agarose solution was mixed during cool-down below 50°C. In the 
meantime, 250 ml running buffer were prepared: 225 ml H2O + 25 ml 10 x TBE/EtBr. Five 
milliliter of the EtBr/TBE (2 x) were added to the agarose and spilled on the gel chamber (setup 
with inserted comb). The gel rested until it was hardened (3 x polymerization time). Meanwhile, 
the samples were prepared: 2 µl sample +1.3 µl 2.5 x HSE buffer. The samples were gently 
mixed on a vortexter. Four µl of DNA low ladder (N3233) (1:10 dilution, 50 ng/µl) and 2 µl of 
prepared samples were put on the gel. At first, a field strength of 3 V/cm was applied which 
lasted for 10 min. and was then changed to 5 V/cm for the remaining 1.5 h. Afterwards the gel 
was put into the INTAS PCI–Gel–Imager and exposed with 254 nm ultraviolet light. The 
fluorescence was recorded by a digital camera.  
 Agilent microarray analysis 
DNA microarrays simultaneously measure the expression of thousands of genes. They are 
produced on glass slides or other substrates and contain DNA sequences (e.g. cDNA fragments 
produced by PCR, short or long oligonucleotides) spotted or synthesized in situ on the surface 
in a known order. The probe features are placed on the slide surface with robotic arms or built 
one base at a time with photolithographic or other synthesis technologies. In case of Agilent 
microarrays, 60 nt oligonucleotide probes are synthesized in situ using a technology similar to 
inkjet printing. Nucleotides are specifically printed to defined positions corresponding to the 
microarray design and incorporated into the growing oligonucleotide sequence by the use of 
highly efficient coupling reagents. Each oligonucleotide sequence is assigned a so-called ‘Probe 
ID’ whose identity and location is stored in an annotation file provided by the company (Agilent 
Technologies, Germany). The microarray slides used in this study were 4x44k Horse Genome 
arrays (252132210082, 252132210083, 252132210084, 252132210085, 252132210088, 
252132210089, 252132210102) and 4x44k Porcine Genome arrays (252644010216, 
252644010217, 252644010218, 252644010219, 252644010220, 252644010221) with 4 array 
areas on each slide with 44,000 probes, respectively. In order to control labeling efficiency and 
detection sensitivity, probes designed against different mRNA spike-in control transcripts are 
replicated 30 times on the microarray. Furthermore, probes were included that were present 10 
times on the array to allow intra-array reproducibility. Isolated RNA has to be converted into 
fluorescently labeled cRNA which can then hybridize to the respective complementary probes. 
For detection of hybridized cRNAs, the cRNA was labeled with cyanine 3 (Cy3), a widely used 
fluorescent marker. 
2.5.8.1. Agilent Quick Amp Labeling Kit, one-color 
The microarray analysis was run according to the manufacturer’s instructions. The first step 
was to prepare the Agilent One-Color Spike in Mix provided by the company and the RNA 
samples. As starting material for the labeling reaction, 500 ng total RNA were prepared in 5.3 
μl RNAse-free water. 
II - MATERIALS AND METHODS 
24 
2.5.8.2. Agilent Low RNA Input Quick Amp Labeling Kit, one-color 
At first the Agilent One-Color Spike in Mix and the RNA samples were prepared for labeling 
reaction as provided by the company. Therefore 100 ng total RNA was diluted in 2.5 μl RNAse-
free water.  
2.5.8.3. cDNA synthesis 
In the first step the RNA is reverse transcribed into double-stranded cDNA using a modified 
reverse transcriptase (Moloney Murine Leukemia Virus Reverse Transcriptase, M-MLV RT), 
an RNA-dependent DNA polymerase which needs a primer to start the cDNA synthesis. A T7 
promoter primer was added to the total RNA samples. M-MLV RT is the preferred reverse 
transcriptase for long mRNA templates because the RNase H activity of M-MLV RT is weaker 
than the commonly used Avian Myeloblastosis Virus (AMV) reverse transcriptase. RNase H 
separates the DNA-RNA hybrid in a hydrolytic manner through a metallic ion. It is also 
responsible for the removing of RNA primers and therefore allows the completion of the 
synthesized dsDNA. Dithiothreitol (DTT) is applied to renaturate wrongly folded proteins. 
RNase–out inhibits degradation via RNases in this step. 
2.5.8.4. Production of Cy3-labelled cRNA  
The synthesis of the labelled cRNA is carried out using a T7 RNA polymerase. The polymerase 
synthesizes the cRNA starting at the T7 promoter sequence which was introduced with the T7 
promoter primer during cDNA synthesis. In this step the Cyanine3–labelled CTP is 
incorporated. Since the reaction is, in principle, a so-called run-off transcription, the RNA 
polymerase can bind multiple times to the promoter and synthesize multiple cRNA copies from 
one cDNA template facilitating up to 1000-fold amplification of the original template mRNA. 
For example, in case of 100 ng total RNA as starting material, at least 3 µg cRNA are produced 
from 3 ng polyA+ RNA (approx. 3% of total RNA). After amplification, the purification of 
cRNA was carried out with Qiagen RNeasy kit. The columns contain a silica gel membrane, 
which preferentially binds the RNA. After the last centrifugation step the purified cRNA is 
eluted with 30 µl of nuclease–free water and put on ice. For quantifying the cRNA, samples 
were measured with the Nanodrop 1000 (program ‘Microarray’) and specific activity (label 
incorporation) and yield of cRNA were calculated (Equation II-2). 
cRNA yield: 
(Concentration of cRNA (ng/μl)) * 30 μl (elution volume) / 1000 = μg of cRNA. 
Specific activity: 
(Concentration of Cy3) / (Concentration of cRNA) * 1000 = pmol Cy3 per μg cRNA           
Equation II-2: Calculation of cRNA yield and specific activity. Cy3-Cyanine 3 
For the ‘Agilent Quick Amp Labeling Kit, one-color ‘ the company suggests that if the cRNA 
yield is less than 1.65 μg and the specific activity less than 9.0 pmol Cy3 per μg cRNA the 
preparation should better be repeated. To continue to hybridization process the company 
suggest by using the ‘Agilent Low RNA Input Quick Amp Labeling Kit, one-color’ the cRNA 
yield should be no lesser than 1.65 µg and the specific activity no lesser than 6.0 pmol Cy3 per 
μg cRNA.  
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2.5.8.5. Hybridization to microarrays 
Each gene transcript is represented on the slide by one or more single-stranded oligonucleotides. 
The labeled cRNA can bind to complementary probes via hydrogen bonds building a double 
helix. To optimize the kinetics of hybridization the cRNA strands have to be fragmented. In 
order to do so Blocking and Fragmentation buffer were added to each sample and the samples 
were then incubated for 30 min. at 6°C. The fragmentation process was stopped utilizing the 
provided Hybridization buffer. The hybridization processes are demonstrated in Figure II-1. 
The samples were then immediately loaded onto the gasket slides located in the hybridization 
chamber. Subsequently the microarray slides were placed on top of the gasket slides forming a 
’Sandwich’ and the hybridization chambers were carefully screwed according to the 
manufacturer’s instructions. The hybridization assemblies were put into the hybridization oven 
and incubated at 65°C and 10 rpm for 17 hours. Before starting the washing process, Triton X-
102 (0.005 %) detergent was added to the wash buffers provided by the company. Triton X-
102 effectively removes background artifacts without affecting the stringency of the wash 
buffers (cited from agilent.com). Unhybridized cRNA strands were washed off carrying out 
‘washing procedures’ as described in ‘Agilent microarray hybridization chamber user guide’ 
and ‘Agilent protocol’ (controlling temperature within preheated W2 buffer-step, stabilization 
and drying solution not used).  
Figure II-1: Schematical illustration of microarray hybridization. Cy3-labelled cRNA is put on top of the 
oligonucleotide array (4x44k) and after hybridization process not hybridized cRNA is washed off. Microarrays are 
scanned with a 532 nm laser (green channel) for detection of Cy3-labelled probes. Graphic was established using 
CorelDraw X6 software. 
2.5.8.6. Scanning of microarrays 
The microarray scanner plays a pivotal role in the DNA microarray processing workflow and 
can profoundly affect the quality and reliability of microarray data (cited from agilent.com). 
High-throughput gene expression data from microarray experiments are collected by scanning 
the signal intensities of the corresponding spots on the array by dedicated fluorescence scanners. 
For the recent high-density microarray chips, the scanners used for imaging need to have high 
resolution lasers for dye excitation at different wavelengths and photomultiplier tubes (PMT) 
for signal detection (Schermer, 1999). The signal intensities are proportional to the amounts of 
hybridized cRNA and can be used to compare gene expression levels between different samples. 
The Agilent G2565CA Microarray Scanner features two lasers (SHG-YAG-Laser and Helium-
Neon Laser) that can measure fluorescence intensity in the green channel (Cy3-532 nm) and in 
the red channel (Cy5 633 nm). It also provides an automatic PMT gain calibration prior to each 
scan and the dynamic range is >105 for a single scan in 20 bit scan mode (see Agilent G2565CA 
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Microarray Scanner System user guide on www.agilent.com). Immediately after the washing 
process the slides were put into slide holders provided by the company for scanning process. 
Scanning was performed at 3 µm scan resolution (20 bit, single pass).  
 Data analysis for microarrays 
2.5.9.1. Feature extraction, filtering, normalization and statistical analysis 
Processing of images generated by the scanner was performed with Feature Extraction Software 
10.7.3.1 (Agilent Technologies). The computer algorithm converts the images into the 
numerical information that quantifies gene expression. At first, the identity of the position of 
the features that are arranged in a grid is found. Next, the software determines the pixels in the 
area of a feature which are part of the feature, and so their intensity will be counted towards a 
quantitative measurement of intensity at that feature. In Agilent Feature Extraction software 
this step is called ‘variable circle segmentation’ that fits a circle of variable size onto the region 
containing the feature. For determining if the feature intensity is significant compared to the 
background intensity, the ‘well-above-background’ test is processed. This test depends upon an 
estimation of background error after background subtraction which is performed via the 
calculation of a background surface fit. This is estimated by using negative control features and 
features in an intensity-range similar to the negative controls. Replicated probes were then 
leveled using ‘intra-array variations’. The resulting processed signal intensities were 
subsequently filtered in MS Excel based on the ‘Is well above background’ flag. For the equine 
dataset the filter threshold was “detected in 4 of 5 samples in at least one of the five 
experimental groups”. The filter threshold for the porcine dataset was “detection in 3 of 4, 4 of 
5 and 5 of 6 samples in at least one of the five experimental groups”, respectively. The processed 
signal intensities for the remaining features for the equine dataset were processed with the 
BioConductor package ‘vsn’ and for the porcine dataset scaled to the 75th percentile for inter-
array normalization. For both data sets, a heatmap based on pair-wise distances (BioConducter 
package ‘geneplotter’) was generated for the quality control of the datasets. Significance 
analysis was performed using the SAM function of the ‘siggenes’ package (BioConducter, 
multiclass). For equine data the false discovery rate (FDR) was 1 % and for porcine data set 
0.1%. The equine data discussed in this publication have been deposited in NCBIs Gene 
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through 
GEO Series accession number GSE39043. 
In order to improve the annotation of the probes (assignment to known horse, pig and human 
genes) BLAT and BLAST analyses were performed using Ensembl and NCBI BLAST to obtain 
equine, porcine and human (putative orthologous genes), Entrez Gene identifiers and the 
corresponding gene information. Furthermore, for equine annotation the UCSC genome 
browser was used and porcine array annotation was additionally run using Bowtie, RefSeq, 
TIGR, and UniGene databases. 
2.5.9.2. Cluster analysis and DAVID functional annotation clustering 
In order to classify the obtained differentially expressed genes (DEGs) according to their gene 
expression profile during the equine and porcine estrous cycle, clustering with the ‘Self-
organizing tree algorithm’ (SOTA, MeV 4.7.1, TM4 software site) was performed.  
The correlation of obtained DEGs from equine and porcine gene expression analysis was 
estimated using MS Excel. At first the correlation coefficient was determined (=Correl r term), 
then the test statistic (t-value) was calculated and furthermore, to develop the significance of 
results, the p-value was defined (p<0.05). 
 
II - MATERIALS AND METHODS 
27 
Correl r:    t-value:  
	r (X,Y) ∑ (x-x)(y-y)
∑ (x-x)2(y-y)2
								 ; 			t 	 ∗ 									 ; 	  ,  sample mean 
Equation II-3: Determination of significant correlated differentially expressed genes in both species. 
Based on calculated significance standards (positive and negative correlation) the resulting list 
of DEGs was then further divided according to profile clustering from SOTA analysis. 
Functional classification of the DEGs was done for each expression cluster with the ‘Functional 
annotation clustering’ tool of the Database for Annotation, Visualization, and Integrated 
Discovery (DAVID) (Dennis et al., 2003). This analysis was performed on the basis of Entrez 
Gene IDs of the putative human orthologous genes. For significance statement and graphical 
illustration pattern throughout the equine and the porcine estrous cycle, and for positive and 
negative correlation analysis, the clustering was calculated in percentage using ‘chart’ in 
database software. In addition, the list of significant positive and negative correlated genes was 
compared to the list of differentially expressed genes in bovine endometrium (list was 
established by (Mitko, 2008)) to further compare gene expression patterns between different 
species. 
 Quantitative real–time RT-PCR (qPCR) 
Amplification and simultaneous quantification of DNA was carried out by a technique called 
quantitative real-time reverse transcription polymerase chain reaction (qPCR). This method is 
based on the PCR, which is used to amplify a targeted cDNA molecule. The key feature is the 
detection of synthesized DNA as the reaction progresses in real time. The qPCR experiments 
were performed according to the StepOneTM Software V 2.1 – Protocol with SYBR Green 
reagent (SYBR Green I dye, Roche). The SYBR Green (fluorescence) reagent binds to the DNA 
whereby the fluorescence of the reagent increases. The threshold cycle (CT), which inversely 
correlates with the target mRNA concentration, was measured as the cycle number at which the 
SYBR Green fluorescence signal appeared above the background threshold. CT values of the 
target genes were normalized against the reference gene ubiquitin B (UBB). The reference gene 
was chosen based on corresponding literature and experience from previous studies. Additional 
reference genes were tested but did not show stable expression over all 5 times. All PCRs were 
performed in duplicates. 
2.5.10.1. cDNA synthesis 
The same RNA samples as for microarray analysis were used for quantitative real-time RT-
PCR (qPCR). First-strand cDNA was synthesized starting from 1 μg total RNA with the 
SprintTM RT Complete-Double Pre Primed Kit. The total RNA was diluted in a total volume of 
20 μl with distilled water and added to each well containing lyophilized reagents. The solution 
was gently mixed and put in a pre-warmed PCR-thermal cycler and incubated for 60 min. at 42 
° C. The reaction was terminated by heat inactivation at 70 ° C for 10 min. and 60 µl nuclease-
free water was added to the cDNA samples. 
2.5.10.2. Quantitative real-time PCR protocol 
The quantitative real-time PCR experiments were performed in accordance to the StepOne TM 
Software V 2.1–Protocol type comparative Ct with SYBR Green reagent for both data sets. All 
PCRs were performed in duplicates in a reaction volume of 10 µl. Nine microliter of master 
mix solution + 1 µl of sample cDNA were put into one well on a 48 well PCR plate and covered 
with film (Table II-5). The plate was then gently mixed and centrifuged with Beckman 
centrifuge. The reaction process was continued with Step One equipment as followed: thermal 
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cycler profile initial denaturation at 95 ° C for 10 min followed by 40 cycles of denaturation, 
annealing and amplification (95°C 15 s, 60°C 1 min.). Melting curve analysis was performed 
with 95 ° C 15 s, 60 ° C 1 min., 95 ° C 15 s. 
Component                 Volume [µl] for 2 reactions 
FastStart SYBR Green Master Mix (2x) (Roche) 11 
Water 8.2 
Forward Primer (10 pMol) 0.4 
Reverse Primer (10 pMol) 0.4 
Total Reaction mix Volume 20.0 
Table II-VIII: Reaction mix for qPCR.Calculation was run using StepOne TM software V2.0. 
 Analysis of qPCR datasets 
The threshold cycle (CT), which inversely correlates with the target mRNA level, was measured 
as the cycle number at which the reporter fluorescent emission appeared above the background 
threshold. CT values were normalized against the reference gene UBB. The further analysis of 
Ct–values for equine data was performed with the ‘R’ package LIMMA (linear models of 
microarray data) - a statistical analysis tool based on the F-tests. Additionally, for both datasets 
(equine and porcine), one–way ANOVA tests were run for analysis of significance (P< 0.05). 
 Analysis and purification of qPCR products 
The size and the sequence of qPCR products were analyzed to confirm the amplification of 
target gene-specific DNA fragments. A microdialysis was used to purify qPCR products from 
PCR buffer components and remaining PCR primer, salts and free nucleotides. Therefore the 
PCR products were transferred onto a specific nuclear pore membrane (pore diameter 0.025 
µm, diameter 45 mm) used as a filter. The TE buffer was diluted in a ratio of 1:4 (10 ml TE + 
30 ml H2O) with nuclease-free water and put into a petri dish. The dish was put on top of a 
magnetic stir plate with a magnetic stir bar. The membrane was marked and gently placed onto 
the diluted TE buffer. Approx. 20 µl of PCR reactions were pipetted on top of the membrane 
and left to dialyze for about 30–45 min. Afterwards the buffer was removed and samples were 
transferred from the membrane to fresh reaction vials and stored at -20 ° C until further 
processing. PCR products were analyzed with Agilent Bioanalyzer 2100 DNA 1000 Kit as 
described in 2.5.6.2. 
 „Sanger“-sequencing of purified qPCR products 
The concentrations of qPCR products were measured with an Agilent Bioanalyzer 2100 as 
described in 2.5.6.2. Three pmol primer (forward or reverse) and 3 µl of the dialyzed qPCR 
product were mixed and the reaction volume was filled up with water to a total volume of 6 μl. 
DNA sequencing was performed on a capillary sequencer (Avant 3100) by the sequencing 
service of LAFUGA Genomics.
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III. RESULTS 
 Peripheral plasma progesterone (P4) concentrations 
 Equine P4 concentrations 
Table III-1 summarizes all P4 concentrations measured in each mare. For measurement of 
plasma progesterone (P4) concentrations, blood samples were collected in different cycles 
(when the corresponding biopsy was taken), except for samples on day 0. 
Sample-
ID 
P4 concentration 
[ng/ml] 
Sample-
ID 
P4 concentration 
[ng/ml] 
Sample-
ID 
P4 concentration 
[ng/ml] 
D0M1 1.2 D8M1 23.1 D16M1 1.2 
D0M2 0.8 D8M2 30.0 D16M2 1.2 
D0M3 1.4 D8M3 23.4 D16M3 1.2 
D0M4 0.8 D8M4 21.1 D16M4 2.3 
D0M5 1.0 D8M5 14.8 D16M5 3.7 
D3M1 4.1 D12M1 11.0   
D3M2 6.3 D12M2 11.9   
D3M3 11.2 D12M3 12.3   
D3M4 5.0 D12M4 26.8   
D3M5 8.5 D12M5 14.7   
Table III-I: P4 concentration in each mare on five different times during estrous cycle.P4 concentrations in 
peripheral blood plasma were measured based on the ELFA technique. D-day, M-mare, P4-progesterone. 
Figure III-1: Equine plasma progesterone (P4) concentrations. P4 concentrations are shown as means (ng/ml-
vertical axis) with standard deviation measured in blood samples collected on each time (horizontal axis- day of 
the cycle) of biopsy collection. Diagramm was established in MS Excel. 
Altogether, P4 concentrations were low on day 16 (1.2-3.7 ng/ml), basal on day 0 (0.8-1.4 
ng/ml), rising on day 3 (4.1-11.2 ng/ml), highest on day 8 (14.8-30.0 ng/ml) and in average 
second highest on day 12 (11.0-26.8 ng/ml). Standard deviation of P4 concentrations was 
highest on days 8 and 12 (5.5 and 6.5), respectively. Results show similarity in P4 profiles 
between all mares on each times of the estrous cycle (calculated in mean) (Figure III-1). 
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 Porcine P4 concentrations 
Blood samples for measurement of plasma progesterone (P4) concentrations were collected 
from six different cycling gilts on each of the five different time points (when animals were 
slaughtered and endometrial tissue were taken) (Figure III-2 (means and standard deviation)). 
Twenty-four (labeled in grey in Table III-2) out of the 30 animals have been chosen for 
microarray analysis. For day 0 gilt number 23 (D0S23) was excluded because of two times 
higher concentrations than the remaining gilts as well as number S9 and S11 for day 3 (D3S9 
and D3S11). For day 6 gilt number 13 (D6S13) was excluded because of only half as high P4 
concentration. For day 12 gilts with the highest and lowest P4 concentrations were excluded 
(D12S21 and D12S24).  
P4 concentrations showed lowest levels on day 0 (0.2-0.3 ng/ml) which are followed by 
increasing levels on day 3 (5.0–7.6 ng/ml) and rising till day 6 (11.2-18.1 ng/ml). Highest 
concentrations were reached on day 12 (25.0-35.7 ng/ml). For the samples taken on day 18, the 
concentration levels were decreasing (2.3-15.8 ng/ml) except for sample D18S28 (42.8 ng/ml). 
Standard deviation of P4 concentrations was highest on days 12 and 18 (11.9 and 14.9). 
Table III-II: P4 concentrations in each gilt on five different times during estrous cycle. Animals highlighted in 
grey were excluded for further processing. D-day, S-sow/gilt, P4-progesterone. 
Figure III-2: Porcine plasma progesterone (P4) concentrations. Figure shows P4 concentrations for all 30 animals 
measured in blood samples as mean (ng/ml-vertical axis) taken at the time (horizontal axis-day of the cycle) of 
sample collection. Diagramm was created using MS Excel. 
 
Sample-
ID 
P4 concentration 
[ng/ml] 
Sample-
ID 
P4 concentration 
[ng/ml] 
Sample-
ID 
P4 concentration 
[ng/ml] 
D0S19 <0,2 D3S11 9.5 D12S3 34.2 
D0S20 <0,2 D3S12 6.6 D12S4 14.3 
D0S21 <0,2 D6S13 4.5 D12S5 25 
D0S22 0.3 D6S14 11.2 D12S6 28 
D0S23 0.6 D6S15 18 D18S25 2.3 
D0S24 <0,2 D6S16 11.6 D18S26 3.4 
D3S7 7 D6S17 16.8 D18S27 14.4 
D3S8 7.6 D6S18 18.1 D18S28 42.8 
D3S9 11.4 D12S1 50 D18S29 15.8 
D3S10 5 D12S2 35.7 D18S30 8.1 
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 Endometrial samples 
 Equine endometrial samples 
The volume percentage of luminal epithelium (LE), blood vessels (BV), glandular epithelium 
(GE) and the remaining tissue (Rest) was estimated in the endometrial biopsy samples using 
quantitative stereological techniques to verify similar percentages of endometrial cell types 
between biological replicates and to see if there are differences in percentages during the estrous 
cycle. The volume fractions were in a range from 0.5 % to 1.1 % for LE, from 1.4 % to 2.4 % 
for BV, from 30.1 % to 34.4 % for GE, and from 63.5 % to 68.1 % for the remaining tissue 
(Figure III-3). A trend (p=0.084) for higher volume percentage on days 12 and 16 was observed 
for GE. Standard deviations were higher for the observed proportions of LE and BV. 
Altogether, the analysis showed no statistically significant difference for all analyzed 
compartments between biological replicates and during the estrous cycle (Table III-3).  
 
Figure III-3: Quantitative stereological analysis.Quantitative stereological analysis was performed for equine 
biopsy samples collected from five mares (N=5) on five different days (horizontal axis) during the estrous cycle. 
The volume fraction of sample tissue is calculated as mean (percentage) and presented in logarithmic scale 
(vertical-axis). LE-luminal epithelium, BV-blood vessels, GE-glandular epithelium, Rest-remaining tissue. 
Diagramme was established in MS Excel. 
Sample-ID LE [%] BV [%] GE [%] Rest [%] 
D16M1 1.5 1.1 31.2 66.2 
D16M2 0.8 0.6 32.5 66.0 
D16M3 1.2 2.1 35.0 61.7 
D16M4 1.0 2.0 39.0 58.0 
D16M5 0.8 1.3 32.3 65.5 
D0M1 0.7 2.6 26.2 70.5 
D0M2 1.1 2.5 27.7 68.7 
D0M3 0.5 1.4 27.7 70.4 
D0M4 0.5 2.9 33.1 63.4 
D0M5 1.0 2.4 29.3 67.3 
D3M1 1.1 1.5 25.1 72.2 
D3M2 0.3 2.1 34.5 63.1 
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D3M3 0.9 2.3 30.2 66.6 
D3M4 1.1 0.3 33.8 64.9 
D3M5 0.8 1.9 30.8 66.5 
D8M1 0.8 2.4 27.6 69.2 
D8M2 0.3 1.2 24.9 73.7 
D8M3 1.2 2.2 33.2 63.4 
D8M4 0.3 2.2 32.6 64.9 
D8M5 0.7 2.8 32.3 64.2 
D12M1 0.2 0.6 30.4 68.8 
D12M2 1.3 1.1 33.6 64.0 
D12M3 0.2 1.2 30.5 68.1 
D12M4 0.4 2.2 40.4 57.0 
D12M5 0.5 2.3 37.2 60.0 
ANOVA1 0.204 0.132 0.084 0.260 
Table III-III: Results of quantitative stereology.LE: luminal epithelium; BV: blood vessels; GE: glandular 
epithelium; Rest: remaining tissue; %: volume percent, 1 ANOVA- Analysis of Variance of p-values.  
 Porcine endometrial samples 
The endometrium of gilts slaughtered on day 0 showed no abnormality. Eleven early CLs in 
the left ovary from gilt number S9 and S11 were found on day 3 (D3S9 and D3S11) of the 
estrous cycle. In addition, the endometrium of D3S9 was very much vascularized and the uterus 
was also very, very small. In general, the uteri of all animals on day 3 were very small (just as 
one of animals on day 6 compared to others). The uterus of D6S13 hardly showed any 
vascularization. It was suspected that the stage of D6S13 did not correspond to day 6 but seemed 
more likely to be from day 0. P4 concentration reflected this statement. Sample collection 
protocol for day 12 (D12S01-S06) showed ‘not OK’ for D12S04. The left ovary contained only 
five CL’s but very little ones figuring together like ‘raspberry-shaped’. D12S01 showed 23 
CL’s in the right and 21 CL’s in the left ovary. Therefore, the very high P4 concentration in 
D12S01 and the very low P4 concentration in D12S04 corresponded with the status of the 
ovaries. Sample collection on day 18 revealed very well developed uteri with a very gelatinous 
mucosa for animals D18S25-D18S27. Twenty-two CL’s were counted in the left ovary of 
animal D18S28 in contrast to 9 CL’s as in the remaining animals on day 18. This is in agreement 
with the almost three times higher P4 value in this animal compared to the animals D18S27 and 
D18S29. The P4 concentration was even 10 times higher than in the remaining animals on day 
18.  
 Isolation of RNA 
 Isolated RNA from equine samples 
Results of RNA isolation from all 25 equine biopsy samples showed stable values for 260/280 
ratios but a tendency to higher rates for 260/230 ratios. The RIN values showed middle based 
position ranging from 6.8 to 9.4. The RIN of sample D3M5 was the lowest with 6.80 and D3M3 
showed highest RIN value of 9.4 (Table III-4). 
Sample ID Concentration RNA [ng/µl] 260/280 nm 260/230 nm RIN 
D0M1 606 1.95 2.26 8.3 
D0M2 939 1.97 2.33 7.6 
D0M3 928 2.00 2.33 9.0 
D0M4 718 1.94 1.92 8.1 
D0M5 724 1.95 2.30 8 3 
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D3M1 1457 2.00 2.31 9.3 
D3M2 1556 1.98 2.27 8.4 
D3M3 188 1.99 2.17 8.6 
D3M4 1997 1.99 2.29 9.4 
D3M5 1717 2.00 2.20 6.8 
D8M1 1073 1.99 2.25 9.0 
D8M2 2081 1.94 2.12 8.2 
D8M3 2053 1.98 2.21 8.9 
D8M4 2133 1.98 2.15 8.9 
D8M5 1876 1.99 2.17 6.9 
D12M1 1204 1.99 2.29 8.2 
D12M2 1035 1.98 2.25 8.3 
D12M3 1446 2.00 2.25 7.1 
D12M4 1426 2.00 2.23 8.6 
D12M5 1698 1.98 2.14 8.9 
D16M1 930 1.99 2.18 8.4 
D16M2 745 1.93 2.02 7.6 
D16M3 845 1.97 2.32 8.6 
D16M4 912 1.93 2.05 8.1 
D16M5 762 1.95 2.21 7.3 
Table III-IV: Concentration, spectotrophomatrical analysis and RIN of equine RNA samples.RIN-RNA integrity 
number, D-day, M-mare. 
 Isolated RNA from porcine samples 
In average the 90 porcine samples showed stable values for 260/280 ratios but, as with the 
equine samples, a tendency to higher rates for 260/230 ratios. The RIN values showed good 
ranges (from 7.9 to 10.0) (Table III-5). 
Sample ID Concentration RNA [ng/µl] 260/280 nm 260/230 nm RIN 
D12S1-f 1258 1.94 2.33 8.6 
D12S1-m 953 1.92 2.24 9.0 
D12S1-b 1079 1.98 2.00 9.5 
D12S2-f 1518 2.04 1.88 9.7 
D12S2-m 1049 2.04 1.26 9.4 
D12S2-b 840 1.97 1.99 7.9 
D12S3-f 879 1.99 1.85 9.5 
D12S3-m 988 1.90 2.33 9.6 
D12S3-b 1221 1.92 2.3 9.5 
D12S4-f 1115 1.99 2.03 9.4 
D12S4-m 233 2.01 1.52 9.8 
D12S4-b 355 1.8 2.48 8.8 
D12S5-f 1597 2.02 1.90 10 
D12S5-m 1204 2.04 1.61 8.0 
D12S5-b 1030 2.05 1.84 9.6 
D12S6-f 1199 2.05 1.58 9.2 
D12S6-m 1492 2.02 1.76 9.2 
D12S6-b 1455 2.00 2.04 9.4 
D3S7-f 1471 1.98 2.28 10 
D3S7-m 2614 1.9 2.02 10 
D3S7-b 1465 1.97 2.17 8.0 
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D3S8-f 1299 1.97 2.11 8.1 
D3S8-m 1258 2.01 1.82 8.2 
D3S8-b 1251 1.97 1.79 8.2 
D3S9-f 2558 1.93 2.21 8.4 
D3S9-m 2268 1.94 2.19 8.3 
D3S9-b 2535 1.89 2.06 8.1 
D3S10-f 1140 1.97 1.95 10 
D3S10-m 1893 1.95 2.16 10 
D3S10-b 1587 1.98 2.06 10 
D3S11-f 1120 1.95 2.32 10 
D3S11-m 2341 1.96 2.03 10 
D3S11-b 1427 2.01 1.80 10 
D3S12-f 1885 1.97 2.13 10 
D3S12-m 2190 1.95 2.14 10 
D3S12-b 2467 1.93 2.07 10 
D6S13-f 1138 2.01 1.99 10 
D6S13-m 1118 2.02 2.21 10 
D6S13-b 748 1.98 1.22 10 
D6S14-f 1574 1.98 1.97 9.7 
D6S14-m 1021 2.06 1.94 9.6 
D6S14-b 1701 1.95 2.06 9.8 
D6S15-f 1381 2 1.86 9.6 
D6S15-m 1444 2.02 1.99 9.1 
D6S15-b 1129 2.01 1.64 9.3 
D6S16-f 1314 2 2.18 10 
D6S16-m 724 2.05 1.63 9.1 
D6S16-b 1364 2.05 1.47 9.6 
D6S17-f 2147 1.92 2.17 10 
D6S17-m 1406 1.99 1.96 10 
D6S17-b 1069 2 1.54 10 
D6S18-f 2048 1.92 2.38 8.9 
D6S18-m 1772 1.96 2.28 9.0 
D6S18-b 2459 1.91 2.11 9.2 
D0D19-f 2166 1.93 2.22 10 
D0S19-m 725 2 1.95 10 
D0S19-b 402 1.93 1.94 10 
D0D20-f 1025 1.94 1.94 9.9 
D0S20-m 989 1.98 2.13 9.7 
D0S20-b 804 2.01 1.98 9.9 
D0D21-f 1139 1.98 1.97 9.8 
D0S21-m 1318 1.94 1.98 9.8 
D0S21-b 1171 1.96 2.09 10 
D0D22-f 1202 1.94 2.05 10 
D0S22-m 1871 1.94 2.06 10 
D0S22-b 1839 1.99 2.03 10 
D0D23-f 1156 1.93 1.77 9.8 
D0S23-m 1593 1.94 2.07 9.8 
D0S23-b 2139 1.94 2.06 9.9 
D0D24-f 629 1.87 2.15 9.8 
III - RESULTS 
35 
D0S24-m 1499 1.95 1.95 9.8 
D0S24-b 910 1.97 2.05 9.7 
D18S25-f 417 1.89 2.3 9.5 
D18S25-m 537 1.99 2.77 9.5 
D18S25-b 280 1.91 1.8 9.4 
D18S26-f 639 2.04 2.67 9.4 
D18S26-m 713 1.99 2.7 9.4 
D18S26-b 701 1.99 2.6 9.2 
D18S27-f 842 1.94 2.02 9.0 
D18S27-m 813 1.92 2.54 8.9 
D18S27-b 870 1.94 2.03 9.5 
D18S28-f 653 1.93 2.62 8.9 
D18S28-m 341 1.82 2.35 8.8 
D18S28-b 348 1.8 2.37 8.5 
D18S29-f 375 1.8 2.34 8.5 
D18S29-m 2063 1.92 2.22 9.3 
D18S29-b 718 1.93 2.66 9.3 
D18S30-f 1184 1.95 2.03 9.7 
D18S30-m 832 1.95 2.04 9.8 
D18S30-b 418 1.89 1.85 9.8 
Table III-V: Concentration, spectotrophomatrical analysis and RIN of porcine RNA samples.RIN-RNA integrity 
number, D-day, S-sow, f-front, m-middle, b-back 
 Microarray data 
 Microarray analysis of equine endometrium during the estrous cycle  
The 4x44 Horse Genome microarray was run according to manufacturer’s protocol. Due to 
manufacturer’s problems with quality of some components of the labeling kit, several kits had 
to be run with different lot numbers. The cRNA samples with best Cy3 incorporation and cRNA 
yield from same endometrial samples were pooled together for best results. 
 Heatmap  
After data processing and normalization the microarray data set was initially analyzed with a 
heatmap based on pairwise distances (Figure III-4). Samples collected on day 8 as well as 
samples from day 12 clustered together in separate groups clearly distant from the samples 
collected on day 16, day 0, and day 3. Also the samples from day 0 and day 3 formed relatively 
homogeneous groups. Samples from day 16 were the most heterogeneous group, where 4 
samples clustered together and one (D16M1) was more similar to samples from day 0. 
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Figure III-4: Heatmap of pairwise distances from equine microarray data set. Pairwise distances were calculated 
based on the normalized signal intensities of the differentially expressed probes. Each column represents one 
sample and shows the distance to all samples (including itself) with red for distance = 0 and dark blue for the 
highest observed distance. Illustration was edited with CorelDraw X6 software and results have been published by 
Gebhardt and coworkers (Gebhardt et al., 2012). D-day, M-mare. 
 Clustering of similar mRNA expression profiles (MeV/SOTA)  
For identification of differentially expressed genes and estimation of the false discovery rate 
(FDR), SAM (Significance Analysis of Microarrays, (Tusher, 2001)) was used which is a part 
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of the R package Siggenes. Statistical analysis of microarray data revealed almost 10,000 
differential probes (siggenes, multiclass, FDR 1 %). These microarray probes represented 
approx. 4,996 different genes/transcripts which are listed in supplementary data. For classifying 
these genes according to their gene expression during the estrous cycle a clustering based on 
similarity in expression profiles (MeV, SOTA algorithm) was performed (Figure III-5- see next 
page). 
This mRNA expression profiling analysis revealed eight major expression profiles. In cluster 1 
(637 genes) the genes showed in average highest expression levels on day 0 and low levels 
during the luteal phase. Expression of some of these genes already increased on day 16. The 
genes in cluster 2 (582 genes) showed mRNA expression profiles with highest levels from day 
0 to day 3 and low levels from day 8 to day 16. Expression of the majority of genes in cluster 3 
(721 genes) peaked on day 3. For the genes in cluster 4 (501 genes) highest mRNA levels were 
found from day 3 to day 8. In cluster 5 (701 genes) the genes showed profiles that are similar 
to those in cluster 4 but with later increase and higher levels up to day 12. Cluster 6 (709 genes) 
displayed higher mRNA expression levels from day 8 to day 12 and lowest levels on the 
remaining days of the estrous cycle. The highest expression levels in cluster 7 (501 genes) were 
found on day 12 with a slight decrease to day 16 and lower levels on day 0, day 3 and day 8. 
Genes clustering together in in cluster 8 (644 genes) showed highest mRNA levels on day 16 
and lowest levels on day 3 and day 8.  
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Figure III-5: Clustering based on similarity in gene expression profiles during the equine estrous cycle Relative gene expression levels during the estrous cycle were obtained 
for all differentially expressed genes by calculation of mean-centered expression values (vsn-normalized value of one time point minus mean of vsn-normalized values of all 5 
time points, vsn-normalized values are in log2 scale). Self-organizing tree algorithm (SOTA) of MeV software (version 4.7.1) was used to obtain groups of genes with similar 
expression profiles. Vertical axis is in log2 scale and shows the deviation from the mean expression during the estrous cycle. Horizontal axis shows the day of the estrous cycle. 
The SOTA dendrogram (bottom right) shows the similarity between clusters and mean expression changes during the cycle. Figure was edited in CorelDraw X6 and previously 
published in Gebhardt et.al (Gebhardt et al., 2012). 
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 Functional annotation clustering  
In order to characterize molecular functions and assigned biological processes as over-
represented during different phases of the estrous cycle, functional annotation clustering 
(DAVID) was performed for the individual clusters of genes with similar expression profiles 
obtained by SOTA clustering. This analysis resulted in a relatively large number of significant 
annotation clusters of related functional terms that represented distinct over-represented 
functions/processes for different cycle stages. For graphical illustration of these processes a 
diagram based on the frequency patterns (numbers of genes on different cycle stages) during 
the cycle was plotted (Figure III-6). The selected functional categories were clustered according 
to their frequency patterns during the estrous cycle. Total results of DAVID functional 
annotation charts (Category/Term, Genes, FDR, P-values, and Enrichment score) are provided 
in supplementary data. 
 
Figure III-6: Representation of selected functional categories/terms during the equine estrous cycle. Functional 
terms over-represented during distinct phases of the estrous cycle were selected from DAVID functional 
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annotation clustering analysis. Numbers of genes assigned to these functional terms (in rows) are shown for each 
SOTA cluster (in columns) as percentage of the number of all differentially expressed genes assigned to a term 
(white = 0 %; black = 50 %). SOTA cluster with highest RNA expression: 1- on day 0, 2-from day 0 to day 3, 3- 
on day 3, 4-from day 3 to day 8, 5- on day 8, 6- from day 8 to day 12, 7-from day 12 to day 16 and 8- on day 16. 
Graphic was edited using CorelDraw X6 software. 
In Figure III-6 the genes in Cluster 1 (highest mRNA expression levels on day 0) represented 
processes related to functional categories like ‘collagens’, ‘extracellular matrix (ECM)’, ‘focal 
adhesion’ and ‘translational elongation’. Highest numbers of genes were found for Cluster 2 
(genes with highest expression levels from day 0 to day 3) as related to the categories 
‘translational elongation’ and ‘ribosome’. Specifically for cluster 3 (highest expression levels 
on day 3), categories related to ‘cell cycle’, ‘mitosis’, and ‘chromosome’ were highly 
overrepresented and showed highest numbers of genes. The category ‘protein disulfide 
isomerase activity’ showed a likewise distinctive pattern and was represented only in SOTA 
Clusters 4 and 5 (3 and 4 genes, respectively). Cluster 4 represents genes with highest 
expression from day 3 to day 8 and Cluster 5 genes with highest mRNA expression on day 8. 
Cluster 6 represented genes with highest mRNA levels from day 8 to day 12. Functions and 
processes, such as metabolic processes (lipids, fatty acid, glucose), secretory processes 
(vesicles, endoplasmic reticulum, Golgi) and cell junctions showed numerous genes with 
highest mRNA expression during the luteal phase (SOTA clusters 4, 5 and 6). Furthermore, the 
analysis of Cluster 7 (highest mRNA expression from day 12 to day 16) revealed 
overrepresentation of categories like’ focal adhesion’. Cluster 8 (highest mRNA levels on day 
16) showed over-representation for the functional terms ‘immune response’, ‘complement 
activation, classical pathways’, ‘collagens’ and ‘regulation of cell growth’. Some functional 
categories showed a kind of biphasic pattern of their representation during the estrous cycle, 
such as ‘angiogenesis’ and ‘blood circulation’ with highest numbers of genes during estrus (on 
day 0) and during the luteal phase, respectively.  
 Genes involved in prostaglandin metabolism and signaling and in steroid 
hormone signaling 
Genes involved in prostaglandin metabolism and signaling and in progesterone and estrogen 
signaling play an important regulatory role during the estrous cycle. Related genes were 
obtained from corresponding Gene Ontology categories (www.geneontology.org), a search in 
the Entrez Gene database (www.ncbi.nlm.nih.gov/gene) and in the literature, respectively. For 
steroid hormone signaling, only selected genes were used, e.g. classical and non-classical 
hormone receptors and related receptors and some genes encoding steroid hormone metabolic 
enzymes. Relative expression values of DEGs matching this candidate list were subjected to 
hierarchical clustering for gene expression during the estrous cycle in equine endometrium for 
a cluster analysis (Figure III-7). 
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Figure III-7: Heatmap of genes related to prostaglandin metabolism and signaling and to steroid hormone 
signaling. Figure shows hierarchical clustering of gene expression during the estrous cycle in equine endometrium 
(MeV software, version 4.9.0). Color scale is from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold 
higher (log2-fold=2) than the mean (red). Graphic was edited using CorelDraw X6 software. 
These genes showed a variety of distinct expression profiles during the cycle. Estrogen-related 
receptor alpha (ESRRA) and gamma (ESRRG) mRNAs showed completely different expression 
changes during the cycle compared to the classical nuclear receptors, so did progesterone 
receptor membrane component 1 (PGRMC1). In contrast, Estrogen receptor 1 mRNA (ESR1) 
showed a very similar profile to G protein-coupled estrogen receptor 1 mRNA (GPER) with 
highest levels on day 3 and lowest on day 12, whereas progesterone receptor mRNA (PGR) had 
highest expression on day 0 decreasing to day 12. Messenger RNA levels of prostaglandin E 
synthases (PTGES, PTGES2, PTGES3) were in average highest during the luteal phase whereas 
PGE receptor mRNAs (PTGER2, PTGER3, PTGER4) showed completely different expression 
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profiles. Most of the genes involved in arachidonic acid metabolism had their highest mRNA 
levels at estrus. Prostaglandin D2 synthase 21kDa (PTGDS) mRNA showed highest levels on 
day 0 and on day 3. Additionally, oxytocin, prepropeptide (OXT) mRNA showed highest 
expression on day 0 and lowest on day 16. Interestingly, hydroxyprostaglandin dehydrogenase 
15- (NAD) (HPGD) which is known to metabolize prostaglandins was also regulated during 
the estrous cycle with highest levels on day 3 and on day 0. Some of the results have been 
published by Gebhardt and coworkers (Gebhardt et al., 2012). 
 Genes related to ‘regulation of apoptosis’ 
A manageable number of genes related to the regulation of apoptotic functions were found as 
over-represented (18 genes in total) whereof one third was up-regulated during estrus phase 
(baculoviral IAP repeat containing 3, BIRC3, caspase 7, apoptosis-related cysteine peptidase 
CASP7, interleukin 1 receptor, type I, IL1R1, interferon regulatory factor 1, IRF1, mitogen-
activated protein kinase kinase kinase 14, MAP3K14, and phorbol-12-myristate-13-acetate-
induced protein 1, PMAIP1), three genes showed highest mRNA expression during early luteal 
phase (cytochrome c, somatic, CYCS, endonuclease G, ENDOG, and helicase, lymphoid 
specific, HELLS) and the remaining genes were up-regulated during the luteal phase (BCL2-
like 1, BCL2L1, BCL2/adenovirus E1B interacting protein 3-like, BNIP3L, granzyme B 
(granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1), GZMB, insulin-like growth 
factor 1 receptor, IGF1R, interleukin-1 receptor-associated kinase 4 and 2, IRAK4/2, 
myelocytomatosis oncogene, MYC, and TNFRSF1A-associated via death domain, TRADD). 
For apoptosis signaling, candidate genes were found using www.wikipathways.com and 
compared to the list of DEGs found in equine endometrium (Table III-8).  
 
Figure III-8: Heatmap of expression profiles for genes related to 'regulation of apoptosis'. Relative expression 
values of differentially expressed genes matching the apoptosis candidate list were subjected to hierarchical 
clustering for gene expression during the estrous cycle in equine endometrium (MeV software, version 4.9.0). 
Color scale is from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold higher (log2-fold=2) than the mean 
(red). Graphic was edited using CorelDraw X6 software. 
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 Genes related to angiogenesis, blood circulation and vasculature development  
The functional categories ‘angiogenesis’, ‘blood circulation’ and ‘vasculature development’ 
found as over-represented during the estrous cycle were obtained from corresponding Gene 
Ontology categories, search in Entrez Gene, WikiPathways, KEGG database and in literature. 
Relative expression values of differentially expressed genes matching this candidate list were 
subjected to hierarchical clustering for gene expression during the estrous cycle in equine 
endometrium (Figure III-9).  
 
Figure III-9: Graphical illustration of mRNA expression profiles of genes related to ‘angiogenesis’, ‘blood 
circulation’ and ’vasculature development’. Heatmap was established using MeV software (V 4.9.0). Color scale 
is from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold higher (log2-fold=2) than the mean (red). 
Graphic was edited using CorelDraw X6 software.  
Most of the genes showed up-regulation during the estrus phase (17 out of 24 genes). 
Angiopoietin-like 6 (ANGPTL6) showed highest expression on day 3 and on day 8. During 
luteal phase 6 genes were up-regulated. Two of these genes (mitogen-activated protein kinase 
2, MAP2K2 and nitric oxide synthase 3, NOS3) showed already up-regulation on day 3, highest 
expression on day 8 and slightly expression on day 12. Angiotensin I converting enzyme (ACE) 
and endothelial PAS domain protein 1 (EPAS1) were up-regulated on day 8 and on day 12.
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 Microarray analysis of porcine endometrium during the estrous cycle  
 Heatmap 
The normalized dataset (differentially expressed genes from Significance analysis of 
microarrays (SAM)) was used for calculation of pairwise distances and drawing a heatmap 
(Figure III-10). The heatmap clearly demonstrates a homogenous group clustering of samples 
collected on day 0, day 3, day 6 and day 12. Samples collected on day 18 were clearly more 
heterogenous with two samples (D18S25 and D18S26)  separated from the other 4 samples in 
this group.  
 
Figure III-10: Heatmap of pairwise distances from porcine microarray data set. One sample is represented by one 
column that demonstrates the distance to all samples (including itself) with red for distance = 0 and dark blue for 
the highest observed distance. Illustration was edited with CorelDraw X6 software. D-day, S-sow. 
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 Clustering of similar mRNA expression profiles (MeV/SOTA) 
For the identification of differentially expressed genes, the data set was analyzed using the same 
bioinformatics tools as for the equine data set. The microarray probes represented 9,275 
different genes/transcripts as listed in supplementary data. A cluster analysis based on 
similarities in gene expression during the estrous cycle was performed using corresponding 
software (MeV, SOTA algorithm) (Figure III-11-see next page). 
Eight major expression profiles have been established. The first Cluster (1244 genes) shows 
mRNAs with highest levels at estrus (day 0) and very low levels during metestrus, diestrus and 
preestrus. In the second Cluster (849 genes) highest mRNA expression levels were observed in 
the phase from day 0 to day 3. Cluster 3 (897 genes) contained genes with highest mRNA 
expression on day 3 with increased levels on day 0 and lowest expression levels during late 
luteal phase. Messenger RNA levels in Cluster 4 (3163 genes) showed highest number of genes 
in total. In this Cluster, levels started to decrease on day 12 and were lowest on day 18 and day 
0. The highest mRNA levels in Cluster 5 (421 genes) spanned from day 6 to day 12 with low 
increase on day 18 and showed low levels on day 0 and day 3. In Cluster 6 (448 genes) mRNA 
expression profiles showed highest levels on day 12 and minor levels on day 6 and day 18. 
Messenger RNA levels in Cluster 7 (421 genes) were higher from day 12 to day 18 and showed 
lowest expression during estrus (day 0). The last Cluster (Cluster 8) contained 1109 genes. 
Their mRNA levels were very low on day 6 and showed highest expression from day 18 to day 
0.  
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Figure III-11: Clustering of genes with similar gene expression profiles in porcine endometrium during the estrous cycle. Calculation of mean centered expression values 
(normalized value of one time point minus mean of normalized values of all 5 time points) revealed relative gene expression levels during the estrous cycle for the differentially 
expressed genes. MeV software (SOTA version 4.8.1) was used to obtain clusters of genes with similar expression profiles. The SOTA dendrogram (bottom right) shows the 
similarity between clusters and mean expression changes. Vertical axis is in log2 scale and shows the deviation from the mean expression during the estrous cycle. Horizontal 
axis shows the day of the estrous cycle. Graphic was edited with CorelDraw X6 software. 
Day      0          3          6           12           18         0      Cluster 
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 Functional annotation clustering 
The characterization of molecular functions and biological processes over-represented during 
different phases of the porcine estrous cycle was performed using functional annotation 
clustering (DAVID) for the clusters of genes with similar expression profiles that were obtained 
by SOTA clustering. The results revealed numerous significant annotation clusters of related 
functional categories representing distinct over-represented processes on different times during 
the cycle (Figure III-12-see next page).  
In Clusters 1 and 2 (highest levels on day 0 and from day 0 to day 3) processes related to 
‘collagens’, ‘immune response’ and ‘cell adhesion’ were highly over-represented. In addition, 
genes assigned to the category ‘angiogenesis’ and ‘vasculature’ were over-represented in 
cluster 1. This category, interestingly, showed three peaks in numbers of genes during the cycle: 
on day 0, from day 3 to day 6 and from day 12 to day 18. Specifically for Cluster 3 (highest 
expression levels on day 3) categories related to ‘mitosis’, ‘cell cycle’ and ‘chromosome’ 
showed highest numbers of genes. Functions and processes, such as metabolic processes (lipids, 
fatty acid, glucose), secretory processes (vesicles, endoplasmic reticulum, Golgi apparatus) and 
cell junctions showed numerous genes with highest mRNA expression during early luteal phase 
(SOTA cluster 4, highest level from day 3 to day 6). ‘Lipid metabolism’ was over-represented 
in cluster 5 (highest mRNA expression from day 6 to day 12) and with the second highest 
number of genes in Cluster 6 (highest level on day 12). For Cluster 8 (representing genes with 
highest expression on day 18) genes assigned to categories such as ‘collagens’, and ’immune 
response’ were over-represented (see supplementary data). 
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Figure III-12: Heatmap with selected functional categories/terms during the porcine estrous cycle. Functional 
terms over-represented during distinct phases of the estrous cycle were selected from DAVID functional 
annotation clustering analysis. Numbers of genes assigned to these functional terms (in rows) are shown for each 
SOTA cluster (in columns) as percentage of the number of all differentially expressed genes assigned to a term 
(white = 0 %; black = 50 %). SOTA-Cluster with highest gene expression: 1- on day 0, 2-from day 0 to day 3, 3- 
on day 3, 4-from day 3 to day 6, 5- from day 6 to day 12, 6- on day 12, 7-from day 12 to day 18 and 8- on day 18. 
Graphic was edited using CorelDraw X6 software. 
 Genes related to prostaglandin metabolism and signaling and to steroid 
hormone signaling 
As for the analysis of the equine estrous cycle, genes assigned to prostaglandin metabolism and 
signaling and to steroid hormone signaling were selected from the DEG’s and used for a 
clustering analysis. Genes were obtained from corresponding Gene Ontology categories 
(www.geneontology.org), search in the Entrez Gene database (www.ncbi.nlm.nih.gov/gene) 
and in the literature. For steroid hormone signaling, only selected genes were used, e.g. classical 
and non-classical hormone receptors and related receptors and some genes encoding steroid 
hormone metabolic enzymes (Figure III-13-see next page). 
Estrogen receptor 1 mRNA (ESR1) showed a very similar profile to progesterone receptor 
mRNA (PGR) and interleukin 1B (IL1B) with highest levels on day 0 and total down regulation 
during the luteal phase, whereas G protein-coupled estrogen receptor 1 mRNA (GPER) showed 
highest expression from day 6 to day 12. Progesterone receptor membrane component 1 and 2 
(PGRMC1, PGMRC2) mRNAs showed slightly different expression changes during the cycle 
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compared to one another; PGRMC1 showed highest mRNA level from day 6 to day 18 while 
PGRMC2 mRNA was highest expressed only on day 6. Messenger RNA levels of prostaglandin 
E synthase (PTGES) showed highest mRNA level on day 12 of the estrous cycle in contrast to 
prostaglandin D synthetase 2 and prostaglandin E synthetase 3 (PTGD2, PTGES3) which 
showed lowest levels during the luteal phase. PTGE receptor mRNAs (PTGER2, PTGER3, 
PTGER4) showed completely different expression profiles. Prostaglandin-endoperoxide 
synthase 2 (prostaglandin G/H synthase and cyclooxygenase, PTGS2) showed high expression 
on day 12 and day 18. Additionally, prostaglandin-endoperoxide synthase 1 (prostaglandin G/H 
synthase and cyclooxygenase, PTGS1) showed highest mRNA expression on day 0. The 
prostaglandin F receptor (PTGFR) and its negative regulator (PTGFRN) showed contrary 
expression profiles; PTGFR is up-regulated during luteal phase while PTGFRN is down-
regulated during this time in reproductive cycle. OXTR was highly expressed on day 18, 
respectively. 
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Figure III-13: Graphical illustration of genes related to prostaglandin metabolism and signaling and steroid 
hormone signaling. Relative expression values of differentially expressed genes matching this candidate list were 
subjected to hierarchical clustering for gene expression during the estrous cycle in porcine endometrium (MeV 
software, version 4.8.1). Color scale is from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold higher 
(log2-fold= 2) than the mean (red). Graphic was edited using CorelDraw X6 software. 
 Genes related to ‘regulation of apoptosis’ 
An expression heatmap for genes related to ‘regulation of apoptosis’ is shown in Figure III-14. 
For apoptosis signaling, candidate genes were found using www.wikipathways.com.  
 
Figure III-14: Heatmap of expression profiles during the estrous cycle in porcine endometrium for genes related 
to 'regulation of apoptosis'. Relative expression values of differentially expressed genes matching this candidate 
list were subjected to hierarchical clustering for gene expression (MeV software, version 4.8.1). Color scale is 
from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold higher (log2-fold=2) than the mean (red). Graphic 
was edited using CorelDraw X6 software. 
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Several functional categories for the regulation of apoptotic functions were found as over-
represented for the genes with highest mRNA concentrations during the estrus phase (14 out of 
24 genes in total for the category 'regulation of apoptosis'),e.g., the nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 1A and E (NFKB1A, NFKB1E) and caspase 10 apoptosis-
related cystein peptidase (CASP10). Four of these genes showed earlier or later up-regulation; 
helicase, lymphoid specific (HELLS) and myelocytomatosis oncogene, (MYC) show up-
regulation during metestrus also whereas Fas cell surface death receptor (Fas), and  myeloid 
cell leukemia sequence 1 (MCL1) show earlier up-regulation on day 18 and insulin-like growth 
factor 1 receptor (IGFR1) was already up-regulated on day 12. Four genes related to regulation 
of apoptosis showed highest mRNA expression on day 3; cytochrome c, somatic (CYCS), IAP-
binding mitochondrial protein (DIABLO), hara-kiri BCL2 interacting protein (contains only 
BH3 domain) (HRK), and caspase 1, apoptosis-related cysteine peptidase (CASP1) with slightly 
up-regulation on day 6. During the early luteal phase, 4 genes showed highest mRNA 
expression (BCL2/adenovirus E1B interacting protein 3-like (BNIP3L) the nuclear factor of 
kappa light polypeptide gene enhancer in B-cells 1B (NFKB1B), CASP8 and FADD-like 
apoptosis regulator (CFLAR) and lymphotoxin alpha (LTA)).The remaining genes showed 
diverse regulation throughout metestrus and diestrus.  
 Genes related to angiogenesis, blood circulation and vasculature development 
In addition to genes involved in steroid hormone signaling and regulation of apoptosis, genes 
involved in ‘angiogenesis’, ‘blood circulation’ and ‘vasculature development’ were obtained as 
highly over-represented during the estrous cycle. These genes were identified by comparison 
to corresponding Gene Ontology categories, search in the Entrez Gene, WikiPathways, KEGG 
database, and literature. Relative expression values of differentially expressed genes matching 
this candidate list were subjected to hierarchical clustering for gene expression during the 
estrous cycle (Figure III-15). During preestrus, angiopoietin 2 (ANGPT2), angiopoietin-like 4 
(ANGPTL4), endothelial PAS domain protein 1 (EPAS1), kinase insert domain protein receptor 
(KDR), nitric oxide synthase 3 (endothelial cell) (NOS3), tyrosine kinase, endothelial (TEK), 
and vascular endothelial growth factor A (VEGFA) showed up-regulation with slightly higher 
regulation of mRNA on day 12. Following estrus, angiopoietin-like 6 (ANGPTL6) shows over-
expression on day 3 and on day 8. During luteal phase several genes showed highest mRNA 
expression e.g. mitogen-activated protein kinase kinase 1 (MAP2K1), nitric oxide synthase 3 
(endothelial cell), NOS3), angiotensin I converting enzyme 2 (ACE2), and endothelial PAS 
domain protein 1 (EPAS1). 
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Figure III-15: Messenger RNA expression profiles of genes related to ‘angiogenesis’, ‘blood circulation’ and 
‘vasculature development’ in porcine endometrium. Heatmap was established using MeV software (V 4.9.0). 
Color scale is from 4-fold lower (log2-fold=-2) than the mean (blue) to 4-fold higher (log2-fold=2) than the mean 
(red). Graphic was edited using CorelDraw X6 software 
 Validation of microarray data by the use of quantitative real-time RT-PCR 
(qPCR) 
Microarray results were exemplarily confirmed with the analysis of selected genes by 
quantitative real-time RT-PCR (qPCR). The genes were selected based on the results of the 
clustering of similar expression profiles. Primers were designed with the NCBI Primer Blast-
tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi?LINK_LOC=BlastHome) 
based on the accession number of the original target sequence of the microarray probe. All gene 
symbols, Entrez IDs, Accession No’s and sequences of used primers are shown in Tables II-1a, 
b and II-2. The length of all primers were between 18 and 25 nt, with GC content ranging from 
30 % to 70 % and the melting temperature (Tm value) was between 59° C and 61° C. Amplicon 
length ranged from 80 to 200 bp. Primer pairs were selected separated by at least one intron on 
the corresponding genomic DNA. Genes were selected as representatives from functional 
annotation clustering (DAVID) and by literature. For some of the analyzed genes t-test p-values 
for the qPCR results were not significant (p >0.05) due to variations in expression between 
animals of the same cycle stage. To confirm specificity of qPCR products and to verify product 
length and quantity of product/transcript, the samples were first purified with microdialysis and 
afterwards analyzed with an Agilent 2100 Bioanalyzer and sequenced. 
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 Analysis of selected genes (Equus caballus) 
Agarose gel electrophoresis was used to analyze PCR products obtained for equine samples. 
Results showed one clear product at an annealing temperature of 60°C only for 11 out of 22 
oligonucleotide primer pairs. Remaining 11 pairs were run again at an annealing temperature 
of 62°C, 64°C and 68°C. For the following genes one specific product was obtained for the 
annealing temperature of 60°C: ABCA1, ANXA3, CDK4, CXCR4, ERGIC1, ERP29, INHBA, 
MCM7, PGRMC1, SERPING1, SNRPA and SPP1 and could verify the microarray results. In 
addition, for the following genes a specific product was observed at an annealing temperature 
of 64°: ACTB, COL1A1, RNA18S, RPL7, RPS27A, SLC25A22 and UBB which are shown in 
Figure III-16. COL1A1 and UBB showed the same results during estrous cycle as microarray 
data. The primer pairs still yielding diverse products/transcripts were run again with an 
annealing temperature of 68° (CDH16 and GAPDH). Product length, annealing temperature 
and melting point of all oligonucleotides are summarized in Table III-6. H3F3A showed a 
fluctuating pattern during the cycle and the microarray results could not be validated using 
qPCR technique. Furthermore, results showed an increase of actin B (ACTB) on day 3 with 
slightly increased expression on day 0 that could be verified with qPCR but did not reach 
statistical significance in the statistical analysis (data not shown) Messenger RNA profiles for 
CDH16 and H3F3A showed higher expression on day 0 for ‘vsn’ value compared to the qPCR 
analysis but within relatively slight deviation. Analysis for ERGIC1 showed lower expression 
on day 3 for ‘vsn’-values. GAPDH was higher expressed on day 0 and lower on day 3 according 
to qPCR vs. microarray. Additionally, RPL7 showed up-regulation for qPCR analysis on day 8 
and down-regulation for microarray data vice versa for SLC25A22 mRNA expression. RPS27a 
analysis revealed different almost contrary results for all times during the estrous cycle. Results 
for the remaining 14 genes were in very good agreement between analyses (Figure III-17). 
Gene Symbol 1 
Product size 
[base pair] 
Annealing temperature [°C] 2 Melting point [°C] 3 
ABCA1 156 60 81.5 
ACTB 132 64 87.4 
ANXA3 145 60 79.4 
CDH16 140 68 85.4 
CDK4 163 60 85.5 
COL1A1 185 64 87.5 
CXCR4 125 60 79.3 
ERGIC1  172 60 83.5 
ERP29 171 60 80 
GAPDH 138 68 82 
H3F3A 146 68 83.5 
INHBA 196 60 80.4 
MCM7  189 60 82.5 
PGRMC1 197 60 85 
RPL7 137 64 82 
RPS27a 156 64 76 
SERPING1 92 60 81 
SNRPA 200 60 75 
SLC25A22 161 64 85.5 
SPP1 82 60 77.7 
UBB 86 64 76.9 
Table III-VI: Annealing temperature, melting point and product length for qPCR.Table shows a summary for 
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equine qPCR analysis. 1 official Gene Symbol, 2 and  3 provided by software. 
 
 
Figure III-16: Agarose analyses of qPCR products. A) gel shows results after qPCR with annealing temperature 
of 64°C, B) gel shows results after qPCR with annealing temperature of 68°C. C) N3233 New England BioLabs 
Low molecular weight marker. bp-base pair. 
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Figure III-17: Correlation of microarray and qPCR data of equine analysis. Relative expression levels were 
calculated (vsn value of one time point minus mean vsn values of all 5 time points; Mean Ct-values of all 5 time 
points minus Ct-value of one time point) and shown as a heatmap (MeV software, version 4.9.0. Color scale is 
from 2-fold lower (log2-fold=-1) than the mean (blue) to 2-fold higher (log2-fold=1) than the mean (red). Figure 
was edited using CoreDraw X6 Software. M–microarray, P-qPCR. 
 Analysis of selected genes (Sus scrofa) 
Heatmap (Figure III-18) shows results of quantitative real-time PCR (qPCR) of selected genes. 
Fifteen genes were selected for validation by qPCR. ANXA7 showed higher expression on day 
3 in qPCR analysis compared to microarray data. BAALC was still up-regulated on day 18 
according to qPCR compared to microarray results. CXCR4, PGF and SERPING1 showed 
different expression for qPCR and microarray on day 0 and on day 3 and COL1A1 showed 
different expression values on day 3 as well as FGFR1. Remaining genes were in very good 
agreement between results of the different techniques. Table III-7 summarizes annealing 
temperature and product size for the selected primer pairs used for quantitative real-time PCR 
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(qPCR) analysis. 
Table III-VII: Product size and annealing temperature for qPCR.Summary of porcine qPCR analysis is shown. 1 
official gene symbol.Bp-basepair, °C-celcius. 
 
Figure III-18: Correlation of microarray and qPCR data of porcine analysis. Heatmap (MeV software, version 
4.9.0) demonstrates the correlation of microarray data and qPCR data of porcine samples. Relative expression 
levels were calculated (normalized value of one time point minus mean normalized values of all 5 time points; 
mean Ct-values of all 5 time points minus Ct-value of one time point). Color scale is from 2-fold lower (log2-
fold=-1) than the mean (blue) to 2-fold higher (log2-fold=1) than the mean (red). Figure was edited using 
Gene 
Symbol1 
Product 
size [bp] 
Annealing 
temperature [°C] 
Gene 
Symbol1 
Product size 
[bp] 
Annealing 
temperature [°C] 
ABCA1 161 60 H3F3A 200 60 
ANXA7 102 60 PGF 155 60 
BAALC 162 60 SERPING1 137 60 
CCNE1 182 60 SNRPA 121 60 
CDK4 113 60 SPP1 134 60 
COL1A1 118 60 TIMP-3 155 60 
CXCR4 80 60 UBB 142 60 
FGFR1 86 60    
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CoreDraw X6 Software. M–microarray, P-qPCR. 
 Comparison of gene expression profiles during the equine and the 
porcine estrous cycle 
To make a statistical relevant statement regarding the comparison of expression profiles 
between equine and porcine endometrium, the significance of the correlation of gene expression 
profiles during the estrous cycle was further determined. All significant positively and 
negatively correlated genes were analyzed in relation to the SOTA clustering. Additionally, 
functional annotation clustering was performed using DAVID bioinformatics tool to show 
distinct molecular and biological processes as over-represented in each cluster compared.  
 Significance of correlation between differentially expressed genes in both species 
In total, the comparison of the datasets revealed approx. 1862 genes/transcripts referred to as 
differentially expressed in both species. The comparison provided 690 genes as positively 
correlated (p<0.05) and 151 genes as negatively correlated (p<0.05). The calculation and list of 
genes can be found in supplementary data. An illustration summarizing bioinformatics analyses 
of distinct molecular functions and biological processes of positively and negatively correlated 
genes is shown in Figure III-19 and 20. 
 Relation of positively correlated genes to SOTA clustering analyses 
The 690 genes that were assigned as significantly positive correlated were analyzed according 
to the cluster analysis (SOTA cluster) of both species (Table III-8). 
A total number of 48 genes were up-regulated on day 0 (Cluster 1-Eca, Cluster 1-Ssc) in both 
species. 15 genes clustered together on day 0 in equine expression profiling and showed high 
mRNA expression from day 0 to day 3 (Cluster 2) in the pig. Additionally, 15 genes were up-
regulated on day 18 (Cluster 8) in the pig and on day 0 in the mare concurrently. Only 3 genes 
were up-regulated on day 3 (Cluster 3) in the pig and on day 0 in the mare. 14 genes assigned 
as up-regulated in Cluster 1 (Ssc) were up-regulated from day 0 to day 3 (Cluster 2) in the mare 
and 21 genes were already up-regulated on day 16. Only 2 genes showed highest mRNA levels 
on day 3 in the mare. 34 genes showed highest mRNA levels from day 0 to day 3 (Cluster 2-
Eca, Cluster 2-Ssc) in both species. 35 genes were up-regulated on day 3 in the pig and from 
day 0 to day 3 in the mare at the same time. Additionally, out of 9 genes that were up-regulated 
from day 0 to day 3 in the mare, 7 genes were clustered together in cluster 4 and 2 genes showed 
up-regulation in cluster 8 in the pig. Comparison of mRNA expression on day 3 (Cluster 3-Eca, 
Cluster 3-Ssc) in both species revealed 107 genes as up-regulated, which is the highest amount 
of genes clustering together. Of 173 genes that were up-regulated on day 3 in the mare, 29 genes 
showed highest mRNA levels from day 0 to day 3, 33 genes were up-regulated during early 
luteal phase and 4 genes showed higher mRNA profiles during estrus phase in the pig. Vice 
versa, of 154 genes that were assigned as up-regulated on day 3 in the pig, only 9 genes showed 
later increase of expression during the estrous cycle in the mare. 44 genes of positive correlation 
were clustered together from day 3 to day 8 in the mare and from day 3 to day 6 in the pig 
(Cluster 4-Eca, Cluster 4–Ssc). Whereas only 8 genes were additionally up-regulated in the 
mare, 135 genes were up-regulated in the pig at this time during cycle; 67 genes were up-
regulated on day 8, 28 genes showed highest mRNA expression from day 8 to day 12 and 40 
genes were up-regulated earlier in equine estrous cycle concurrently. During diestrus, the 
analysis revealed 11 genes as up–regulated in both species (Cluster 5-Eca, Cluster5–Ssc). 19 
genes showed highest mRNA expression later in the equine cycle. Cluster 6 of both species 
(from day 8 to day 12-Eca, on day 12-Ssc) showed 10 genes as up-regulated. Additionally, 30 
genes showed earlier up-regulation and 4 genes were up-regulated later in time during porcine 
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estrous cycle. From 19 genes that were assigned as up-regulated on day 12 in the pig, 11 genes 
were up-regulated from day 12 to day 16, 2 genes showed highest mRNA on day 16 and 6 genes 
were clustered together related to day 8 in the mare. In Cluster 7 a total number of 33 genes and 
in Cluster 8 a total number of 47 genes showed higher mRNA levels in both species. Twelve 
genes were up-regulated in cluster 7 in the mare and in cluster 8 in the pig at the same time. 
Eighteen genes were up-regulated in cluster 7 in the pig and in cluster 8 in the mare 
concurrently. 
Table III-8: Overview of significantly positive correlated genes in relation to cluster analyses. SOTA cluster: all 
expression cluster obtained from the analysis of all genes found as differentially expressed during the equine and 
porcine estrous cycle (MeV analysis).Genes: number of significant positive correlated (p<0.05) genes as assigned 
to both expression cluster, grey background-genes as up-regulated in both species in the same cluster number, 
brown background-more than 10 genes clustered together. D-day. 
 Relation of negatively correlated genes to SOTA clustering analyses 
150 genes were assigned as negatively correlated (p<0.05) and analyzed in relation to SOTA 
clustering analyses (Table III-9). 
Most of the genes showed negative correlation on day 0 (Cluster 1) in each species (separately) 
and during the luteal phase. 62 genes were up-regulated from day 3 to day 6 in the pig whereof 
22 genes showed up-regulation in cluster 1 (highest level on day 0) and 36 genes were up-
regulated in cluster 8 (highest level on day 16) in the mare. From 29 genes that were up-
regulated on day 0 in the pig, 12 genes were up-regulated on day 8 and 11 genes showed up-
regulation from day 8 to day 12 in the mare concurrently. 
 
 
 
 
 
S
u
s 
sc
ro
fa
 
Equus caballus 
SOTA 1 2 3 4 5 6 7 8 
total 
S
O
T
A
 Day in cycle 0 0-3 3 3-8 8 8-12 12-16 16 
1 0 48 14 2 0 0 0 0 21 85 
2 0-3 15 34 29 1 0 1 0 0 80 
3 3 3 35 107 7 2 0 0 0 154 
4 3-6 0 7 33 44 67 28 0 0 179 
5 6-12 0 0 0 0 11 11 6 2 30 
6 12 0 0 0 0 6 10 11 2 29 
7 12-18 0 0 0 0 0 4 33 18 55 
8 18 15 2 2 0 0 0 12 47 78 
total 81 92 173 52 86 54 62 90 690 
III - RESULTS 
59 
S
u
s 
sc
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fa
 
Equus caballus 
SOTA  1 2 3 4 5 6 7 8 
total 
S
O
T
A
  Day 
in 
cycle 
0 0-3 3 3-8 8 8-12 12-16 16 
1 0 0 0 1 1 12 11 4 0 29 
2 0-3 0 0 0 1 1 7 7 0 16 
3 3 0 0 2 0 0 4 2 1 9 
4 3-6 22 1 0 0 0 0 3 36 62 
5 6-12 3 3 0 0 0 0 0 1 7 
6 12 3 1 0 0 0 0 0 0 4 
7 12-18 0 1 2 2 0 0 0 0 5 
8 18 0 1 0 6 6 6 0 0 19 
total 28 7 5 10 19 28 16 37 151 
Table III-9: Overview of significantly negative correlated genes in relation to cluster analyses. SOTA cluster: all 
expression cluster obtained from the analysis of all genes found as differentially expressed during the equine and 
porcine estrous cycle (MeV analysis).Genes: number of significant negative correlated (p<0.05) genes as assigned 
to both expression cluster, brown background-more than 10 genes clustered together. D-day. 
 Functional annotation clustering  
 Analysis of positive correlated genes 
The characterization of molecular functions and assigned biological processes as over-
represented during different phases of the equine and porcine estrous cycle was performed using 
functional annotation clustering (DAVID) for the clusters of genes with similar expression 
profiles that have been obtained by SOTA clustering and genes as significant positive and 
negative correlated in both species. Two heatmaps based on the frequency pattern (numbers of 
genes on different cycle stages) during the reproductive cycle were plotted for graphical 
illustration of the processes over-represented during distinct phases of the porcine and the 
equine estrous cycle. This graphical illustration is demonstrated in Figure III-19 and 20. 
Selected functional categories were clustered according to their frequency patterns achieved in 
functional annotation clustering for each dataset (list of significant positive and negative 
correlated differentially expressed genes 
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Figure III-19: DAVID functional annotation clustering of all significantly positive correlated genes in both 
species throughout the cycle. Functional terms over-represented during distinct phases of the estrous cycle were 
selected from DAVID functional annotation clustering analysis. Numbers of genes assigned to these functional 
terms (in rows) are shown for each SOTA cluster (in columns) as percentage of the number of all differentially 
expressed genes assigned to a term (white = 0%; black = 50%). Graphic was edited using MeV and CorelDraw 
X6 software.  
Genes with highest mRNA levels on day 0 (Clusters E1 and S1) clustered together in the 
functional groups related to terms such as ‘collagens’, ’extracellular matrix’, ’focal adhesion’ 
and ‘translational elongation’. Cluster E1 showed, in addition, the categories ‘inflammatory 
response’ and ‘ribosomes’ as over-represented. S1 showed lower expression of genes related to 
the category ‘collagens’ in comparison to E1. Clusters E2 and S2 represent highest mRNA 
expression levels from day 0 to day 3 and showed genes as over-represented by the categories 
‘translational elongation’ and ‘ribosome’. Altogether, most expression values of cluster S2 
showed lower expression values than of E2 except for the category ‘collagens’. Specifically for 
clusters E3 and S3 (highest expression levels on day 3) categories related to ‘cell-cycle’, 
’mitosis’ and ‘chromosome’ showed highest numbers of genes. Additionally, cluster E3 showed 
highest expression for the functional term ‘steroid biosynthetic process’. The biological terms 
‘Flavoprotein’, ‘protein transport’, ‘mitochondrion’, ‘glucose and monosaccharide metabolism’ 
and ‘lipid metabolism’ were over-represented in cluster S4 (highest level from day 3 to day 6). 
Cluster E4 (highest level from day 3 to day 8) showed ‘lipid metabolism’ as the only category 
that was over-represented. Interestingly, the expression in cluster S5 (highest level from day 6 
to day 12) and cluster E6 (highest level from day 8 to day 12) showed similar over-
representation represented by functional term ‘steroid biosynthetic process’ other than the 
clusters S5 and E5 (highest level on day 8). Cluster S6 (highest level on day 12) showed slightly 
over-representation for ‘GTPase regulator activity’. Cluster E7 (highest level from day 12 to 
day 16) and S7 (highest level from day 12 to day 18) showed the term ‘angiogenesis’, ‘GTPase 
regulator activity’ and ‘cell junction’ as highly represented. Clusters E8 (highest level on day 
16) and S8 (highest level on day 18) revealed highest mRNA expression for genes assigned to 
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categories as ‘cytokine-cytokine receptor interaction’ and ‘complement activation, classical 
pathways’ 
 Analysis of negatively correlated genes 
Cluster E1 revealed highest mRNA expression for the categories ‘focal adhesion’, ‘extra 
cellular matrix’ and ‘fatty acid and lipid metabolism’ whereas cluster S1 showed highest 
representation for the biological terms ‘glucose and monosaccharide metabolism’ and ’protein 
transport’. Negative correlated genes showed over-representation for ‘monosaccharide 
metabolic process’ in cluster S2 but no representation for cluster E2. The functional categories 
‘collagens’ and ‘cell junctions’ showed over-representation in E5 and S8. Cluster E3 and S3 
revealed highest representation for the category ‘mitosis’, cell-cycle’ and ‘chromosome’. The 
categories ‘angiogenesis’ and ‘vasculature development’ showed over-representation in cluster 
E5 and S8, respectively. Most of the functional terms as over-represented in cluster S4 showed 
same deviation for cluster E8. The clusters E5, S6 and E6 revealed only very low expression 
for all functional categories as well as cluster E2. Negative correlation showed over-
representation for genes assigned to the biological term ’extracellular matrix’ in cluster E1 and 
S4.The category ‘translational elongation’ showed no negative significant regulation at all. 
 
Figure III-20: Representation of selected functional categories of all negative correlated genes in both species 
throughout the cycle. Functional terms over-represented during distinct phases of the estrous cycle were selected 
from DAVID functional annotation clustering analysis. Numbers of genes assigned to these functional terms (in 
rows) are shown for each SOTA cluster (in columns) as percentage of the number of all differentially expressed 
genes assigned to a term (white = 0 %; black = 50 %). Graphic was edited using MeV and CorelDraw X6 software.  
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 Comparison to dynamic gene expression changes during the estrous cycle in 
bovine endometrium (Mitko, 2008) 
4.2.3.1. Positively correlated genes 
In this analysis the list of differentially expressed genes from the study of the bovine 
endometrium (Mitko et al.,'08) was compared to the list of significant positive and significant 
negative correlating genes from the equine and porcine correlation analysis. The analysis 
revealed a total number of 33 genes/transcripts as positively correlated in the equine and porcine 
endometrium and regulated during the estrous cycle in the bovine endometrium. 
Three genes related to the term ‘collages’ were regulated in all three species: COL1A2, 
COL3A1, and COL4A1. In the mare and the pig all three genes show highest expression on day 
0 only in the bovine endometrium COLA41 shows up-regulation during preestrus. In addition, 
the comparison of the transcriptome analysis in all three species revealed an up-regulation of 
the immune-related genes that are involved in the complement system (classical pathway), 
namely complement component genes C1R and the C1 inhibitor SERPING1 (Bauersachs et 
al.,'06, Klein et al.,'06). Slightly correlative expression differences were found within the 
immune-related genes complement component 1, r subcomponent (C1R) and serpin peptidase 
inhibitor, clade G (C1 inhibitor), member 1 (SERPING1). In porcine endometrium both genes 
showed mRNA up-regulation during preestrus (day 18) as in equine endometrium (day 16). 
Other than that, the mRNA expression of C1R and SERPING1 in bovine endometrium showed 
earlier up-regulation on day 12.  
4.2.3.2. Negatively correlated genes 
As with the analysis of significant positive genes, in this analysis the list of differentially 
expressed genes from the study of the bovine endometrium (Mitko et al.,'08) was compared to 
the list of significant negative correlating genes from the equine and porcine correlation 
analysis. The analysis revealed a total number of 7 genes/transcripts as negative correlated in 
the equine and porcine endometrium and regulated during the estrous cycle in the bovine 
endometrium: COL5A3 (collagen, type V, alpha 3), GM2A (GM2 ganglioside activator), MGP 
(matrix Gla protein), NEU1 (sialidase 1 (lysosomal sialidase)), PDIA4 (protein disulfide 
isomerase family A, member 4), TMSB10 (thymosin beta 10) and TNC (tenascin C). 
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IV. DISCUSSION 
The present thesis provides new insights into the gene expression changes in equine and porcine 
endometrium during the estrous cycle and the analysis and interpretation of similarities and 
differences between these species. Since a comparison between species of different mammalian 
groups can be used for the identification of genes related to common and species-specific 
mechanisms for establishment and maintenance of pregnancy (Bauersachs et al., 2012) and the 
regulation of the reproductive cycle, data sets obtained in the gene expression analysis of equine 
and porcine endometrium were analyzed in this regard. Furthermore, a comparison of 
significantly correlated genes in both species to dynamic gene expression changes in the bovine 
endometrium throughout the cycle provided additional insights into interactions and 
characteristics during distinct stages of the estrous cycle.  
At first, limitations of the comparison between the investigated mammalian species regarding 
differences in sample collection, endocrine regulation of the estrous cycle, e.g., profiles of 
progesterone concentration levels and methodic analysis, is debated. Then gene expression in 
the equine and porcine endometrium in relation to their particular biological function during 
distinct events throughout the cycle is discussed, respectively. These consolidated findings are 
compared to one another and discussed in detail referring to distinct reproductive events. At 
last, significant gene expression throughout species during the estrous cycle is analyzed. 
 Comparative methodology  
 Comparison between the analysis of equine and porcine endometrium 
 Sample collection, plasma P4 concentration and tissue composition  
According to the changes in steroid hormone concentrations and corresponding endometrial 
structural and functional changes, the estrous cycle is divided into four different stages; estrus, 
metestrus, diestrus and preestrus corresponding to ovulatory, early luteal, mid luteal and 
follicular phase. Equine biopsy samples were collected on day 16 for beginning of estrus and 
on day 0 as the time shortly after ovulation (two times during estrus phase with low P4 
concentrations). In addition, for the luteal phase, three times were selected for sample 
collection; day 3 for the early luteal phase with P4 concentrations on the rise, day 8 for the mid 
luteal phase (diestrus-highest P4 concentration) and day 12 for the late luteal (decreasing P4 
concentrations). For porcine endometrial samples, collection was performed on day 0 for the 
time around ovulation (low P4 concentrations), respectively. The samples collected on day 18 
(assumingly the time for the beginning of estrus and therefore low P4 concentrations) showed 
higher concentrations of P4 and should be considered as samples collected during late luteal 
phase. Biopsy samples collected on day 3 represent metestrus, the time during the reproductive 
cycle when P4 concentrations start to increase. For the luteal phase, sample collection was 
performed on two different times; day 6 for the early luteal phase and day 12 for diestrus (high 
P4 concentrations). Precise timing of sample collection was controlled by routinely monitoring 
follicular development and ovulation by daily transrectal palpation and ultrasound examination 
in case of equine samples and by rehousing of pigs and induction of ovulation and post mortem 
evaluation of ovary status for porcine samples.  
Furthermore, determination of P4 concentration, as the key hormone which prepares the 
endometrium for establishment and maintenance of pregnancy, was performed to confirm 
timing of sample collection. The analysis of equine blood samples was in agreement with the 
expected P4 concentrations as described throughout literature. The blood samples for some pigs 
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slaughtered on day 18 showed higher levels of P4 concentrations than expected on this time 
during the cycle but showed decreasing levels compared to day 12. One of the animals in this 
group showed an extremely high number of corpora lutea (pl. Corpus luteum) (D18S28 with 
22 CL’s) in the left ovary resulting in the peripheral progesterone concentration of 42.8 ng/ml. 
This value is almost three times higher than the P4 concentrations of 3 other animals in this 
group. In addition, the group of day 18 samples was the most heterogeneous among all. 
However, the progression of P4 concentrations throughout the analyzed stages (except day 18) 
of the estrous cycle was consistent and in good agreement with the literature and the samples 
were further processed. The higher P4 concentrations on day 18 in porcine blood samples could 
have an impact on the comparison of gene expression during this time with the mare and is kept 
in mind until further parts of this discussion. 
As reviewed in Ulbrich et al. (Ulbrich et al., 2012), in addition to collection from defined stages, 
the performance of tissue sampling itself needs to be standardized to ensure i) short times for 
tissue or cell recovery and sampling (instability of RNA), ii) similar times for all biological 
replicates and iii) collection of representative tissue samples. Therefore, sample collection 
procedures were carried out in very strictly manner and described in detail in the protocol. 
Equine endometrial biopsy samples were collected from five cycling mares at five times during 
the estrous cycle. To avoid effects of a previous biopsy collection on gene expression, no more 
than two biopsy samples were taken during the same cycle with an interval of at least 15 days. 
Sample collection procedures are recorded in the dissertation of Dr. ved. med. M. Merkl. The 
collection of the samples was also performed by Dr. vet. med. M. Merkl. The biopsy samples 
were taken transcervical, meaning a relatively ‘blind’ operation. Therefore, every second slice 
of each sample was used for quantitative stereology for the analysis of tissue composition. 
Sample collection from porcine endometrium was performed from 30 different female gilts at 
five different times during the estrous cycle. For each time point six animals were slaughtered 
and post-mortem sample collection and evaluation of ovaries was carried out. Since tissue 
sampling was performed on the opened uterine horns it could be performed in a controlled way, 
and additional analysis of tissue composition (quantitative stereology) was not necessary. Other 
than for equine samples, three endometrial tissue samples were taken from each uterine horn 
(left and right): proximal (i.e. towards the corpus=front), intermedial (middle) and distal (back). 
All tissue samples were immediately transferred into vials containing RNAlater. Since pooling 
of tissue samples from the same animal can be used to reduce variations of tissue composition 
in case of complex tissues, three samples from one uterine horn were pooled (equal amounts of 
total RNA).  
 Quality of the isolated RNA 
The process from collected tissue samples to isolated total RNA comprises many steps that can 
have influences on the quantity of the results. Therefore, control of RNA quality and purity is 
a crucial step in guaranteeing integer stable RNA and receiving meaningful results in gene 
expression profiling experiments. The quantity and purity of isolated RNA was determined 
using a spectrophotometer. In our laboratory the NanoDrop-1000 spectrophotometer was used 
which enables highly accurate analyses of small sample volumes with remarkable 
reproducibility and, therefore, eliminates the need for cuvettes and capillaries without losing 
fractions of the sometimes precious and valuable RNA samples (see product descriptions in 
web). RNA samples should be non-degraded or fragmented and free of protein, genomic DNA, 
nucleases, and enzymatic inhibitors. The purity of RNA was tested by determining the ratio of 
the absorption at 260 and 230 nm which indicates the presence of contaminants like chaotropic 
salts. This ration should not be lower than 2.1. Furthermore, the 260/280-nm ratio indicates 
contamination with DNA, proteins and phenol (2.0 for pure RNA at neutral pH). The most 
impure sample (D6S13-b) was rejected for further analysis. In general, neglectable amounts of 
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chemically degraded RNA are common due to thawing and freezing of samples for several 
times. For even more certainty about the quality of the isolated RNA, RNA integrity was 
analyzed using fluidic chip technology. All samples showed good RNA integrity with slightly 
better porcine (RINs: 7.9-10.0) than equine (RINs :6.8–9.4) quality estimations. Taken together 
the isolated total RNA showed very good quality for the assignment of further analysis and was 
comparable between equine and porcine endometrium. 
 Microarray analyses 
Microarray analysis of equine samples was performed with Agilent Horse genome arrays 
comprising a ‘Quick Amp Labeling Kit (one-color)’ and for porcine samples with Agilent 
Swine genome array and the ‘Low Input Quick Amp Labeling Kit (one-color)’. Except for 
labeling, all other steps were performed by the use of the same Agilent kits and the same 
technical equipment. Both Agilent array experimental designs used in this study were 4x44k 
arrays, meaning there are 4 array areas on each slide with respectively 44,000 oligonucleotide 
probes. As already mentioned, the distribution of the porcine samples of the same time point 
on the slides was not in a random manner. For equine biopsy samples, different samples from 
different mares and different times were loaded on each slide for hybridization to avoid bias 
from technical variation. Unfortunately, the distribution on the slides for porcine samples was 
according to sample numbers which were from D0 through D18. Therefore a bias derived from 
technical deviances cannot be completely excluded.  
 Statistical analysis of microarray data and functional annotation clustering  
Microarrays simultaneously measure transcript abundance for tens of thousands of genes in a 
cell population or tissue sample. The measurement is performed by quantitation of the 
fluorescence intensities of labeled sample cRNA that has hybridized to probes on the array. 
Statements about the relative abundance of a gene transcript in these samples can be made by 
comparing the corresponding fluorescence intensities. Due to variations in sample treatment 
and labeling efficiency the fluorescence intensities have an inter-array variation. For optimal 
comparison, appropriate calibration is necessary, which is also called ‘normalization’. 
Numerous methods exist for normalization (basic processing) of microarray gene expression 
data. These methods can have an important effect on the final analysis outcome. Therefore, it 
is crucial to use methods, which are appropriate for a given dataset in order to assure the validity 
and reliability of expression data analysis. ‘Variance Stabilization and normalization’ 
(BioConductor package VSN) (Huber, 2002) is a method that incorporates data calibration, an 
intensity-dependent error model and data transformation. It is intended to lead to a measure of 
differential expression which is independent of the mean intensity. ‘Vsn’ assumes that less than 
half of the genes on the array are differentially expressed across the experiment. The analysis 
of the 4x44k Horse Genome microarrays was first performed by filtering processed signal 
intensities, that had been generated by Feature Extraction Software 10.7.3.1, in MS Excel based 
on the ‘Is well above background’ flag. The filter threshold was detection in 4 of 5 samples in 
at least one of the five experimental groups for equine samples. For the analysis of 4x44k 
Porcine Genome microarray, the processed signals were obtained in the same way as for equine 
samples. Filtering the processed signal intensities, in MS Excel, was based on the ‘Is well above 
background’ flag with a filter threshold detection in 3 of 4 samples, 4 of 5 samples and 5 of 6 
samples per group. Due to the fact that more than 60 % of the porcine genes on the array were 
differentially expressed, the ‘vsn’-BioConductor package could not be used for this experiment. 
This is why ‘75th percentile’ normalization of the filtered signals was calculated by dividing the 
processed signals by the 75th percentile of each sample in MS Excel and log2 transformation 
and then multiplying by the mean of 75th percentiles of each sample. Altogether, bioinformatics 
analysis revealed 4.996 differentially expressed genes for equine samples and 5.325 known 
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differentially expressed genes for porcine samples. A heatmap based on pair-wise distances 
(BioConducter package ‘geneplotter’) was generated for quality control of each dataset. 
Significance analysis was performed using the SAM function of the ‘siggenes’ package 
(BioConducter, multiclass) for both experimental projects with different false discovery rates 
(equine data-1%, porcine data 0.1%). Most likely sample composition can have strong influence 
on microarray findings based on different mRNA concentration changes in different cell types. 
According to pronounced differences in progesterone concentration on day 18 in porcine 
samples, it was not surprising that those samples showed clustering closer to day 12 with highest 
P4 concentration other than to day 0 as expected. Altogether, the analysis of sample correlation 
(pairwise distances of microarray data sets) showed grouping of samples according to the 
different phases of the cycle. 
Annotation data can be downloaded and therefore updated e.g. at the Agilent homepage. In 
addition, data from genome sequencing projects of different genomes are available through a 
number of genome browsers and genome project databases. To improve the annotation 
(assignment to known horse and human genes), BLAT and BLAST analyses were performed 
using Ensembl and UCSC genome browsers and NCBI BLAST to assigned equine genes and 
human putative orthologous genes, Entrez Gene identifiers and the corresponding gene 
information. All of the probes of the porcine microarray were mapped against the whole 
genome and porcine tanscripts using Bowtie and further the output sequences (primary 
accession) were blasted against human genes using UniGene, TIGR, and RefSeq data bases. 
Due to the enormous number of differentially expressed transcripts/probes and less available 
annotation data in databases, the improvement of the annotation provided by Agilent for porcine 
differentially expressed genes could not be performed in such a good quality as compared to 
the equine data set (9295 probe ID’s but only 7560 Hsa Entrez Gene ID’s). Although the 
technical basis already existed, the major hurdle was incomplete gene annotation, particularly 
for the pig. Furthermore, the knowledge of orthologous genes between mammalian species is 
also far from complete but it is needed for a reliable cross-species analysis to get a unique gene 
identifier for comparison of gene expression data. According to Bauersachs and Wolf 
(Bauersachs et al., 2012) gene symbols cannot be used as unique identifiers, since official gene 
symbols are still not available for all porcine and equine genes (only locus IDs). One possibility 
could be to assign putative human orthologous genes and use human Entrez Gene identifiers as 
a unique identifier. On the basis of these orthologous genes, gene expression data could be 
compared more directly. However, this task is complicated by duplicated genes, highly similar 
genes in closely related members of a gene family, incomplete genome sequences or 
assemblies, incomplete annotation, and the presence of genes specific for different mammalian 
groups (Bauersachs et al., 2012).  
However, the genes obtained from the analyses were classified according to similarities of their 
gene expression profiles during the estrous cycle (MeV software version 4.7.1/SOTA 
algorithm). This revealed 8 clusters of major expression profiles for highest mRNA levels at 
different times during the estrous cycle in both species. Furthermore, for investigating 
differentially expressed genes in relation to their over-representation of distinct functional terms 
DAVID Functional Annotation Clustering (online-tool) was performed for the obtained gene 
clusters. This analysis revealed a number of similar but also many different biological terms as 
over-represented during comparable stages of the equine and porcine reproductive cycle.  
 Validation of microarray data 
In general, results should be validated by additional experiments. Such validation was 
performed using quantitative real-time RT-PCR (qPCR). According to Zhang (Zhang et al., 
2012) gene expression analysis requires the use of reference genes consistently expressed under 
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various conditions. Furthermore, the use of housekeeping genes (HKG) as internal controls for 
quantitative real-time PCR (qPCR) studies of gene expression is based on the assumption of 
their inherent stability (Sadek et al., 2012). Both studies suggested actin beta (ACTB) for HKG, 
and further on Zhang found H3 histone, family 3A (H3F3A) as the most suitable gene for 
accurate normalization. Microarray data showed that mRNA expression of H3F3A followed an 
extreme regulated pattern during the equine and the porcine cycle and could not be used as a 
reference gene with stable expression during the estrous cycle. Furthermore, results of equine 
data showed an increase of actin B (ACTB) on day 3 (verified with qPCR analysis), but did not 
reach statistical significance (q-value = 0.15, threshold q-value = 0.01). Researchers found that 
even house-keeping genes such as ß-actin and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) are up-regulated in endometrium by estradiol (L'Horset et al., 1990). GAPDH 
showed highest expression on day 0 (qPCR analysis) and highest expression on day 3 
(microarray analysis) during equine estrous cycle. However, analyses in both species revealed 
ubiquitin B (UBB) as the best ‘HKG’ candidate. In addition, several genes were selected as 
representatives for typical expression profiles during the estrous cycle. The results for qPCR of 
equine samples confirmed results from microarray analysis within 12 out of 22 genes chosen. 
The aberration within the remaining genes could be a reflection of technical issues. The 
transcription of RNA samples into cDNA provides the most important and also most critical 
step in the qPCR process regarding sample-to-sample variation. First-strand cDNA was 
synthesized for all samples, starting from 1 μg of total RNA with the Sprint™ RT Complete-
Double PrePrimed Kit. Unfortunately, there is no simple method to measure the efficiency of 
reverse transcription of RNA into cDNA. Besides, the mechanical handling of a total volume 
of 20 μl for each sample can be difficult as well. The stripes provided by the company show 
synthetic lids that might not close properly. Due to multiple using and therefore thawing of 
samples, the water could partially sublimate. Another contributing factor in such distribution of 
Ct-values may be the functionality of primers that were used. Sometimes primers are derived 
from predicted sequences that might not represent the real existing transcripts. Due to the lack 
of validated annotation data, several oligonucleotides for equine samples had to be tested by 
changing annealing temperatures of qPCR or even changing primer designs (GAPDH, RPL7, 
SLC25A22 - data only shown for final primer pair). Additionally, the selection of UBB as 
candidate for house-keeping gene might have been a suboptimal choice. Altogether, despite 
some technical inaccuracy and bias in bioinformatics analysis, the results of qPCR analysis 
were overall in accordance with the microarray analysis for equine and porcine experiments.  
 Comparison to the study of bovine mRNA expression profiles in endometrium 
during the estrous cycle (Mitko, 2008) 
According to Mitko et al (Mitko, 2008), the bovine tissue samples used in their study were 
collected on day 18 from heifers which had already low P4 concentrations (shortened cycle) for 
beginning of estrus and on day 0 as the time around ovulation (two time points during estrus 
phase), for metestrus, samples collection was performed on day 3.5 and for the luteal phase two 
times were chosen for sample collection; day 12 (diestrus) with highest P4 concentration and 
day 18 from heifers with still higher P4 concentrations (normal cycle). After collection further 
procedures (samples storing, RNA isolation etc.) were performed according to manufactures 
instruction as it was carried out in the present study. The timing of sample collection was 
controlled by observation of sexual behavior (i.e. toleration, sweating, vaginal mucus) and 
ultrasound-guided follicle monitoring. In order to determine P4 concentrations, blood samples 
were taken. In this regard the procedures were similar.  
Microarray analysis was performed using a custom cDNA array, the BOE (bovine oviduct and 
endometrium) cDNA array version 1. The generation of this array is explained in detail by 
Bauersachs and coworkers (Bauersachs et al., 2007) and can be summarized as follows: the 
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array covered approx. 950 different genes that were annotated based on comparisons to 
common data base sequences. The human orthologous genes were also identified to obtain more 
information regarding gene function. Although the bovine genome array from Affymetrix was 
available, the BOE array had the advantage that it is enriched for genes which were found to be 
differentially expressed during the most important physiological stages of this tissue. 
Furthermore, the relatively small number of represented genes on the BOE array circumvents 
many problems of data evaluation and processing and keeps costs down. The background was 
subtracted with provided software (lowest grid dot) and raw data were normalized applying the 
BioConductor package ‚vsn‘ (Huber, 2002). Microarray results in this study were validated 
using qPCR methods as described earlier (Ulbrich et al., 2004).  
Altogether the results in this study can be used for comparison of results with the present study 
to identify changes in dynamic gene expression throughout species but with some limitations. 
On the one hand, the BOE array data used in the study of Mitko et al. was limited to a 
comparison of differential gene expression during estrus and diestrus phase. On the other hand, 
a comparable time point during the bovine cycle representing early luteal phase is missing in 
the analysis performed by Mitko et al. Both the equine as well as the porcine microarray 
analysis showed 8 major expression profiles throughout the estrous cycle including early luteal 
phase and preestrus. Therefore, the genes found to have a significant correlation (positive and 
negative) in equine and porcine endometrium were compared to the differentially expressed 
genes revealed from bovine endometrium (by Mitko et.al.) throughout the estrous cycle. 
 Exploration of differentially expressed genes throughout the estrous 
cycle 
The results of both studies of endometrial gene expression changes agree well with cyclic 
changes of steroid hormones and findings from histological analysis. Although gene expression 
changes are mainly regulated by the interplay of the ovarian steroid hormones E2 and P4, the 
‘wave-like’ dynamics of gene expression changes (8 major clusters (MeV/SOTA analysis) in 
each species) demonstrate an intricate fluctuating network of regulation throughout the cycle. 
In addition to gene expression profiling, specific gene functions and biological processes 
(bioinformatics analysis of the clusters of genes with similar expression profiles) confirmed 
dynamic gene expression changes in the endometrium in distinct phases during the estrous 
cycle, respectively.  
 Messenger RNA expression profiles in the endometrium during the equine 
estrous cycle 
All differentially expressed genes in the equine endometrium that are discussed in this part are 
summarized in supplementary Table VIII-I. The table shows Hsa gene ID, Hsa gene symbol 
and mRNA expression on D0, D3, D8, D12 and D16, q-values (achieved from microarray 
analysis) and results of SOTA clustering analysis. 
 Genes with highest mRNA expression during estrus 
Cytokines include chemokines, interferons, interleukins, lymphokines and tumor necrosis 
factor and are regulatory proteins secreted by immune cells and other immune component cells 
acting in a paracrine and autocrine manner. The analysis of equine endometrial expression 
during estrus phase (low P4 concentration; from day 16 to day 0) revealed a very huge number 
of genes representing the cytokine family; the chemokine (C-C motif) ligand family (CCL2, 
CCL3L3, CCL5, CCL8, CCL13, CCL15, CCL21), the chemokine (C-X-C motif) ligand family 
(CXCL1, CXCL5, CXCL6, CXCL9, CXCL10, CXCL16, CXCL17) and the interleukin family 
(IL8, IL15, IL32, IL34), attractors for almost all types of immune cells, such as monocytes, 
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macrophages, dendritic cells, neutrophils, B-cells, T-cells, and natural killer cells (Gebhardt et 
al., 2012). Furthermore, in reproductive biology, chemokines have been implicated in crucial 
processes such as ovulation, menstruation, embryo implantation, parturition and pathological 
processes such as preterm delivery, HIV infection, endometriosis and ovarian hyperstimulation 
syndrome (Cocchi et al., 1995, Simon et al., 1995). Results were confirmed by the analysis of 
functional annotation clustering that revealed several categories for immune system functions 
(e.g. inflammatory response, immune response) as over-represented during this time in cycle. 
Additionally, mRNA expression of the chemokine (C-C motif) receptor (CCR9) and three genes 
representing the chemokine (C-X-C motif) receptors (CXCR1, CXCR4 and CXCR7) were up-
regulated during estrus. Results from qPCR analysis confirmed the expression pattern for 
CXCR4 showing highest mRNA levels on day 0 and lowest during the luteal phase. 
Furthermore, the mRNA expression of the interleukin IL8 (highest level on day 16, higher levels 
on day 0) is in good agreement with results of the recent study by Fumuso et al. (Fumuso et al., 
2007) which observed up-regulation of this gene in the endometrium of mares in estrus 
compared to diestrus. The functions of interleukins are wide spread throughout all kinds of 
tissue and species. So far, interleukins have been demonstrated to stimulate prostaglandin 
production in the endometrium in many species besides the mare (Kotwika et al., 1999, 
Krzymowski, 1990, Soede, 1997, Virolainen et al., 2005. , Waclawik, 2011). Moreover, most 
recent studies showed an up-regulation of endometrial interleukin 1 alpha (IL1A) and 
interleukin 6 (IL6) mRNA expression during the follicular phase of the equine estrous cycle, as 
well as their promotion of endometrial cell proliferation and also that E2 enhanced their support 
of PG production (Szostek et al., 2014). However, results in this study revealed no detection of 
neither IL-1α nor IL-6 in the equine endometrium but its receptor interleukin 1 receptor, type 1 
(IL1R1) showed highest expression on day 16. 
Phospholipase A2 is an essential enzyme for the release of the arachidonic acid from the cell 
membrane which is the starting molecule of the biosynthesis of prostaglandins. Annexins, a 
family of intracellular proteins with calcium–dependent phospholipid binding properties, can 
affect many components of the inflammatory reaction by inhibition of phospholipase A2 and 
suppression of neutrophil and monocyte migration (Gerke V., 2002). Data showed up-
regulation of ANXA3 mRNA on day 16 (microarray and qPCR) and down-regulation during the 
luteal phase. However, Mitko et al. (Mitko, 2008) found a number of genes such as lectin 
galactoside-binding soluble 1 (LGALS1), tenascin C (TNC), osteonectin (SPARC), proprotein 
convertase subtilisin/kexin type 5 (PCSK5), gastrin releasing peptide (GRP), annexin A2 
(ANXA2) and nephroblastoma overexpressed gene (NOV) as up-regulated during estrus in 
bovine endometrium, which have been described as positively involved in the regulation of the 
process ‘invasive growth’. The decreased mRNA levels of these genes during the luteal phase 
may be associated with the regulation of non-invasive implantation in cattle and in mares. Out 
of this group of genes, results of microarray analysis of equine endometrium revealed higher 
expression of TNC, SPARC, and NOV on day 0 during equine estrous cycle. The increased 
mRNA concentrations of genes coding for specific surface antigens indicates infiltration and 
activation of the endometrium with immune cells during estrus, respectively. Continuatively, 
researchers assumed that cytokines may play a role in local changes, such as angiogenesis, cell 
proliferation, and other processes taking place in the endometrium (Szostek et al., 2014). This 
statement is verified by the findings of the functional terms ‘angiogenesis’, ‘blood circulation’ 
and ‘vasculature’ as over-represented during this time in cycle. Several genes with highest 
mRNA levels during the estrus phase that were found as assigned to members of the 
angiopoietin system (angiopoietin 2, ANGPT2; angiopoietin-like 1, 2 and 4, ANGPTL1, 
ANGPTL2, ANGPTL4; TEK tyrosine kinase, TEK), the VEGF system (neuropilin 2, NRP2, 
kinase insert domain receptor (KDR, also known as VEGFR2)), genes related to endothelial cell 
regulation (endothelins 1 and 2, EDN1/EDN2; the receptor for EDN1, endothelin receptor type 
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A, EDNRA; endothelial cell surface expressed chemotaxis and apoptosis regulator, ECSCR), 
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (ACE2), and fibroblast growth 
factor 2 (basic) (FGF2) were found as up-regulated during estrus (data published in (Gebhardt 
et al., 2012). The over-representation of these genes is a sign for increased growth that occurs 
during ovulatory phase and of vascular changes which could be related to the observation that 
‘inflammatory response’ genes are over-represented during the same time, since inflammatory 
responses and vascular responses are tightly connected (Saban et al., 2010). In addition, up-
regulation of a number of angiogenic factors by E2 was shown in sheep (Johnson et al., 2006). 
The immune response can be divided into two types: innate (non-adaptive or non-specific) and 
adaptive or specific immune response (Dalin et al., 2004). The complement cascade is part of 
the innate immune response which contributes to the elimination of cellular antigens. Three 
biochemical pathways are known to activate the complement system: the classical complement 
pathway, the alternative complement pathway, and the lectin pathway. Results of DAVID 
functional annotation clustering revealed the category ‘complement activation, classical 
pathway’ as over-represented on day 16 during the equine estrous cycle. The complement 
cascade mediates a series of biologic reactions, which include increased vascular permeability, 
chemotaxis, opsonization prior to phagocytosis, activation of membrane lipases, and lysis of 
target organisms. Complement activity as well as isolation of complement cleavage products 
have been demonstrated in the equine reproductive tract (Asbury et al., 1982, Watson et al., 
1987a). Four genes assigned to the complement cascade were found as up-regulated in equine 
endometrium: complement component 3 (C3), complement component 4 binding protein, alpha 
and beta (C4BPA, C4BPB ), complement component 1, r subcomponent (C1R), complement 
component 7 (C7) and serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 
(SERPING1). SERPING1, encoding a protein known as C1 inhibitor, regulates complement 
pathway activation and blocks the activity of plasma kallikrein and the activated form of factor 
XII in blood (Davis, 2008). These two proteins participate in the production of bradykinin, 
which promotes inflammation by increasing vascular permeability. However, Hayashi et al 
(Hayashi et al., 2011) showed that SERPING1 may suppress inflammation promoted by 
bradykinin but in bovine ovarian follicles. Klein et al. (Klein et al., 2006) suggested that the 
up–regulation of SERPING1 mRNA in the bovine uterine glandular and luminal epithelial cells 
on day 18 during pregnancy could be a mechanism to protect the embryo against an attack from 
the maternal immune system in case of pregnancy. In addition, five genes representing the 
superfamily of the SERPINs (SERPINA1, SERPINA5, SERPINE1, SERPINE2 and SERPINI1), 
which are involved in inflammation processes and other processes like fibrinolysis, coagulation, 
cell mobility, cellular differentiation and apoptosis, were found to be up-regulated during estrus 
phase. Regarding the fact that the group of SERPINs is further separated e.g. SERPINA14 is 
represented in a limited group of species (Padua et al., 2010) and only little is known about 
their potential functions during the estrous cycle further analyses are necessary. The 
inflammatory process involves chemokine-initiated recruitment of polymorphonuclear 
neutrophils (PMNs) and other inflammatory cells to the area of insult, leading to the removal 
of pathogens and resolution of inflammation (Parham, 2005). Complement products as well as 
leukotriene B4 (LTB4), prostaglandin E (PGE), and prostaglandin F2alpha (PGF2a) may all 
serve as chemoattractants for polymorphonuclear neutrophils (PMNs) in the uterus (Lees et al., 
1986, Watson et al., 1987a, b). The genes with highest expression levels during estrus clearly 
indicate that the endometrium prepares for uterine clearance needed during and after mating 
which is probably further triggered by spermatozoa and components of the seminal plasma 
(Troedsson, 2001) leading for example to influx of PMNs into the uterine lumen (Troedsson, 
1999). Although the mares used in this study were not inseminated, the corresponding immune-
related genes (inflammatory response, cytokine-cytokine receptor interaction, complement and 
coagulation cascades, innate immune response) were up-regulated during estrus, which is 
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probably caused by effects of estrogen in preparation for the shock of intrauterine insemination 
in the mare (Gebhardt et al., 2012). Besides, the findings indicate a reconstruction at the end of 
the estrous cycle to prepare the endometrium for the onset of a new cycle. 
Furthermore, several genes with highest mRNA concentrations during estrus were related to 
‘extracellular matrix (ECM)’ and the process of ‘focal adhesion’ (adhesion of cells to ECM): 
e.g. three representatives of the matrix metallopeptidase family (MMP3, MMP9 and MMP28). 
Matrix metalloproteinase (MMPs) are calcium- and zinc-dependent proteases (peptidases) 
believed to be responsible for degradation and reorganization of ECM in tissues (Nagase et al., 
2006). In addition MMPs are involved in laminitis, osteoarthritis, recurrent airway obstruction, 
skin wounds repair, degenerative diseases of the central nervous system, ulcerative keratitis, 
cancer (Clutterbuck et al., 2010) and equine endometriosis (Walter et al., 2005). In relation to 
the term ECM, the functional term ‘collagens’ (e.g. 19 genes) was found as over-represented 
during estrus. A decrease in collagen fibers has been observed during the pre-implantation 
phase in bovine endometrium in a recent study (Yamada et al., 2002) which is in line with the 
lower mRNA levels of collagen genes (e.g. COL1A1) at diestrus. Microarray data revealed 
highest expression of COL1A1 on day 0 which was confirmed by qPCR experiments. The 
mRNA expression profile of these genes and the results of the study from Yamada et al. 
(Yamada et al., 2002) suggest a complex regulation of the ECM remodeling in the endometrium 
during the estrous cycle.  
As the endometrial changes during estrus are mainly controlled by estradiol, the large number 
of genes related to estrogen metabolism and signaling is coherent at this time during the estrous 
cycle. Besides, FGF9 has been described as one of the mediators of estrogen signaling in the 
endometrium (Tsai et al., 2002). In case of pregnancy, FGF9 mRNA has been found as 
increased in pregnant endometrium by Merkl et al. (microarray 9-fold, qPCR 8-fold up-
regulated in day 12 pregnant endometrium (Merkl et al., 2010)) and has been described as an 
autocrine endometrial stromal growth factor induced by E2 in human endometrial stroma (Tsai 
et al., 2002). Induction of FGF9 expression by PGE2 through the EP3 receptor was also 
demonstrated in human endometrium (Chuang et al., 2006). Microarray analysis revealed 
highest mRNA expression of prostaglandin E receptor 3 (PTGER3 (subtype EP3)) on day 0 
which is in good agreement as well as highest FGF9 mRNA concentration on day 16 and on 
day 0 following serum E2 levels. In addition, the mRNAs of two estrogen related receptors, 
estrogen-related receptor alpha (ESRRA) and estrogen-related receptor gamma (ESRRG) were 
also found as differentially expressed during the estrous cycle. ESRRG showed lowest 
expression levels on day 3 and highest levels on day 0, and ESRRA had lowest levels on day 0 
and highest on day 8 and slightly over-expressed on day 16. Estrogen-related receptors are a 
subfamily of orphan nuclear receptors closely related to the classical estrogen receptors and 
have been shown to share target genes, co-regulatory proteins, etc. with classical ESRs and can 
influence the estrogenic response (Giguere, 2002). Although ESRRs lack identified natural 
ligands (orphan nuclear receptor), binding and activation by phytoestrogens have been shown 
(Hirvonen, 2011).  
In addition, several genes related to PG metabolism and signaling showed up-regulation 
throughout the cycle. Prostaglandin E receptor 4 (PTGER4 (subtype EP4)), phospholipase A2, 
group IVA (PLA2G4A, cytosolic, calcium dependent), and solute carrier organic anion 
transporter family, member 2A1 (SLCO2A1, PG transporter) showed highest mRNA 
concentrations on days 16 and day 0. In contrast, Merkl et al. (Merkl et al., 2010) found all four 
genes to be increased on day 12 in pregnancy of equine endometrium compared to non-pregnant 
controls indicating a shift from maternal to a possible conceptus derived E2 induction. In case 
of pregnancy, conceptus mobility is at maximum between days 11 and days 14 after ovulation. 
It is apparent that localized myometrial contractions provide the driving force that literally 
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squeeze the vesicle around the uterine lumen (Cross et al., 1988, Ginther, 1984). In addition, 
Stout and Allen (Stout, 2001) postulated a possible role of PGE and PGF2a in intrauterine 
migration of the equine conceptus as both prostaglandins are known to have potent actions on 
smooth muscle activation. As non-pregnant endometrium shows mRNA expression of two 
receptors of PGE as up-regulated in this time period, a possible preparation of the uterus for 
eventual pregnancy is reasonable. PGF2a can be produced directly from PGH2 by aldo-keto 
reductase family 1 members B1 and C3 (AKR1B1 and AKR1C3) and can be synthesized via 
PGE2 by the action of the enzymes carbonyl reductase 1 (CBR1), AKR1C1 and AKR1C2 or 
by reduction of PGD2 by AKR1C3 (Catalano et al., 2011, Dozier et al., 2008). Following 
biosynthesis, PGF2α, exerts its function through the G protein coupled receptor PTGFR 
(Abramovitz et al., 2000), preferentially. Our data showed highest expression of AKR1C1 on 
day 12 during the equine estrous cycle as luteolysis is about to start while its receptor, 
prostaglandin F receptor (PTGFR,also known as FP) was highly expressed on day 3.  
As reported, endometrial stimulation with high-dose of E2 increased myometrial oxytocin 
receptor density in human uterus (Richter et al., 2003) and furthermore, oxytocin and certain 
prostaglandins have been demonstrated to stimulate uterine contractility via different 
mechanisms (Turnbull, 1971). Increased expression of prostaglandin-endoperoxide synthase 2 
(PTGS2), also known as cyclooxygenase 2 (COX2), was found in uterine epithelial cells on day 
15 of the cycle, whereas increase of endometrial PTGS2 expression was inhibited in pregnant 
mares Our data showed increased mRNA expression of PTGS2 on day 16 when luteolysis is in 
process. Aurich (Aurich, 2011) suggested an important role of COX2 in pulsatile secretion of 
oxytocin within the onset of luteolysis in the mare which is in good agreement to results of the 
present study as oxytocin, prepropeptide (OXT) showed highest expression on day 0, higher 
expression during the luteal phase and lowest on day 16 following E2 concentrations. The 
importance of physical clearance as an part of the uterine defense system was suggested in 
studies using fluid accumulation in the uterus following experimentally induced endometritis 
in susceptible mares (Allen et al., 1988, LeBlanc et al., 1989, Troedsson, 1999)Furthermore, 
recent investigations suggest an important role of PGF2a in this physical clearance, as 
myometrial contractions are regulated by PGF2a together with oxytocin in mares (Asbury et 
al., 1982, Goddard et al., 1985). This has been clarified by Cadario and coworkers (Cadario et 
al., 1995) who used phenylbutazone to inhibit PGF2a induced myometrial contractions and 
observed a delayed clearance of radiocolloids from the uteri of reproductively normal mares. 
Equine endometrial secretory cells produce, store and secrete oxytocin and are thus most likely 
involved in stimulating and maintaining uterine contractility (Bae et al., 2003). The secretory 
activity of the endometrium during estrus together with increased myometrial activity 
contributes to uterine clearance mechanisms that void uterine infection (Aurich, 2011). Data 
indicate a role of endometrial OXT in uterine contractility stimulated by E2 as well. Altogether, 
the complex regulation of genes involved in PG metabolism and signaling suggests an 
important role of the corresponding genes in the regulation of the estrous cycle.  
The results of dynamic gene expression during the estrus phase indicate a relation of genes 
involved in ‘immune system function’ with the ‘vasculature’ and ‘angiogenesis’ of endometrial 
tissue involving ECM remodeling and complex tissue reconstruction and beginning of cell 
proliferation. 
 Genes with highest mRNA expression during early luteal phase 
Cyclic changes in the endometrium are a complex process governed by the interplay of several 
signaling pathways that critically regulate cell growth and proliferation. Tissue maintenance is 
an ongoing process in which progenitor cells differentiate into various cell types to perform 
specialized functions while the undifferentiated cells are then removed without affecting 
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neighboring cells and overall tissue structure (Medh et al., 2000), thereby maintaining steady 
state kinetics via low rate apoptosis that complements mitosis (Roberto da Costa et al., 2007). 
Several studies regarding cyclic pattern in cell proliferation and apoptosis in the uterine 
endometrium in relation to ovarian steroid hormone secretion in humans (Harada et al., 2004, 
Jones et al., 1998) and animal species, such as pigs (Kaeoket et al., 2001, Okano et al., 2007, 
Wasowska et al., 2001), mice (Sato et al., 1997), dogs (Chu et al., 2002), rats (Lai et al., 2000), 
hamsters (Sandow et al., 1979) and in rabbits (Nawaz et al., 1987) have been published. In 
addition, few studies (Aupperle et al., 2000, Gerstenberg et al., 1999, Roberto da Costa et al., 
2007) have been performed analyzing the role of apoptosis and cell proliferation in the 
regulation of endometrial changes during the equine estrous cycle. Gilbert and coworkers 
(Gilbert, 1992) found, by counting mitotic figures that most luminal epithelial cells divide in 
late estrus, whereas most glandular epithelial cells divide on day 4 of diestrus in the mare 
endometrium. Moreover, latter researcher have been the first to suggest that luminal and 
glandular epithelial cells should be regarded as functionally distinct cell populations since they 
show different cyclic responses (Gilbert, 1992). Results of the study by Roberto da Costa 
(Roberto da Costa et al., 2007) support this argument as they observed higher proliferation 
during the luteal phase in glandular and luminal cells but not in the stroma (superficial and 
deep). DAVID functional annotation clustering revealed biological categories such as ‘cell-
cycle’, ‘mitosis’ and ‘chromosome’ as over-represented following estrus. In addition, cyclin-
dependent kinase 4 (CDK4) mRNA showed highest level on day 3 during the cycle (microarray 
and qPCR data). Cell proliferation and apoptosis are hormone-dependent physiological 
processes involved in endometrial growth and regression (Roberto da Costa et al., 2007). A 
huge number of factors control the initiation of physiological cell turnover and apoptosis, 
including the cellular environment, growth factors, cytokines and hormones, which can act in 
an autocrine, paracrine and endocrine manner (Kayisli et al., 2002). Results of the study by 
Roberto da Costa (Roberto da Costa et al., 2007) demonstrated higher active caspase-3 in 
stromal cells being significantly higher in the follicular phase than during luteal phase but no 
significant differences in LE and sGE. In mammalian cells, activation of caspase-3 has been 
shown to occur through two major apoptotic pathways which are initiated by the Fas ligand 
complex and cytochrome c (Hengartner, 2000). The gene expression profiling showed several 
genes related to regulation of apoptosis as over-represented throughout the cycle. In order to 
understand the interaction of these genes and their products, further detailed studies of dynamic 
gene expression changes in the endometrium related to the regulation to apoptosis should be 
performed in the field of research of equine reproduction.  
During the estrous cycle, the endometrium releases oxytocin-induced luteolytic pulses of PGF 
that result in functional and structural regression of the ovarian corpus luteum (CL), termed 
luteolysis (Spencer, 2004). The mechanism that develops in the endometrial LE and sGE 
requires sequential effects of progesterone, estradiol, and oxytocin, acting through their 
respective receptors (Spencer et al., 2002, Spencer, 1996). Several studies in ovine 
endometrium observed increased expression for all three respective receptors at estrus (Spencer 
et al., 1995a, Wathes et al., 1993) stimulated by estrogen levels that peak from the ovulatory 
Graafian follicle. Following estrus, progesterone levels increase and act via PGR to block 
expression of estrogen and oxytocin receptor in the endometrial LE and sGE which are therefore 
not detected during most of diestrus (days 5 to 11) in the ovine estrous cycle (McCracken, 
1980). Microarray analysis revealed highest mRNA expression of PGR from day 0 to day 3 and 
endometrial mRNA concentration for estrogen receptor 1 (ESR1) from day 16 to day 3 in the 
equine cycle. This is additionally in agreement with the results of Hartt et al. who found highest 
mRNA levels on days 0, 17 and 20 of the estrous cycle, but did not investigate day 3 (Hartt, 
2005). Receptors for both steroid hormones exist in the luminal and glandular epithelium and 
stroma of the equine endometrium. The expression of the progesterone receptor gene (PGR) in 
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equine endometrium decreases during the luteal phase particularly in luminal and glandular 
epithelium (Hartt, 2005). However, the study by Spencer et al. in sheep suggested a rapid 
increase in expression of estrogen receptor on day 13 followed by oxytocin receptor on day 14 
in LE and sGE following the loss of PGR block (Spencer et al., 1995b). This increase could not 
be detected in the present study in equine endometrium for ESR1 but the mRNA expression of 
ESRRG showed a similar profile. In addition, the study by Starbuck (Starbuck, 1998) found 
high oxytocin receptor expression on day 14 of the equine estrous cycle. The oxytocin receptor 
(OXTR) showed highest mRNA expression from day 12 to day 16 during the estrous cycle but 
did not reach statistical significance (q-value 0.05, threshold q-value 0.01). As already 
mentioned, oxytocin, prepropeptide (OXT) mRNA change was found during the equine estrous 
cycle. Equine endometrial secretory cells produce, store and secrete oxytocin and are thus most 
likely involved in stimulating and maintaining uterine contractility (Bae et al., 2003). In 
addition to a role of oxytocin in myometrial activity in context with uterine clearance data 
suggest a storage of endometrial oxytocin prepropeptide during early luteal phase and release 
at the onset of PG synthesis and therefore a role in the mechanism in equine luteolysis. In 
addition, G protein-coupled estrogen receptor (GPER) showed a profile similar to ESR1 mRNA 
with highest levels on day 3 as in human endometrium where GPER expression is also regulated 
during the cycle with highest mRNA levels during the proliferative phase (Plante et al., 2012). 
Moreover, several studies (Tomanelli et al., 1991, Watson, 1992) showed that the concentration 
of both E2 and P4 receptor proteins in the mare endometrium increased at estrus and early luteal 
phase and decreased in the mid and late luteal phase. Similar to sheep, results from horse 
suggest that expression of estrogen and progesterone receptor is positively regulated by 
circulating levels of estrogen and negatively by progesterone, respectively (Hartt, 2005).  
Altogether, the expression patterns of these selected genes involved in steroid hormone 
signaling indicate a complex regulation of E2 effects on the endometrium starting on day 0 and 
persisting to day 3 during the estrous cycle. Furthermore, less up-regulation of genes related to 
estrogen signaling during the late luteal phase are in contrast to a possible interaction with 
ovarian FSH (second FSH peak). Besides, detailed studies of dynamic temporal and spatial 
gene expression changes have to be performed to understand the interaction of genes related to 
steroid hormone signaling and metabolism and their respective receptors - especially the role 
of endometrial oxytocin regulation in the equine endometrium – and the connection to cell 
proliferation pattern and apoptosis, respectively. 
 Genes with highest mRNA expression during luteal phase 
Highest mRNA concentrations for genes coding for enzymes involved in fatty acid metabolism, 
such as acyl-CoA synthetases, acyl-CoA dehydrogenase (ACADL), carnitine 
palmitoyltransferases, acetyl-CoA acyltransferase 2 (ACAA2), acetyl-CoA carboxylase beta 
(ACACB), enoyl-CoA delta isomerase 2 (ECI2), hydroxyacyl-CoA dehydrogenase/3-ketoacyl-
CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit (HADHB), and ELOVL 
fatty acid elongase 5 (ELOVL5) were observed during this time of the estrous cycle. Both 
adiponectin receptors 1 and 2 (ADIPOR1, ADIPOR2) of the adipocytokine signaling pathway 
were found as expressed. Expression of ADIPOR1 and ADIPOR2 was also described in murine 
and human endometrium during the time of implantation and in pre-implantation endometrium, 
respectively (Evans et al., 1997, Knox, 2005). The increased fatty acid synthesis suggests a 
need for provisioning of the preattachment equine conceptus (in case of pregnancy) with 
essential fatty acids and retinoids. Suire et al. (Suire, 2001) suggested that equine uterocalin 
(official name and symbol: P19 lipocalin, P19) binds fatty acids and lipids and transports them 
to the conceptus. The mRNA expression profile of P19, coding for one of the major, 
progesterone-dependent proteins secreted into the uterine lumen of the mare (Crossett et al., 
1998) was similar to those genes involved in fatty acid metabolism with highest expression 
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during luteal phase and lowest on day 0 of the estrous cycle. Furthermore, fatty acids are, 
substrates in prostaglandin synthesis. Effects of P4 during the time of highest P4 levels are 
mainly mediated via stromal cells that still express PGR (Fortune et al., 2001) and via other 
types of non-classical progesterone receptors such as progesterone receptor membrane 
component 1 and 2 (PGRMC1, PGRMC2) (Signoret, 1970). PGRMC1 belongs to the 
membrane–associated progesterone receptor (MAPR) protein family which is widespread in 
eukaryotes and involved in regulating numerous biological functions (Cahill, 2007). PGRMC1 
expression has been demonstrated in several female reproductive tissues in different 
mammalian species (Luciano, 2011). The analysis of PGRMC1 mRNA expression in the uterus 
revealed a down-regulation from the proliferative (i.e. epithelial cell cycle progression, mucosal 
edema and angiogenesis) to the secretory (i.e., mitosis blockade, cellular differentiation and 
mucosal secretion) phase of the human menstrual cycle (Geisert et al., 1994). Despite the 
dynamic regulation of PGRMC1 in the human endometrium, PGRMC1 expression does not 
change during the estrous cycle in the cow, respectively (Luciano, 2011). Data for equine 
endometrium showed highest mRNA expression of PGRMC1 during the luteal phase. 
Additionally, several studies indicated that progesterone mediates an anti-apoptotic action 
through PGRMC1 but in the ovary (Mansouri et al., 2008, Peluso et al., 2006). 
In addition to genes related to steroid-hormone signaling, genes with highest levels on days 8 
and 12 were predominantly related to protein secretion as indicated by functional categories, 
such as ‘protein transport’, ‘endoplasmic reticulum’ and ‘Golgi apparatus’, to signaling 
processes and to metabolic processes, such as ‘monosaccharide metabolic process’ and ‘lipid 
metabolism’. Specifically, genes involved in ‘fatty acid metabolism’, ‘adipocytokine signaling 
pathway’, ‘PPAR signaling pathway’, and ‘glycerophospholipid metabolism’ were found in the 
expression clusters with highest mRNA levels during this time of the estrous cycle. The 
functions of the genes involved in protein secretion, signaling, metabolic processes during this 
phase of the cycle indicate that the equine endometrium prepares for the support of embryo 
growth and development (data published in (Gebhardt et al., 2012). Highly significant over-
representation of molecular functions and biological processes related to cell proliferation for 
genes with highest mRNA levels on day 3 and highest expression levels of “supportive” genes 
with functions related to protein secretion and nutrient supply during the luteal phase of the 
estrous cycle is in good agreement with results of a recent study of asynchronous embryo 
transfer that showed a relatively wide period of time for the establishment of pregnancy in the 
mare (Adams, 1999). In this regard, the situation in equids seems to be different compared to 
ruminants, where an adequate timing of P4-regulated changes in the endometrium is the 
prerequisite for normal embryo development and conceptus elongation (Fortune, 1994, 
Morales, 2000).  
The genes for nitric oxide synthase 3 (NOS3), angiotensin I converting enzyme (peptidyl-
dipeptidase A) 1 (Genbacev et al., 2003), angiotensinogen (Gilles et al., 2003), angiomotin 
(AMOT) angiopoietin-like 6 (ANGPTL6), and endothelial PAS domain protein 1 (EPAS1) 
showed their highest mRNA levels during diestrus. Differential expression of NOS3 protein 
was described in human endometrial vessels with highest expression in the early secretory 
phase (Sayasith et al., 2007). Renin stimulates the cleavage of angiotensinogen to angiotensin 
which is subsequently cleaved into peptides with either vasodilator or vasoconstrictor activities 
by angiotensin-converting enzymes (see KEGG pathway ko04614 Renin-angiotensin system) 
(Ginther et al., 2008). Interestingly, mRNA coding for ACE2 that produces vasodilators from 
angiotensin I and II was highest at estrus, whereas mRNA coding for ACE that produces the 
potent vasopressor angiotensin II was highest on day 8 of the estrous cycle. Studies of uterine 
blood flow in cyclic mares found highest blood flow on days 0 and 10/11 (Alexander et al., 
1982, Aurich et al., 1995) which correlates with the observation that the genes in this study 
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related to the functional terms ‘blood circulation’ and ‘angiogenesis’ were predominantly found 
in the expression clusters with highest mRNA concentrations during estrus and in expression 
clusters with highest mRNA concentrations on days 8 or 12. The comparison to studies of gene 
expression during the time around maternal recognition of pregnancy (MRP) (Merkl et al., 
2010, Tortonese et al., 2001) shows that expression of similar genes is induced during estrus 
and on days 12 and 14 of pregnancy indicating a specific induction of those genes by the 
presence of the conceptus, probably by conceptus estrogens. Additionally to genes involved in 
mentioned signaling pathways, secreted phosphoprotein 1 (SPP1, also known as osteopontin) 
mRNA was found as up-regulated during the luteal phase. Since SPP1 is an extracellular 
matrix/adhesion molecule that is up-regulated in the pregnant uterus of all mammals examined 
to date (White et al., 2005) and only little is known about its regulation during the reproductive 
cycle in non-pregnant animals, the up-regulation and thereby the function of SPP1 in this 
context remains unclarified. In mice uteri SPP1 is up-regulated during estrus However, White 
et al. (White et al., 2005) supported the hypothesis that SPP1 has functions in implantation and 
placentation of mammalian species especially in the pig. Additionally, Yoo et al. (Yoo et al., 
2006) suspected an anti-apoptotic role of SPP1 but in the neonate. Results in Figure IV-1. 
 
Figure IV-1: Summary of the results from the analysis of equine endometrium during the estrous cycleThe equine 
estrous cycle is 21 days in length and the day of ovulation is defined as D0. The main phases of the cycle and the 
analyzed days (D0, D3, D8, D12, D16-exterior lettering) are shown. Progesterone (P4) concentration during the 
particular phase is given in each corner. Internal circle (pink) shows over-represented biological functions during 
the specific phases of the estrous cycle achieved from DAVID functional annotation clustering analysis. External 
circle (green) represents single genes or groups represented by several genes with highest mRNA expression 
during the corresponding time of the estrous cycle. Blue area demonstrates conclusions (potential connection to 
changes in endometrium). Connection between events are demonstrated with arrows. ACADL-acyl-Coenzyme A 
dehydrogenase, long chain, ADIPOR1-adiponectin receptor 1, AMOT-angiomotin C1R-complement component 1, 
r subcomponent, C3-complement component 3, CDK4-cyclin dependent kinase 4, ECM-extracellular matrix, e.g.-
for example, ELOVL5-ELOVL fatty acid elongase 5, EPAS1-endothelial PAS domain protein 1, ESR1-estrogen 
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receptor 1, ESRRA,G-estrogen-related receptor alpha, gamma, FGF9-fibroblast growth factor 9, GPER- G protein-
coupled estrogen receptor, NOS3-nitric oxide synthase 3 (endothelial cells), NRP2-neuropilin 2, OXT-oxytocin, 
PGRMC1-progesterone receptor membrane component 1, PGR-Progesterone receptor, PMN-polymorphnuclear 
neutrophils, PTGER3,4-prostaglandin receptor 3 and 4, PTGES-prostaglandin E synthase, PTGS2-prostaglandin-
endoperoxide synthase 2, TEK-TEK tyrosine kinase, endothelial 
 Messenger RNA expression profiles in the endometrium during the porcine 
estrous cycle 
Supplemental Table VIII-III summarizes all differentially expressed genes in the porcine 
endometrium that are discussed in this part. The table shows Hsa gene ID, Hsa gene symbol 
and mRNA expression on D0, D3, D6, D12 and D18, q-values (achieved from microarray 
analysis) and the number of Cluster from SOTA clustering analysis. In addition a summary of 
the results is shown in Figure IV-2. 
2.2.1 Genes with highest mRNA expression during estrus  
Dynamic changes in the uterine endometrium are a type of homeostasis and are associated with 
proliferation and exclusion of cells. Apoptosis plays a major role during development and is 
also involved in the homeostasis of the uterus that involves various hormones and cytokines. 
Additionally, it has been defined for the human uterus that it is a mechanism by which uterine 
luminal epithelium and glands degenerate in the absence of embryonic factors and regenerate 
in a cycling fashion through the cycle (Dery et al., 2003). Furthermore, it was demonstrated in 
hamster and rat uterine epithelium during the estrous cycle by electron microscopy, that 
numerous epithelial cells undergo apoptosis at estrus (Sandow et al., 1979). The number of 
different cell types involved in apoptotic cell death exhibits a scientific challenge that has not 
been completely clarified yet. Several factors such as nitric oxide synthase (NOS) (Tschugguel 
et al., 1999), tumor necrosis factor-alpha (TNFa) (Tabibzadeh, 1995), Fas (TNF receptor 
superfamily, member 6) (Fas) (Harada et al., 2004) and interleukin-1 (IL1) (Tanaka et al., 1998) 
are known to induce apoptosis in epithelial cells of the human endometrium. In addition, 
ovarian hormone withdrawal may play a key role in the regulation of endometrial apoptosis 
(Rotello et al., 1992, Slayden et al., 1993). As for the expression of TNFa in the estrous cycle 
in the mouse, no or only slight expression of TNFa mRNA was observed in uterine tissues 
during preestrus, estrus, and early luteal phase, but the expression increased in the late luteal 
phase (Roby, 1994). Microarray data showed genes coding for IL1ß as up-regulated on day 0, 
nitric oxide synthase 3 (NOS3, endothelial cell) and 1 (NOS1, neuronal) and TNF as up-
regulated on day 18 as well as Fas (TNF receptor superfamily, member 6) with highest mRNA 
expression from day 18 to day 0 during the cycle in pigs. In accordance to the results from 
microarray analysis, DAVID functional annotation clustering revealed the category ‘regulation 
of apoptosis’ as over-represented during the estrus phase in porcine endometrium. Small 
nuclear ribonucleoprotein polypeptide A (SNRPA) is an important gene which had been 
reported to function in binding stem loop II of U1 snRNA and may be involved in coupled pre-
mRNA splicing and the polyadenylation process. Recently many reports described that SNRPA 
is associated with the regulation of apoptosis (Degen et al., 2000, Hof et al., 2005). Detailed 
function of SNRPA in this context has to be clarified. Microarray data for SNRPA mRNA was 
validated by qPCR analysis showing highest expression on day 3. Moreover, results of a recent 
study of endometrial gene analysis in non-pregnant and pregnant sows on day 14 after ovulation 
(Østrup et al., 2010) revealed 22 genes assigned to the biological term ’apoptosis’ (15 up- and 
7 genes down-regulated in pregnant endometrium) which is in good agreement to the study of 
Samborski et al.(Samborski et al., 2013) that showed genes related to the ‘regulation of 
apoptosis’ as over-represented on day 14 in pregnant pigs. Results in the latter study showed 
characteristic pro-apoptotic genes like BCL2-antagonist/killer 1 (BAK1), BCL2/adenovirus 
E1B 19kDa interacting protein 3 (BNIP3), caspases 1 (intrinsic pathway) and 10 (extrinsic 
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pathway) (CASP1, CASP10), Fas and tumor necrosis factor (ligand) superfamily, member 10 
(TNFSF10/TRAIL) as well as anti-apoptotic genes B-cell CLL/lymphoma 2 family (BCL2A1, 
BCL2L14), baculoviral IAP repeat containing 3 (BIRC3), and CASP8 and FADD-like apoptosis 
regulator (CFLAR) to be increased in pregnant endometrium among others. The present 
microarray results in cyclic porcine endometrium showed the genes coding for CASP10, 
TNFSF10 and BIRC3 with highest mRNA levels on day 0, Fas as up-regulated from day 18 to 
day 0 and CASP1 as highly expressed on day 3 during the cycle among others, respectively. 
The similarity in gene expression analysis between pregnant (D14) and cycling (D0) pigs could 
be due to elevated estrogen levels around estrus and estrogen signaling of the conceptus in case 
of pregnancy. Okano et al. (Okano et al., 2007) have investigated the morphological features 
and occurrence of apoptosis in the porcine endometrium during the estrous cycle with main 
focus on surface epithelium (SE), glandular epithelium (GE) and stroma cells. The results in 
this study clearly showed a peak of apoptosis at estrus which may be explained by the exclusion 
of many cells from the epithelium from preestrus to the early luteal phase by programmed cell 
death. Thus apoptosis was suppressed in the epithelium in accordance to the high levels of 
progesterone from the functional corpora lutea, and the surface epithelium remained in a low 
columnar or cuboidal state. Okano and coworkers further suggested that apoptosis frequently 
switches from the surface epithelium to the stromal cells during estrus (Okano et al., 2007). The 
expression patterns of genes assigned to ‘regulation of apoptosis’ indicate a complex 
rearrangement of cells including cell death and proliferation in the porcine endometrium during 
this time of the estrous cycle. However, the relationship between apoptosis and uterine function 
in the pig has not been fully analyzed yet. In order to understand the interaction of these genes 
and their products, further detailed studies of dynamic protein expression and localization of 
expression in different endometrial compartments have to be performed.  
Blood levels of estrogen reach a peak during estrus phase which is rapidly followed by a marked 
surge of progesterone during the early luteal phase. Estrogens regulate growth, development, 
and behavior associated with reproduction. As already mentioned, one pivotal effect of estrogen 
is its regulation of estrogen receptor 1 (ESR1) and progesterone receptor (PGR) gene 
expression. The presence of these specific receptors is the primary determinant of tissue 
responsiveness to steroid hormones (Webb et al., 1992); estrogen up-regulates both receptors, 
whereas progesterone inhibits ESR1 expression and has a negative effect on PGR expression 
in epithelial cells (Spencer et al., 1996). During the ovine estrous cycle, ESR1 and PGR 
abundance increases as levels of estrogen rise in the circulation (Koligian et al., 1977, Ott et al., 
1993). The observed mRNA expression pattern for estrogen receptor 1 (ESR1) in the porcine 
endometrium during the estrous cycle are in good agreement to latter statement; highest 
expression on day 0, decrease on day 3 and lowest expression during the luteal phase. In porcine 
endometrium, mRNA for one estrogen-related receptors that have been shown to share target 
genes, co-regulatory proteins, etc. with classical ESRs and are able to influence the estrogenic 
response (Giguere, 2002), estrogen-related receptor beta (ESRRB), was differentially expressed 
with highest expression on day 3. As already mentioned binding and activation by 
phytoestrogens have been shown (Hirvonen, 2011) for estrogen-related receptors although 
ESRRs lack identified natural ligands (orphan nuclear receptor). Furthermore, the actions of 
progesterone on tissues are controlled through interaction with the progesterone receptor 
(PGR), which has been characterized as a ligand activated transcription factor that functions to 
regulate gene expression (Pru et al., 2013). In the pig, PGR mRNA and protein decrease in the 
uterine luminal epithelium during the first week of the estrous cycle (Mathew et al., 2011). 
Results of a recent study showed further down-regulation in PGR as less pronounced in the 
uterine glandular epithelium and occurrence within the endometrial stroma or within the 
myometrium (Geisert et al., 1994). In addition, PGR down-regulation in the pig uterus is 
initiated by day 8 and is completed by day 12 in both cyclic and pregnant animals (Geisert et 
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al., 1994, Persson et al., 1997). Microarray data in this study are in good agreement as they 
showed down-regulation of PGR mRNA after day 0 with lowest level on day 12. Cellular 
mechanisms that control the down-regulation itself, however, are largely unknown.  
During the estrous cycle and the establishment of pregnancy, endometrial cells undergo rapid 
growth and differentiation, extracellular matrix (ECM) break down and remodeling (Curry et 
al., 2001, Yamada et al., 2002). These changes in the endometrium are partly modulated by the 
expression of the matrix metalloproteinase system, a disintegrin and metalloproteinase with 
thrombospondin motif (ADAMTS)-1 and extracellular matrix metalloproteinase inducer 
(EMMPRIN) in coordination with ovarian steroids (Mishra et al., 2010). In accordance with 
DAVID functional annotation which revealed the biological term ‘extracellular matrix’ as over-
represented (starting on day 0 and continuing to day 3), several genes representing the matrix 
metalloproteinase (MMP) family (MMP2, MMP7, MMP12, and MMP14 - highest mRNA on 
day 0 and MMP11, MMP17, and MMP25 – highest mRNA from day 0 to day 3) were found as 
highly expressed during this time in cycle. The MMP family consists of more than 20 related 
proteolytic enzymes which include four comprehensive classes: collagenases, gelatinases, 
stromelysins, and membrane-type enzymes (MT-MMPs). These proteinases exhibit common 
features such as i) synthesis of the MMPs as preproenzymes that are secreted as inactive pro-
MMPs, ii) activation of the latent zymogen in the extracellular space, iii) recognition and 
cleavage of the ECM by the catalytic domain, and iv) inhibition of MMP action in the 
extracellular environment by both serum-borne and tissue-derived metalloproteinase inhibitors 
(TIMPs) (as reviewed in (Curry et al., 2001). The collagenases (i.e., MMP-1, MMP-8, and 
MMP-13) are able to catalyze a crucial cleavage of collagens which changes the stability and 
solubility properties. Conspicuously in this context, none of these MMPs were found as 
differentially expressed in the porcine endometrium. In addition, the functional category 
’collagens’ was over-represented starting from estrus and continuing till metestrus. Several 
genes showed highest mRNA expression assigned to this category on day 0 (COL1A1, 
COL1A2, COL3A1, COL4A1, COL5A1, COL12A1, and COL 17A1) and from day 0 to day 3 
(COL4A5, COL4A6, COL5A2, COL6A3, COL7A1, COL14A1, and COL15A1) in the 
endometrium of the pig. The results from qPCR analysis validated highest mRNA expression 
of the gene COL1A1 on day 3. As noted above, the activity of the MMPs in the extracellular 
space is controlled by MMP inhibitors referred to as tissue inhibitors of metalloproteinases 
(TIMPs). TIMPs 1-4 have been shown to be involved in the maintenance of balanced ECM 
remodeling. In general, far less tissue remodeling occurs during the estrous cycle exhibited by 
many mammalian species compared to primates. Therefore, in the uterus of domesticated 
animals, only moderate expression of MMPs and their interaction with TIMPs has been 
observed compared to more robust expression during the tissue-loss and -repair processes that 
are the hallmark of the menstrual cycle (Curry et al., 2001). Some studies analyzing the cyclic 
changes of MMP mRNA expressions during the estrous cycle, e.g. in rodents have been 
performed (Rudolph-Owen et al., 1997, Woessner, 1996) showing MMP-2, MMP-7, and MMP-
11 as highly expressed during preestrus and estrus. Furthermore, the expression profile of the 
MMP system and their interaction with their inhibitors in the uterus of domestic species, 
including the cow (Maj et al., 1997) and sheep (Salamonsen et al., 1995) were reported only in 
association with the tissue dynamics of pregnancy. In this regard results of the study from 
Ulbrich et al. indicated a TIMP-2 involvement in very early local maternal recognition of 
pregnancy (Ulbrich et al., 2011) in cattle. In addition, studies in gene expression in bovine 
endometrium during the estrous cycle indicated a stimulation of TIMP-2 by progesterone 
(Bauersachs et al., 2005, Hampton et al., 1995). In ovine endometrium, TIMP2 mRNA (1·0 kb 
transcript) abundance has been shown to be stimulated by P4 and to be increased on day 10 of 
the cycle (Hampton et al. 1995). Microarray data showed up-regulation of TIMP-3 mRNA 
expression on day 12 (validated by qPCR analysis) and of TIMP2 mRNA from day 12 to day 
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18 during the porcine estrous cycle confirming a stimulation by P4. Furthermore, estrogens, 
interferons (IFNs), and prolactin (PRL) have the potential to interact with P4 to influence 
synthesis of SPP1 (secreted phosphoprotein 1- commonly referred to as osteopontin (OPN) and 
formerly known as bone sialoprotein 1, early T-lymphocyte activation 1) in the GE (Craig et 
al., 1991). In addition, increases in transcription of the OPN gene may be induced by 
interleukin-1 beta (IL-1ß), transforming growth factor beta-1 (TGFß1), fibroblast growth factor 
(FGF), tumor necrosis factor alpha (TNFa), interferon gamma (IFNγ), and 1,25-dihydroxy 
vitamin D3 (Mukherjee et al., 1995, Omigbodun et al., 1997, Rittling et al., 1997, Safran et al., 
1998). Its expression is regulated in LE by estrogens but whether estrogens act directly on LE 
or indirectly through another uterine factor still remains unknown. The conservation across 
various forms of placentation suggests that SPP1 provides functions that are basic to pregnancy 
establishment and maintenance (White et al., 2005). Additionally, Burghardt and coworkers 
(Burghardt et al., 2002) showed that SPP1 is a component of the ovine and porcine histotroph 
which is characterized by a complex temporal and spatial pattern of uterine and conceptus 
secretions involving immune, epithelial and stromal cells. It is further found that these events 
are orchestrated to contribute to conceptus attachment and implantation and, conclusively, 
hypothesized that OPN has potential influence on the events of implantation and subsequent 
placental development. To date no published data exist on the role of OPN during the 
reproductive cycle. Microarray data showed highest mRNA expression level for SPP1 on day 
0 (validated by qPCR analysis) in non-pregnant pigs. In general, OPN binds primarily to αvß3 
integrin heterodimers by its Arg-Gly-Asp (RGD) sequence, however, other OPN receptors have 
been described; the integrin heterodimers αvß1, αvß5, and αv8ß1 have affinities for the RGD 
motif of OPN that are similar to αvß3 (Denda et al., 1998, Hu et al., 1995) and OPN contains a 
cryptic binding sequence recognized by the αv9ß1 integrin heterodimer (Smith et al., 1996). 
Several genes coding for integrins (20 genes) were found as differentially expressed throughout 
the porcine cycle; most showed highest levels during estrus but only one integrin alpha v with 
no specific ß subunit - integrin, alpha V (ITGAV-vitronectin receptor, alpha polypeptide, 
antigen CD51). It was also demonstrated in sheep that OPN contains a Gly-Leu (GL) sequence 
which is indicative of those that are susceptible to cleavage by various MMPs. Indeed, 
commercial substrates for MMP 2 and MMP 7 activity contain this sequence (Pro-Leu- Gly- 
Leu) and substrates for MMP 1, 3, 8 and 9 all contain variations on the x-y-Gly-z motif 
(Salamonsen et al., 1995). Johnson and coworkers summarized and defined the functions of 
OPN (as reviewed in (Johnson et al., 2003) as i) an ECM molecule that mediates cell-cell and 
cell-matrix adhesion and communication, ii) a cytokine that can exhibit pro-inflammatory 
properties (e.g., macrophage/monocyte and T-cell recruitment and stimulation of cytokine 
production), anti-inflammatory actions (e.g., inhibition of inducible nitric oxide production and 
MMP-2 expression), and effects on tissue repair at sites of inflammatory responses, and iii) an 
intracellular protein associated with hyaluronan-CD44-ERM (ezrin/radixin/moesin) 
attachement complex in migrating cells. In domestic animals, there is a delay between 
blastocyst hatching from the zona pellucida and conceptus attachment to the uterine epithelium, 
and this is referred to as the pre-implantation stage. The ability of blastocysts to adhere to a 
variety of cell types and extracellular matrix (ECM) components and of the normally 
noninvasive pig blastocyst to invade and form a syncytium when placed on an ectopic site 
(Samuel et al., 1972) supports the concept of uterine control of implantation. However, during 
the pre-receptive, non-adhesive stage, uterine epithelial cells are known to exhibit an abundant 
surface glycoprotein, mucin 1 (Bowen et al., 1996, Burghardt et al., 2002) (Muc-1, cell surface 
associated) that diminishes during the receptive phase in most mammals including the pig. 
Bowen and coworkers (Bowen et al., 1996) showed Muc-l staining on the apical surface of 
porcine endometrial epithelium as maximal at estrus (Day 0) and on Day 4, but decreased to 
non-detectable levels by Day 10 in both cyclic and pregnant gilts. The microarray data showed 
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highest mRNA expression of Muc-1 on day 0 and lowest during the luteal phase of the porcine 
cycle. In addition, DAVID functional annotation clustering revealed the biological terms ‘cell 
adhesion’ and ‘cell-cell adhesion’ as over-represented during estrus. Furthermore, the 
accessibility of integrin receptors to their ligands may be controlled by the cyclic pattern of 
anti-adhesive glycoproteins such as MUC1 which may constitute a barrier to invasiveness on 
the LE in pigs and sheep. Available evidence indicates that the implantation adhesion cascade 
in these species is initiated following down-regulation of MUC1 (Bowen et al., 1996, Burghardt 
et al., 2002, Johnson, 2001). As a multiparous animal, the pig usually ovulates more than one 
follicle during one cycle, which is why the porcine endometrium must provide more structural 
flexibility. A sophisticated balance between the MMPs and their inhibitors is necessary to allow 
remodeling of the ECM while limiting the site and extent of proteolysis. A more accurate 
understanding of the role that MMPs and TIMPs play as regulators of growth, cellular 
differentiation, and specialized tissue function is crucial to fully comprehend all aspects of 
ovarian and uterine physiology (Curry et al., 2001) and the morphological regulation pattern 
during the estrous cycle, respectively. Results of gene expression patterns suggest a role of OPN 
in ECM remodeling in the cycling pigs and a possible interaction with Muc-1 and other 
unknown interacting partners contributing from uterine pre-receptive to receptive stage. The 
expression pattern clearly indicate a positive effect of estrogen signaling on both genes. Hence, 
the function and regulation of SPP1 and interacting partners such as Muc-1 and integrins is a 
very complex field, further analysis has to be performed. 
2.2.2. Genes with highest mRNA expression during metestrus  
Following estrus, estradiol that is suggested to lead to a pro-inflammatory response within the 
uterus (Tibbetts et al., 1999) decreases and progesterone which creates an anti-inflammatory 
environment by regulating the expression of various cytokines (Park et al., 2011) increases. 
Several genes related to the biological categories ‘immune response’ and ‘inflammatory 
response’ showed highest mRNA concentrations during the estrous cycle (D0, D3 and D6) in 
the porcine endometrium. These genes mainly represented the chemokine (C-C motif) ligand 
family (CCL3L3, CCL5, CCL8, CCL11, CCL17, CCL21, CCL26, CCL27, CCL28) and the 
chemokine (C-C motif) receptors (CCR1, CCR2, CCR4, CCR5, CCR7, CCR 9, CCR10), the 
chemokine (C-X-C motif) ligand family (CXCL2, CXCL3, CXCL4, CXCL6, CXCL9, CXCL10, 
CXCL11, CXCL17) and the chemokine (C-X-C motif) receptor (CXCR3, CXCR4, CXCR6). 
Microarray data of C-X-C chemokine receptor type 4 (CXCR4) confirm biological functional 
terms and processes with slightly deferment results in qPCR analysis. In addition to 
chemokines, some representatives of the interleukin family (IL1ß, IL4, IL5, IL6, IL7, IL8, IL10, 
IL15, IL16, IL18) and theirs respective receptors (IL2RB (interleukin-2 receptor subunit beta-
like), IL4R, IL6R, IL7R, IL17RE (interleukin-17 receptor E-like), IL21R (interleukin-21 
receptor-like), IL22RA1 (interleukin 22 receptor, alpha 1)) showed higher mRNA 
concentrations on D0, D3 and D6 during the estrous cycle. In women, interleukins (IL11 and 
IL15) were demonstrated to stimulate the proliferation of human natural killer (NK) cells and 
cytokine production by these cells and can affect the proliferation and differentiation of T helper 
cells within the uterus (Dimitriadis et al., 2002, Okada et al., 2000). Besides, NK cells are 
suggested to play a role during pregnancy (Kaeoket et al., 2001). To date the role of NK cells 
in the porcine endometrium during the estrous cycle is not clarified, and neither published study 
exist about the specific role of the immune system during the estrous cycle. In addition to 
categories assigned to immune functions, the biological terms ‘cell-cycle’, ‘mitosis’ and 
‘chromosome’ were found as over-represented during this time in cycle. In this regard, 
microarray data showed the gene cyclin E1 (CCNE1) and cyclin dependent kinase 4 (CDK4) as 
highest expressed on day 3 (both genes were validated by qPCR analysis). Supposedly there is 
a connection between cell proliferation pattern and ‘immune-sytem’ functions since the NK 
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cells in the pig are present in the uterine stroma and infiltrate the surface and glandular 
epithelium during early diestrus.  
As already noted, fibroblast-growth factor 9 (FGF9) has been described as one of the mediators 
of estrogen signaling in the endometrium (Tsai et al., 2002). The results of the study by Østrup 
et al (Østrup et al., 2010) showed that FGF9 up-regulation in pregnant porcine endometrium 
might be stimulated by the conceptus, whereas its receptor FGFR3 is down-regulated. In 
contrast, FGF9 mRNA concentration in the cycling porcine endometrium was highest on day 
3 during the cycle and its receptor (FGFR3) was up-regulated during luteal phase. Additionally, 
FGF9 was identified previously as a growth factor in human endometrium. The localization is, 
however, different. In pigs, the strongest staining for FGF9 was observed at the apical domain 
of the glandular epithelial cells (Østrup et al., 2010) in humans, glandular epithelium only 
expresses the gene at low levels (Tsai et al., 2002). The expression patterns of FGF9 and its 
receptor (FGFR3) suggest that these genes not only play a role involved in pregnancy but during 
the estrous cycle as well. Furthermore, fibroblast-growth factor receptor 1 (FGFR1) mRNA 
expression was up-regulated from day 0 to day 3 during the porcine reproductive cycle 
(validated by qPCR analysis). The study of Agas et al. (Agas et al., 2013) showed that PGF2a 
acts as a strong mitogenic and survival agent on osteoblasts, and these effects are mediated, at 
least in part, by the binding of fibroblast growth factor-2 (FGF-2) to the specific receptor 
FGFR1. Although FGF-2 was identified in endometrial epithelium, stroma and myometrium of 
gilts during the estrous cycle, no regulative changes were detected (Wollenhaupt et al., 2004). 
Finally in this context, it has been shown that estrogens produced by porcine conceptuses bind 
to ESR1 in the LE to induce the maximal levels of FGF7 expression observed on day 12 of 
pregnancy (Ka et al., 2007). In addition, Samborski (Samborski et al., 2013) and coworkers 
found decreased expression of FGF7 in day 14 pregnant endometrium that agrees with the 
negative effect of long-term estradiol treatment on FGF7 expression, which were found in 
neonatal ovine endometrium (Hayashi et al., 2005). Furthermore, higher expression of FGF7 in 
porcine endometrium on day 12 of pregnancy and after E2 treatment of endometrial explants 
from day 9 of the estrous cycle was observed (Ka et al., 2000). The latter group suggested an 
indication of a specific role of the growth factor FGF7 particularly during the time of conceptus 
elongation between days 10 and 12 in pregnancy. FGF-7 is known to be involved in 
differentiation, and morphogenesis via binding to the transmembrane tyrosine kinase receptor 
FGFR2IIIb (Ornitz et al., 1996). Microarray data revealed higher expression of FGF-7 and 
FGFR2 from day 12 to day 18 which is in correlation to findings of recent studies (Ka et al., 
2000, Wollenhaupt et al., 2005) and suggests a P4 dependent expression in non-pregnant sows. 
The results of gene expression patterns of the fibroblast-growth factors and their respective 
receptors indicates a steroid hormone-dependent signaling shift; estrogen signaling during 
estrus phase and conceptus signaling in case of pregnancy during luteal phase. Altogether, the 
complex regulation of genes involved in steroid hormone signaling suggests an important role 
of the corresponding genes in the regulation of endometrial functions during the estrous cycle. 
The results in this study suggest an estrogen induced immune answer in regard to cell 
proliferation and degeneration involved in remodeling of the endometrium. 
2.2.3 Genes with highest mRNA expression during the luteal phase 
Not only the endometrium but also blastocysts in many species, including mouse (Marshburn 
et al., 1990), rat (Parr et al., 1988), rabbit (Dey et al., 1980), sheep (Hyland et al., 1982) cow 
(Lewis et al., 1982), human (Holmes et al., 1980) and pig (Davis et al., 1983) appear to have 
the capacity of transforming arachidonic acid into its biological active derivatives via PG G/H 
synthase enzyme (PGHS) pathway, resulting in the production of PGE2 and PGF2a. Our results 
of the microarray analysis showed increased expression of prostaglandin E receptor 4 gene 
(PTGER4) already shortly after ovulation and prostaglandin E receptor 3 gene (PTGER3) 
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during early luteal phase, while prostaglandin E receptor 2 gene (PTGER2), phospholipase A2-
like, group IVA (PLA2G4A), solute carrier organic anion transporter family, member 2A1 
(SLCO2A1, PG transporter) and the prostaglandin F receptor (PTGFR) were up-regulated 
during the luteal phase. It has been found during the time around luteolysis, when PGF2a pulses 
in venous blood are high, that COX-1 and -2 expression in porcine endometrium (Ashworth et 
al., 2006) as well as the expression of PGF synthase (Waclawik et al., 2006) significantly 
decrease on days 16 to 20 in the cycle. These data confirm that the higher PGF2a peaks in 
venous blood during luteolysis do not result from the ongoing intensified synthesis and 
secretion of PGF2a. Furthermore, it was suggested that this finding could be a result of 
degeneration of endometrial cells from which PGF2a is released, as well as the excretion of 
tissue fluid containing proteins binding PG’s and their metabolites, which takes place during 
uterine contraction (Krzymowski et al., 2008). Microarray data showed that cyclooxygenase-2 
(COX-2, also known as prostaglandin-endoperoxide synthase (PTGS)) was up-regulated 
starting on day 12 continuing to day 18 indicating an interaction of these genes with uterine 
contraction but no analysis was performed measuring PGF2a concentration in venous blood. 
The peak of COX-2 expression could therefore be within day 12 and day 18 of the estrous cycle 
since the day of luteolysis (D14) was not analyzed. In addition, results of a recent study showed 
a significant increase in endometrial PTGS2 mRNA in the endometrial LE from day 10 to day 
18 of the estrous cycle and early pregnancy, where it is optimally placed to possibly mediate 
placentation in pigs (Kraeling et al., 1985). Latter researchers hypothesized that the increased 
expression of PTGS2 in the uterine LE is temporally associated with the loss of the progesterone 
receptor (PGR) from the uterine LE (Geisert et al., 1994) and further suggested a possible 
induction through activation of the NFkB pathway which has been detected in the human 
endometrium (Page et al., 2002). In the pig uterus oxytocin receptor (OXTR) was expressed in 
greatest abundance on luminal epithelial cells, whereas stromal cells possessed the least amount 
of receptors (Boulton et al., 1996). Oxytocin receptors have been characterized on the 
endometrium of cyclic pigs (Whiteaker et al., 1994) and on the myometrium from a late 
pregnant sow (Soloff et al., 1974). Microarray analysis of the porcine endometrium revealed 
higher expression of OXTR mRNA from day 12 to day 18 and highest on day 18 of the estrous 
cycle indicating a role in the regulation of luteolysis in the pig. Altogether, gene expression of 
genes related to PG and steroid hormone metabolism and signaling was clearly highest during 
luteal phase.  
In the uterus, spatiotemporal synthesis and secretion of various growth factors, cytokines, lipid 
mediators and transcription factors triggered by steroid hormones are thought to play an 
important role in uterine function. The process of angiogenesis and regulation of blood flow 
plays also an important role in the context of endometrial remodeling during the estrous cycle 
(Bauersachs et al., 2008). Vascular endothelial growth factor (VEGF) has emerged as an 
important regulator of angiogenesis (Wollenhaupt et al., 2004). The latter research group found 
endometrial VEGF as sensitive to P4 signaling in the pig. Microarray data of this study are in 
good agreement since VEGFA mRNA was up-regulated during luteal phase. In addition, 
neuropeptide Y (NPY) is a potent angiogenic factor as well as a stimulator of vascular smooth 
muscle proliferation (Abe et al., 2007) and was found as up-regulated from day 6 to day 12 in 
porcine cycle. The bovine proenkephalin (PENK) mRNA, which is increased during diestrus, 
was found to be up-regulated in the rat endometrium during secretory phase (Jin et al., 1988) 
and also positively regulated by progesterone in the endometrium of mice (Cheon et al., 2002). 
For this gene the mRNA pattern is similar in ruminant species and rodents, but different in 
primates. Microarray data for porcine endometrium showed PENK as up-regulated during 
diestrus. Furthermore, the receptor for endothelial cell regulation 1 (EDN1) and angiotensin I 
converting enzyme (peptidyl-dipeptidase A, ACE) were found as highly expressed from day 3 
to day 6. Messenger RNA levels were highest for members of the angiopoietin system TEK 
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(tyrosine kinase, TEK), leucyl/cystinyl aminopeptidase (LNPEP), type-1 angiotensin II 
receptor-like (AGTR1), cathepsin A (CTSA) and angiotensinogen-like (AGT) which codes for 
the progenitor of angiotensin II (a potent vaso-constrictor) and was described to regulate feto-
placental angiogenesis in the ovine placenta (Zheng et al., 2005) on day 18 of the porcine 
estrous cycle. Wollenhaupt further found that one of the two receptors for VEGF (VEGF-R2) 
is only increased after the treatment with both steroid hormones. This would demand the 
interaction with conceptus estrogen signaling during early pregnancy when P4 is elevated. In 
addition, the results of this work showed up-regulation of VEGF system (a co-receptor for 
VEGF, neuropilin 1 and 2, NRP1 and NRP2), thimet oligopeptidase 1 (THOP1) and glutamyl 
aminopeptidase (aminopeptidase A, ENPEP) but during estrus phase. Following estrus, 
endothelin 3 (EDN3) and the rennin-binding protein (RENBP) showed highest expression from 
day 0 to day 3. However, most of the genes assigned to the biological category ‘angiogenesis’ 
and ‘vasculature’ in the pig showed fluctuating profiles: their highest mRNA concentrations 
were found during estrus, from day 3 to day 6 but also on day 18. This also indicates a more or 
less independency in signaling from either steroid hormones, or at least, when both E2 and P4 
are necessary for activation, an interaction with conceptus estrogens.  
Several research groups (Hammond et al., 1993, Mukku et al., 1985, Watson et al., 1996) stated 
that one mechanism for steroid hormones to exert their mitogenic effects on the ovary and the 
uterus might be by stimulating the epidermal growth factor receptor (EGF-R) system 
(Hammond et al., 1993). Wollenhaupt (Wollenhaupt et al., 2004) found EGF-R to be distributed 
in glandular and stromal cells in the porcine endometrium and significantly increased 
concentration within preestrus compared to luteal phase during the reproductive cycle. The 
results of microarray analysis of the porcine endometrium showed an up-regulation of 
epidermal growth factor (EGF), receptor tyrosine-protein kinase erb-3-like and erbB-4-like 
(ERBB3, ERBB4) and erbb2 interacting protein (ERBB2IP) mRNAs from day 12 to day 18 
during the estrous cycle. Furthermore, results of latter study showed an independence of EGF-
R activation from steroid hormones because of no difference in tyrosine phophorylation status 
of the EGFR-R protein on days 12 and days 20 in ovarieectomized pigs. Altogether, more 
detailed studies are required to identify the role of steroid hormone signaling in relation to the 
EGF-R system in the porcine endometrium. 
2.2.4 Genes with highest mRNA expression during late luteal phase 
Steroid hormones are important regulators of reproductive physiology in domestic animals. 
Both estradiol and progesterone mediate dramatic changes in the endometrium during the 
estrous cycle. As already noted, the samples collected on day 18 (assumingly the time for the 
beginning of estrus and therefore low P4 concentrations) showed higher concentrations of P4 
and should be considered as samples collected during late luteal phase. DAVID functional 
annotation clustering revealed the biological category ‘complement activation, classical 
pathway’ as over-represented on day 18. Furthermore, microarray analysis showed five genes 
related to this category as highly expressed; clusterin (also known as apolipoprotein J, CLU), 
complement component 1,s subcomponent (C1s), complement component 1,r subcomponent 
(C1R), complement component 6 (C6) and SERPING1. Role and function of the complement 
cascade in the pig endometrium were not analyzed to date but were already discussed (2.1.1) in 
regard of gene expression during the estrous cycle in equine endometrium. The up-regulation 
in porcine endometrium clearly indicates an involvement of P4 in the complement cascade 
activity. 
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Figure IV-2: Summary of the results from the analysis of porcine endometrium during the estrous cycle The 
porcine estrous cycle is illustrated as black circle (cycle in length is 21 days; from D0 to D0 which is defined as 
the day of ovulation) with main phases and the analyzed days (D0, D3, D6, D12, D18-external lettering). 
Progesterone (P4) concentration during the particular phase is given in each corner. Over-represented biological 
functions during the specific phases of the estrous cycle-achieved from DAVID functional annotation clustering 
analysis-are represented in internal circle (pink). External circle (green) shows single genes or groups represented 
by several genes with highest mRNA expression during the time in estrous cycle. Conclusions about potential 
connection with function of the endometrium are demonstrated in blue area. Connection between events are 
demonstrated with arrows. CCNE1-cyclin E1, CDK4-cyclin dependent kinase 4, ECM-extracellular matrix, e.g.-
for example, ESR1-estrogen receptor 1, gamma, Fas- Fas (TNF receptor superfamily member 6), GPER- G protein-
coupled estrogen receptor, ITGAV-integrin alpha 5, MUC-1-mucin 1, MYC-v-myc avian myelocytomatosis viral 
oncogene homolog, NK-natural killer cells, NOS1,3- nitric oxide synthase 1 and 3, OXTR-oxytocin receptor, 
PGRMC1,2-progesterone receptor membrane component 1 and 2, SPP1- secreted phosphoprotein 1 (osteopontin), 
PGR-progesterone receptor, PMN-polymorphnuclear neutrophils, PTGS2- prostaglandin-endoperoxide synthase 
2, PTGER3,4-prostaglandin receptor 3 and 4, VEGFA-vascular endothelial growth factor A2.3 
 Messenger RNA expression profiles in the endometrium during equine and 
porcine estrous cycle 
So far the present study revealed widespread gene expression changes in equine and porcine 
endometrium during the estrous cycle involving a total number of approx. 14271 genes. These 
gene expression changes were associated with molecular pathways and gene networks that 
describe ECM remodeling and other processes, e.g., immune response and changes in 
vasculature. Given these results, it is crucial to investigate whether these changes in gene 
expression are common or species-specific. Therefore a correlation analysis was performed 
which showed approx. 1862 genes/transcripts referred to as differentially expressed (listed in 
supplementary data) in both species out of which 841 genes showed significant correlation 
(p<0.05). A total number of 691 genes showed positive and 150 genes showed negative 
correlation. Figure IV-3 summarizes the results of the correlation analysis. 
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2.3.1 Genes with highest mRNA expression during preestrus (low P4 levels) 
The phase immediately preceding estrus or the end of luteal phase is characterized by basal 
plasma P4 concentration. In the mare, preestrus begins around day 16 (also referred to as estrus 
phase) which corresponds more or less to day 18 (also referred to as late luteal phase) in the 
pig. Comparing the genes assigned to Clusters 8 (highest mRNA expression on day 16 and on 
day 18, respectively) in both analyses one have to keep in mind, that the P4 concentration of 
blood samples from day 18 in the pig were still relatively high.  
A total number of 47 genes (positively correlated) were up-regulated in both species during this 
time in the cycle. The functional annotation clustering analysis revealed biological terms such 
as ‘cytokine-cytokine receptor interaction’, ‘cell adhesion’, ‘complement activation-classical 
pathway’ and ‘inflammatory response’ as over-represented. For example, SERPING1 and CR1 
were found as highly expressed in both species during this time. Both genes might be 
functioning in the context of ‘immune system’ – as already discussed – as well as the category 
‘complement activation-classical pathway’ since the complement activation is one key 
component of the innate inflammatory response. In addition to inducing inflammation, the 
complement system plays a major role in protecting against infection and killing diseased cells 
(Morris et al., 2009). Most SERPINs inactivate serine proteases and some cysteine proteases, 
and play a functional role in diverse biological processes including fibrinolysis, coagulation, 
inflammation, cell mobility, cellular differentiation and apoptosis (Hayashi et al., 2011, Law et 
al., 2006). SERPING1 is also discussed to be collagen binding and therefore debated to take 
action in the ECM remodeling process in the bovine follicle (Hayashi et al., 2011). Since the 
functional category ‘extracellular matrix’ showed minor over-representation during this time of 
the cycle in both species an involvement in ECM remodeling of SERPING1 is reasonable but 
remains suspicious and further studies in this regard are needed. In addition, SERPINH1 (serpin 
peptidase inhibitor, clade H, member 1), also known as HSP47, was described as collagen-
binding protein of the endoplasmic reticulum involved in collagen processing and secretion 
(Nagata, 1996). Microarray data showed up-regulation for SERPINH1 mRNA from day 0 to 
day 3 in the pig but no regulation in the mare. In the study of Yip and coworkers, many genes 
of the ‘complement and coagulation cascade’ showed lower level of expression in the estrus 
than in the proestrus during the estrous cycle in mice (Yip et al., 2013). The authors found that 
mRNA expression of C3 was elevated in proestrus compared to estrus which is because E2 
stimulates the synthesis of C3, whereas simultaneous or delayed administration of P4 inhibits 
its synthesis (Hasty et al., 1994). Nevertheless, microarray data from this study showed highest 
expression of C3 from day 3 to day 6 in the pig and on day 16 in the mare. Interestingly, 
functional annotation revealed – as already mentioned – terms such as ‘complement activation, 
classical pathway’ and ‘immune response’ as over-represented categories with negative 
correlation; both terms were over-represented in the mare on day 16 but during the early luteal 
phase in the pig. Vice versa, the categories ‘collagen’ and ‘cell junction’ showed over-
representation in the pig on day 18 but on day 8 in the mare. These findings contradict the 
statements of general inhibitory P4 steroid-hormone signaling on C3 (Hasty et al., 1994).  
 Genes with highest mRNA expression during estrus  
Positively correlated genes assigned to Clusters 1 (highest mRNA expression on day 0) 
summarized a number of 48 genes and the genes clustered together in Clusters 2 (highly 
expressed from day 0 to day 3) during the estrous cycle summarized a number of 34 genes. 
Functional annotation clustering of these genes revealed the biological terms ‘extracellular 
region’, ‘collagens’ and ‘focal adhesion’ as over-represented during this time. Four genes were 
assigned to the collagen family (COL1A2, COL3A1, COL4A1, and COL5A1; CL1A1 did not 
show significant correlation; r=0.59 and p-value=0.07). In addition, COL4A5, COL4A6 and 
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COL7A1 were differentially expressed in both species but increased on different times in the 
cycle: on day 0 in the mare and from day 0 to day 3 in the pig. Furthermore, the functional 
terms ‘cell adhesion’ and ‘cell-cell adhesion’ were found as over-represented during this time 
in the estrous cycle. The ADAM metallopeptidase domain 12 and 22 (ADAM12, ADAM22) 
mRNAs were found to be assigned to these categories. Additionally, ADAM metallopeptidase 
with thrombospondin type 1 motif, 19 (ADAMTS19) was found as up-regulated in both species; 
on day 0 in the pig and from day 0 to day 3 in the mare. Members of this family are membrane-
anchored proteins and have been implicated in a variety of biological processes involving cell-
cell and cell-matrix interactions, including fertilization, muscle development and neurogenesis 
which indicates a relation to ECM remodeling that is processing at this time in cycle. As already 
mentioned, ECM turnover and homeostasis is controlled, in part, by the interplay of a specific 
class of proteolytic enzymes known as the matrix metalloproteinases (MMPs) and their 
inhibitors (TIMPs-tissue-derived metalloproteinase inhibitors) (as reviewed in (Curry et al., 
2003). Several members of both families showed highest mRNA levels during the estrus phase 
in the mare and in porcine endometrium but only one representative of the family, namely 
MMP11, was differentially expressed in both species but was excluded by statistics (p-value = 
0.31). This clearly indicates a species-specific regulation of ECM remodeling on single gene 
basis. Probably, in connection with increased, species-specific ECM synthesis, genes relevant 
for protein folding and secretion were found as enriched during estrus. The biological category 
‘ribosome’ and ‘translation elongation’ showed over-representation from day 0 to day 3 in both 
species and additionally on day 3 in the pig. Nine genes coding for ribosomal proteins (RPL18, 
RPL22, RPL29, RPL36AL, RPLP2, RPS10 RPS15, RPSA and RPSAP58) showed highest 
mRNA expression from day 0 to day 3 in the mare and up-regulation on day 3 in the pig. RPL8 
and RPS18 mRNA were increased from day 0 to day 3 in both species. In addition to functional 
categories related to ECM remodeling, the functional term ‘inflammatory response’ was over–
represented on day 0. Two representative genes assigned to this category and coding for the 
chemokine family (C-X-C motif) CXCL6 and CXCL8 were found as up-regulated in both 
species on day 0. The chemokine (C-X-C motif) ligand 9 (CXCL9) showed highest mRNA 
expression on day 0 in the mare and from day 0 to day 3 in the pig.  
Estrogen, acting through its receptor ERα (also known as ESR1), is a critical regulator of uterine 
endometrial epithelial proliferation. Although the dynamic communication between 
endometrial stromal and epithelial cells is considered to be an important component in this 
process, key molecular players in particular compartments remain poorly defined (Pabona et 
al., 2009). Even though both species showed mRNA expression of ESR1 in the endometrium 
during the estrus phase (on day 0 in the pig and on day 3 in the mare) but statistical correlation 
analysis of mRNA levels did not reach significant importance (correlation r=0.41, p-
value=0.24). In addition, Kruppel-like factor 9 (KLF9) (a member of the Kruppel-like family 
of mammalian zinc finger-containing transcription factors and previously designated basic 
transcription element binding protein-1 (BTEB1)) is debated (Dang et al., 2000) to function as 
a co-regulator of steroid hormone receptor signaling in the uterine endometrium (Zhang et al., 
2002). P4 together with estrogen and uterine-associated growth factors coordinates cellular 
proliferation, differentiation, and apoptosis in a temporal- and spatial-specific manner by 
binding to its nuclear receptor PGR (Tsai et al., 1994) which is expressed and regulated 
distinctly in the epithelial and stromal compartments of the uterus (Tibbetts et al., 1998). 
Microarray results of this study showed highest mRNA expression of KLF9 in Clusters 8. 
Results of a recent study by Zhang and co-workers (Zhang et al., 2002) implicate KLF9 as a 
PGR-interacting partner in vitro and suggest a novel mechanism by which progesterone 
regulates the expression of its target genes in uterine epithelial cells during pregnancy. Zhang 
and coworkers further postulated an interaction between KLF9 and HOXA10 in this context and 
showed that HOXA10 directly regulates KLF9 expression in porcine endometrial epithelial 
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cells. HOXA10 has been shown to be expressed in the adult murine (Taylor et al., 1997), canine 
(Guo et al., 2009), primate (Godbole et al., 2007), human (Taylor et al., 1997) and porcine uteri 
(Blitek et al., 2010). In pigs, HOXA10 protein was localized in the luminal and glandular 
epithelium, stroma and blood vessels of the endometrium but also in the myometrium of the 
uterus (Blitek et al., 2010). Furthermore, increased expression of HOXA10 in response to E2 
alone or in the presence of P4 was observed in the endometrium collected on day 9 after estrus 
of the porcine estrous cycle (Blitek et al., 2010). In addition, it was suggested that the activity 
of HOXA10 and HOXA13 may contribute to the differentiation and growth of myocytes during 
the peri-implantation period in pregenant pigs and may be involved in the morphological and 
ultrastructural adaptation of the myometrium to pregnancy (Franczak et al., 2014). HOXA10 
was contained in Clusters 1 and PGR in Clusters 2 which clearly agrees with the suggested 
estrogen action on HOXA10 expression. In addition, the interaction between KLF9 and 
HOXA10 and PGR signaling seems temporally delayed but common in distinct phases.  
Antagonism of estrogenic effects by androgens in the uterus (Leiva et al., 1991), mammary 
gland (Zhou et al., 2000) and sexual receptivity (Blasberg et al., 1998) have been described in 
rats or humans. In pigs, the primary circulating androgen is androstenedione (A4), which serves 
as the principal substrate for E1 synthesis (Simpson et al., 2001). Androgens are also 
synthesized and secreted locally by the porcine myometrium during both early pregnancy and 
luteolysis (Franczak, 2008). Kowalski and coworkers (Kowalski et al., 2004) suggested co-
regulatory roles of AR and ESR1 in endometrial gene expression and cell proliferation and 
further suggested that androgens may also functionally interact with the PGR-mediated 
program of endometrial gene expression. Results in this study showed AR and, as mentioned 
above, PGR as up-regulated (found in Clusters 2) verifying recent statement. 
2.3.2 Genes with highest mRNA expression on day 3 (increasing P4 levels)  
The results of the comparative analysis revealed a total number of 107 genes with positive 
correlation assigned together in Clusters 3 (highest mRNA expression on day 3). Tissue 
remodeling, mitotic activity, and DNA synthesis are accompanied by extensive cell 
proliferation, as indicated by the highest mRNA expression of several genes assigned to DNA 
replication and cell division. For example, cyclin dependent kinases 1 and 4 (CDK1, CDK4), 
cyclin B1, B2 and D1 (CCNB1, CCNB2, CCND1), 4 genes representing cell division cycle 6, 
20, 24 and A3 (CDC6, CDC20, CDC45, CDCA3) and 5 genes encoding centromere proteins 
(CENPE, CENPF, CENPL, CENPM, CENPN) showed up-regulation on this day, as well as 
SNRPA, respectively. In addition, genes encoding many minichromosome maintenance 
complex component proteins (MCM3, MCM4, MCM6 and MCM10) were up-regulated which 
help initiate DNA replication and are also involved in replication elongation (Forsburg, 2004). 
Functional annotation clustering revealed terms such as ‘cell cycle’, ‘mitosis’ and 
‘chromosome’ to be over-represented during this time in cycle. At the cellular level, calcium 
controls a wide variety of cellular functions, e.g., cell growth, proliferation, and cell death 
(Clapham, 2007). Maintenance of calcium balance in the uterus is also critically important for 
many physiological functions, e.g. smooth muscle contraction during embryo implantation 
(Choi et al., 2011a). Expression of the calcium regulatory molecules in the uterine endometrium 
has been reported in several species; e.g. transient receptor potential vanilloid type 6 (TRPV6) 
in the uterine endometrium during the estrous cycle and pregnancy in rats (Kim et al., 2006) 
and mice (Lee et al., 2007) and during the menstrual cycle in humans (Yang et al., 2011) and 
calbindin-D9k (S100G) in the uterine endometrium during the estrous cycle and pregnancy in 
mice (Warembourg et al., 1987), rats (Tatsumi et al., 1999) and pigs (Krisinger et al., 1995). 
Microarray data showed highest level of mRNA expression of TRPV6 in Clusters 7 and S100G 
in Clusters 3 in both species during the estrous cycle. The TRPV6 transcript was highly 
expressed at estrus during the murine estrous cycle, implying that it might be involved in a 
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specific uterine function such as Ca2+ transport (Lee et al., 2007). In contrast, TRPV6 transcripts 
in the rat uterus were highly expressed at diestrus (Kim et al., 2006). Both transient receptor 
potential vanilloid types 5 and 6 (TRPV5, 6) manage the influx of extracellular calcium ions 
into the epithelial cells which are then transported by calcium transport proteins, calbindin-D9k 
(S100G) and calbindin-D28k (CALB1), to the basolateral side of the epithelial cells. 
Subsequently, intracellular calcium ions are extruded to the outside of epithelial cells by 
sodium/calcium exchanger 1 (SLC8A1) (Choi et al., 2011b). SLC8A1 showed highest mRNA 
level on day 0 in both species but correlation did not reach statistical significance (correlation 
r=0.48, p-value=0.16). Taken together, these results indicate that uterine TRPV6, S100G and 
SLC8A1 are regulated differently during the estrous cycle. In the pig and the mare, calcium 
influx seems to start during late luteal phase which is in good agreement indicating P4 influence 
as compared to pregnancy. In addition and contribunting the P4 influence, both genes coding 
for transient receptor potential vanilloid types 5 and 6 (TRPV5, 6) were up-regulated on day 12 
in pregnant mares (Merkl et al., 2010). 
2.3.4 Genes with highest mRNA levels during diestrus (highest P4 levels)  
Diestrus is defined as the time during the estrous cycle with highest P4 levels. In the pig diestrus 
is around day 12 (Cluster 6) and in the mare around day 8 (Cluster 5). A total number of only 
6 genes (namely Acetoacetyl-COa synthetase (AACS), dermatopontin (DPT), glutathione S-
transferase mu 4 (GSTM4), rhophilin, Rho GTPase binding (RHPN2), structural maintenance 
of chromosome 6 (SMC6) and zinc finger and BTB domain containing 7B (ZBTB7B)) were up-
regulated during these phases in the estrous cycle in both species. This low number of genes 
with positive correlation during diestrus indicates a species-specific gene expression and, in 
this regard, regulated changes of the endometrium that are dependent on P4 concentration in 
different ways. Furthermore, only 19 genes showed negative correlation, i.e., were up-regulated 
in diestrus in the mare (Cluster 5) and regulated in different phases in porcine cycle (6 genes 
on day 18 and 12 genes in day 0). Vice versa, 4 genes were found as up-regulated in diestrus in 
the pig (Cluster 6) which showed up-regulation during the cycle in the mare at estrus.  
The transition phase from metestrus (around day 3) to diestrus (highest P4 levels) revealed a 
higher number of correlated genes. Genes clustering together in Clusters 4 (highest mRNA 
levels from day 3 to day 6 in the pig and from day 3 to day 8 in the mare) revealed 44 genes as 
positively correlated. Functional annotation clustering showed over-representation for the 
categories ‘lipid metabolism’, ‘fatty acid metabolism process’, ‘lipid biosynthetic process’ and 
‘monosaccheride metabolic process’ during this time. Lipid metabolism appears in three of the 
top 5 networks, suggesting its importance as a metabolic process in uterine physiology (Killeen 
et al., 2014) which coincides with increased fatty acid catabolism (Mahendroo et al., 1999). 
Fatty acids are essential precursors to steroids and eicosanoids, metabolites necessary for 
normal ovarian and uterine function (Bazer et al., 1994). Furthermore, fatty acid 
supplementation positively influences reproductive performance. Increased fatty acid synthase 
(FASN) would be favorable to deliver the required fatty acid for the assembly of new cell 
membranes, modification of DNA transcriptional machinery and hormone production during 
the estrous cycle. Therefore, the up-regulation of FASN mRNA during estrus  would be 
expected. Nevertheless, mRNA expression of FASN was highest in Clusters 4 in both species. 
The cellular metabolism is a well-represented process in the secretory phase of the human 
estrous cycle. Apolipoprotein D (APOD) is a multifunctional transporter involved in both lipid 
metabolism and the transport of cholesterols. The activation of its expression detected in most 
studies is consistent with the activation of lipid metabolism in the mid secretory phase (as 
reviewed in (Aghajanova et al., 2008). These findings are in good agreement with functional 
annotation clustering and mRNA expression of APOD (did not reach correlation significance 
r=-0.18).  
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Correlation analysis of gene expression revealed 11 genes as positively correlated assigned to 
Clusters 5 (highest mRNA expression on day 8 in the mare and from day 6 to day 12 in the 
pig). Progesterone receptor membrane component 1 (PGRMC1) mRNA profiles showed up-
regulation in these phases and down-regulation during estrus in both species. Additional 
members of steroid hormone metabolism and signaling as well as members of prostaglandin 
metabolism showed negatively correlation; PTGFR showed up-regulation from day 12 to day 
18 in the pig and from day 3 to day 8 in the mare, and PTGER3 showed highest mRNA level 
from day 3 to day 6 in the pig.  
2.3.5 Genes with highest mRNA level during late luteal phase (decreasing P4 level) 
Following luteolysis P4 levels decrease to lowest levels during late luteal phase which is 
represented by genes assigned to Clusters 7 (highest mRNA level from day 12 to day 18 in the 
pig and from day 12 to day 16 in the mare). In both species luteolysis takes place within the 
timespan (around days 14/15). A total number of 33 genes were positively correlated during 
this time in the estrous cycle (Clusters 7). A recent study has demonstrated that on days 15 to 
16 of the estrous cycle in pigs, cytokine action, steroidogenesis and prostaglandin synthesis take 
place in the myometrial tissue (Franczak, 2008). Nevertheless, in equine and porcine 
endometrial tissue ‘angiogenesis’, ‘vasculature development’ and ‘blood circulation’ were 
over-represented during this time in the estrous cycle. A critical element of tissue growth and 
development is the growth of new blood vessels, also known as angiogenesis (Lee et al., 2010). 
Generally, angiogenesis plays an active role in endometrial function, as well as growth of 
ovarian follicles and CL during the reproductive cycle. In a highly dynamic tissue such as the 
endometrium, angiogenesis is necessary for the provision of nutrients (Killeen et al., 2014). 
This study showed highest mRNA expression of vascular endothelial growth factor A (VEGFA) 
during late luteal phase in both species. VEGF is a factor that plays a pivotal role in the 
promotion of blood vessel formation under physiological and pathological conditions (Xiong 
et al., 1998). Furthermore, macrophages are known to produce a variety of angiogenic factors. 
Activated macrophages have the unique capacity to influence the angiogenic process, that is, 
by extracellular matrix remodeling or induction of endothelial cell chemotaxis and 
proliferation. The experiments of the study by Kaczmarek (Kaczmarek et al., 2013) indicate 
increased expression of VEGF that coincided with increased macrophage infiltration of the 
superficial endometrium and endometrial stroma. Since the study of the latter research group is 
based on inseminated pigs and to the actual knowledge macrophages infiltrate the equine and 
the porcine endometrium during preestrus and estrus, the results in this study contradict the 
statement. Additionally, it is postulated that PGs participate in the local increase of endometrial 
vascular permeability, as well as angiogenesis but during implantation. PGE2 up-regulates 
vascular endothelial growth factor (VEGF) in a number of tissues including the uterus (Lopes 
et al., 2006). In addition, the results showed significant up-regulation of the prostaglandin-
endoperoxide synthase 2 (PTGS2) in Clusters 7. This clearly indicates a common onset of 
luteolysis in both species. The correlation between angiogenesis, vasculature and PG signaling 
involvement requires more detailed investigations. All genes that are discussed in this part are 
summarized in Supplemental Table VIII-IV. 
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Figure IV-3 shown on next page. Summary of results from the correlation analysis. Phases of estrous cycle are 
illustrated as black circle (cycle duration is 21 days; from D0 to D0)-Estrus, early luteal phase, diestrus and 
preestrus. Progesterone (P4) concentration during the particular phase is given in each corner. Over-represented 
biological functions of genes with positively correlated expression during specific phases of the estrous cycle – 
obtained from DAVID functional annotation clustering analysis – are represented in the internal circle (pink). 
External circle (green) shows positively correlated genes or groups represented by several genes with highest 
mRNA expression during this time in estrous cycle. Conclusions about potential connection with the function of 
endometrium are shown in the blue area. Connection between events are demonstrated with arrows. AR-androgen 
receptor, ECM-extracellular matrix, FASN-fatty acid synthase, HOXA10-homeobox A 10, PGR-progesterone 
receptor, PTGS2-prostaglandin-endoperoxide synthase 2, VAGFA-vascular endothelial growth factor A. 
2.4 Messenger RNA expression profiles in the endometrium during the bovine, equine 
and porcine estrous cycle  
The comparison of published data from bovine endometrium (Mitko, 2008) with comparable 
phases of the porcine and equine endometrium during the estrous cycle revealed several genes 
as differentially expressed across species. The analysis was performed on the basis of assigned 
putative human orthologous genes and revealed 33 genes as positively and 7 genes/transcripts 
as negatively correlated in equine, porcine and bovine endometrium supplementary Table VIII-
V during the estrous cycle. These numbers are relatively low but the dataset from bovine 
endometrium contained only 230 DEGs. 
Similar to the mare endometrium which showed highest ESR1 mRNA expression on day 3 
during estrous cycle, the bovine endometrial mRNA concentration for ESR1 was increased on 
day 3.5. In the pig, mRNA concentrations are highest on day 0 and slightly increased on day 3 
(no statistical significance achieved). This agrees well with the changes during the ovulatory 
phase that are mainly controlled by estradiol (E2). Results indicate similar interactions in 
estrogen signaling during the estrus phase. In addition, genes related to the family of collagens 
were highest during estrus in all three species: COL1A2, COL3A1, and COL4A1. Due to ECM 
remodeling and thus edematization the highly represented genes related to collagens during 
estrus are in agreement. A number of genes with slightly higher mRNA levels at estrus were 
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found to be in the context of the biological term ‚cell adhesion‘ (e.g. focal adhesion). Genes 
coding for ECM proteins and components of the cytoskeleton, which are linked via paxillin, 
are involved in this process (Mitko, 2008). A possible candidate for the regulation of 
cytoskeleton proteins is polo-like kinase 2 (PLK2), also known as serum-inducible kinase 
(SNK). PLK2 has been shown to play a role in the remodeling of synapses via phosphorylation 
of spine-associated Rap guanosine triphosphatase-activating protein (SPAR), a postsynaptic 
actin regulatory protein, leading to the degradation of SPAR (Pak et al., 2003). PLK2 could 
play a similar role in the modulation of actin filament polymerization in the endometrium 
(Mitko, 2008). Data showed up-regulation for PLK2 from preestrus to estrus in all three species. 
Furthermore, the transcriptome analysis of endometrium of all three species revealed an up-
regulation of the immune-related genes that are involved in the complement system (classical 
pathway), namely complement component genes C1R and the C1 inhibitor SERPING1 
(Bauersachs et al., 2006, Klein et al., 2006). Slightly correlative expression differences were 
found within the immune-related genes complement component 1, or subcomponent (C1R) and 
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1). In porcine 
endometrium both of them showed mRNA up-regulation from day 18 to day 0 as in equine 
endometrium. But the mRNA in equine transcriptome analysis is slightly earlier on day 12. 
Other than that, the mRNA expression of C1R and SERPING1 in bovine endometrium showed 
up-regulation on day 12 and 18 but not on day 0. Differences in endometrial gene expression 
changes between different mammals are probably related to specific histological changes in the 
endometrium during the cycle (Bauersachs et al., 2012).  
Altogether, the exploration of gene expression during the cycle in both species showed common 
regulation in three of the four phases; during estrus, metestrus (early luteal phase) and preestrus 
As for diestrus, correlation showed only a minority of positively regulated genes indicating 
species-specific gene expression changes during this time of the reproductive cycle. Although, 
the functional annotation analysis of the endometrial gene expression during bovine estrous 
cycle revealed the same biological terms as over-represented during distinct phases the analysis 
of gene expression on the basis of single genes revealed only minor similarities. This indicates 
common functionality but species-specific gene expression. 
 Conclusion and forecast 
In conclusion, this study provides a holistic view on the quantitative changes in transcript levels 
during the estrous cycle in equine and porcine endometrium. Microarray analysis identified 
numerous genes as differentially expressed throughout the estrous cycle in both species. 
Furthermore, with focus on specific functional categories and biological processes in relation 
to dynamic gene expression profiles, results pinpoint the molecular reflections of important 
physiological changes in the cyclic endometrium with regard to the crucial role of this tissue 
for successful reproduction. However, detailed and clear functions of many of these genes, 
especially with respect to the many interactions in reproductive processes, are still unknown. 
Furthermore, the comparison of results between species showed many species-specific gene 
expression changes especially during diestrus but also common characteristics for distinct 
phases in both species.  
Results of this study provide the basis for an in-depth analysis of individual genes or particularly 
interesting components of molecular regulation of endometrial changes during the estrous 
cycle, respectively. In addition, the comparison to dynamic gene expression changes in bovine 
endometrium indicates an adaptation of endometrial gene expression to specific differences in 
cyclic endometrial dynamics.   
This study provides an explorative analysis that can be used as a basis for further hypothesis-
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driven investigation in reproduction of domestic animals. Future studies could investigate even 
more stages during the distinct phases of the reproductive cycle using a similar approach to 
provide a more detailed view of dynamic gene expression changes. Furthermore, the optimal 
way for comparison of datasets from different species would be the determination of one-to-
one orthologous genes based on sequence similarities and location in the genome. However, 
results of other groups showed differences in responses to hormonal control and signals of the 
embryo between different compartments. Since this study only investigated tissues that 
contained all compartments, namely LE, GE, blood vessels and stroma, further investigation 
should be performed on separated tissue samples to increase the spatial resolution of gene 
expression. 
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V. SUMMARY 
Analysis and comparison of dynamic mRNA expression changes in the equine and porcine 
endometrium during the estrous cycle 
The endometrium (mucosa of the uterus) exhibits morphological and functional changes during 
the estrous cycle which are mainly regulated by the interplay of the ovarian steroid hormones 
estradiol (E2) and progesterone (P4). According to the changes in hormone concentration the 
estrous cycle can be divided into four different phases: estrus (low P4 level), metestrus (P4 level 
on the rise), diestrus (highest P4 level) and preestrus (decreasing P4 level) corresponding to 
ovulatory, early luteal, mid luteal and follicular phase. 
In order to study the response of the equine and the porcine endometrium to the changing 
hormonal environment during the estrous cycle at the transcriptome level, transcriptome-wide 
microarray analyses were performed. Therefore, endometrial biopsy samples were collected 
from five different mares and endometrial tissue samples after slaughter of 30 different sows 
on five different time points during the estrous cycle. To determine plasma P4 concentrations 
blood samples were collected when the corresponding endometrial sample was taken. 
For equine samples the bioinformatics analysis revealed 4.996 differentially expressed genes 
and 5.325 differentially expressed genes for porcine samples. To obtain detailed information 
about gene expression profiles and co-regulation of genes during the estrous cycle, the 
differentially expressed genes were clustered together based on similarities in mRNA 
expression profiles. In addition, a comparative analysis of both datasets was performed to 
achieve more insights into the species-specific or common gene expression changes. This 
analysis revealed 841 genes as significantly positive and negative correlated in both species, 
respectively. To characterize the differentially expressed genes of individual expression clusters 
in relation to their potential biological functions DAVID functional annotation clustering 
analysis (online-tool) was performed. Expression of selected equine and porcine genes was 
validated using quantitative real-time PCR (qPCR).  
The data from functional annotation analysis revealed biological processes such as ‘extra 
cellular matrix (ECM)’ and ‘collagens’ during estrus, ‘cell cycle’ and ‘mitosis’ during 
metestrus, terms related to ‘secretory activity and metabolism’ and ‘protein transport’ during 
diestrus and ‘cytokine-cytokine receptor interaction’, ‘coagulation cascades’ and ‘inflammatory 
response’ during following preestrus as over-represented in equine endometrium. During 
porcine estrus, the functional categories ‘extra cellular matrix (ECM)’ and ‘collagens’ showed 
over-representation, and during metestrus, the categories ‘cell cycle’ and ‘mitosis’ respectively. 
The biological processes related to immune system functions (e.g. ‘immune response’, 
‘inflammatory response’) showed over-representation during early until mid diestrus, and the 
process ‘regulation of apoptosis’ was over-represented during following preestrus in porcine 
endometrium. Functional annotation clustering of correlated genes (positive and negative) 
showed common biological terms as over-represented such as ‘extracellular matrix’ and 
‘collagens’ during estrus and ‘cell-cycle’ and ‘mitosis’ during metestrus but also revealed 
differences especially during luteal phase, respectively. In addition, the comparison of the genes 
with significant correlation to gene expression profiles in the bovine endometrium (Mitko, 
2008) revealed even more species-specific genes expression profiles. 
Altogether, the results of this study show species-specific preparation for the support of 
potential embryo growth and development and active infiltration of the endometrium with 
immune cells as well as remodeling of endometrial cells during the luteal phase and preestrus. 
Furthermore, the reconstruction of the tissue (ECM remodeling) during estrus and active cell 
proliferation during early luteal phase suggest a common characteristic throughout species. 
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VI. ZUSAMMENFASSUNG 
Untersuchungen und Vergleich der mRNA Expressionsprofile im Endometrium der Stute 
und der Sau während des Sexualzyklus 
Das Endometrium (Gebärmutterschleimhaut) durchläuft morphologische und funktionale 
Änderungen während des Sexualzyklus, welche hauptsächlich durch die Interaktion der 
ovariellen Steroidhormone Östradiol (E2) und Progesteron (P4) reguliert werden. An Hand der 
sich ändernden Hormonkonzentrationen wird der Sexualzyklus in vier verschiedene Phasen 
eingeteilt: Östrus (niedrige P4-Konzentration), Metöstrus (ansteigende P4-Konzentration), 
Diöstrus (höchste P4-Konzentration) und Pröstrus (sinkende P4-Konzentration). Der Diöstrus 
wird auch als Gelbkörperphase oder Lutealphase bezeichnet. 
Um die Änderungen der Gebärmutterschleimhaut der Stute und der Sau in Reaktion auf die sich 
verändernde hormonelle Umgebung auf Trankriptomebene zu untersuchen, wurden 
trankriptom-weite Mikroarray-Analysen durchgeführt. Hierfür wurden von fünf verschiedenen 
Stuten Endometrium-Biopsieproben und 30 verschiedenen Jungsauen Endometrium-Proben 
nach Schlachtung an fünf unterschiedlichen Tagen während des Zyklus entnommen. Zusätzlich 
wurden die Progesteronkonzentrationen über genommene Blutproben bestimmt.  
Die bioinformatischen Analysen der Expressionsdaten der Stute ergaben 4.996 und die beim 
Schwein 5.325 Gene als differentiell exprimiert. Für eine detaillierte Analyse der 
Genexpression und des Koregulationsverhaltens der Gene während des Sexualzyklus wurden 
die differentiell exprimierten Gene basierend auf den Expressionsveränderungen der 
Transkripte in sogenannte Cluster mit ähnlichen Expressionsprofilen eingeteilt. Zusätzlich 
wurde eine Vergleichsanalyse durchgeführt, um genauere Informationen über 
speziesspezifische bzw. generelle Genexpressionsprofile im Zyklusverlauf zu erhalten. Diese 
Analyse ergab 841 Gene mit signifikant positiv bzw. negativ korrelierenden 
Expressionsprofilen. Zur Charakterisierung der biologischen Funktionalität einzelner 
Gengruppen der individuellen Cluster wurde eine funktionelle Annotation mittels DAVID 
(online Software) durchgeführt. Die Expression einzelner ausgewählter Gene wurde mittels 
qPCR validiert.  
Die Ergebnisse der Funktionsanalyse der Stute ergaben charakteristische biologische Prozesse 
als überrepräsentiert, wie zum Beispiel die Kategorien „extrazelluläre Matrix“ und „Kollagene“ 
während des Östrus und die biologischen Prozesse „Zellzyklus“ und „Mitose“ während des 
Metöstrus. Die biologischen Funktionen „Proteintransport“ und Prozesse, die „sekretorische 
Aktivität und Stoffwechsel“ beschreiben, waren vor allem unter den Genen mit erhöhter 
Expression während der Gelbkörperphase überrepräsentiert. Im darauf folgenden Proöstrus 
fielen biologische Prozesse auf, die mit dem Immunsystem zusammen hängen 
(„Immunantwort“, „Zytokin-Zytokinrezeptor Interaktionen“ etc.). Während des Östrus beim 
Schwein zeigten ebenfalls die Kategorien „extrazelluläre Matrix“ und „Kollagene“ und 
während des Metöstrus die biologischen Prozesse „Zellzyklus“ und „Mitose“ erhöhte 
Repräsentanz. Während der frühen bis zur späten Gelbkörperphase waren zum Beispiel die 
Prozesse überrepräsentiert, die das Immunsystem vertreten und im folgenden Proöstrus der 
Prozess der „Regulation der Apoptose“. Dementsprechend ergab die weitere Funktionsanalyse 
der korrelierenden Gene (positiv und negativ) die bei beiden Spezies verbreiteten, biologischen 
Kategorien wie „Extrazelluläre Matrix“ und „Kollagene“ als stark repräsentiert während des 
Östrus und „Zellzyklus“ und „Mitose“ während des Metöstrus, aber auch speziesspezifische 
Unterschiede, vor allem während der Gelbkörperphase. Weiterhin zeigte ein Vergleich mit der 
Genexpressionsanalyse des bovinen Endometriums während des Sexualzyklus (Mitko, 2008) 
weitere speziesspezifische Expressionsprofile auf. 
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Die Ergebnisse dieser Arbeit zeigen eine artenspezifische Vorbereitung der 
Gebärmutterschleimhaut auf die Unterstützung von Wachstum und Entwicklung des Embryos 
und eine aktive Infiltrierung durch Immunzellen sowie den aktiven Umbau endometrialer 
Zellen 
während der Gelbkörperphase und dem Proöstrus. Desweiteren weisen der Umbau der 
extrazellulären Matrix während des Östrus und die aktive Zellproliferation während des 
Metöstrus hingegen auf eine allgemein verbreitete Charakteristik hin.  
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VIII. SUPPLEMENTAL MATERIAL 
Target accession number1 Hsa Entrez 
Gene ID2 
Hsa Gene 
symbol3 
Hsa Gene description4 D0 D3 D8 D12 D16 q.value5 SOTA 
cluster6 
DN511209; ENSECAT00000002458 59272 ACE2 angiotensin I converting enzyme (peptidyl-dipeptidase 
A) 2 
1.15 -0.23 -0.62 -0.58 0.28 0.0004 1 
ENSECAT00000011365 9068 ANGPTL1 angiopoietin-like 1 0.88 -0.21 -0.30 -0.32 -0.05 0.0088 1 
XM_001501670 23452 ANGPTL2 angiopoietin-like 2 0.76 -0.26 -0.42 -0.40 0.31 0.0002 1 
CX601805; ENSECAT00000020044 51129 ANGPTL4 angiopoietin-like 4 1.58 -0.35 -1.26 0.12 -0.10 0.0003 1 
ENSECAT00000026830 6359 CCL15 chemokine (C-C motif) ligand 15 0.97 -0.70 -0.24 -0.42 0.39 0.0006 1 
AY246812 414062 CCL3L3 chemokine (C-C motif) ligand 3-like 3 1.18 -0.65 0.02 -0.23 -0.33 0.0013 1 
ENSECAT00000003108 10803 CCR9 chemokine (C-C motif) receptor 9 0.84 -0.45 -0.52 0.09 0.03 0.0067 1 
CX595027;CX602717; CX604282; 
ENSECAT00000010157 
7373 COL14A1 collagen, type XIV, alpha 1 1.29 -0.56 -0.55 -0.85 0.66 0.0007 1 
ENSECAT00000020087; 
ENSECAT00000020883 
1277 COL1A1 collagen, type I, alpha 1 1.13 -0.31 0.12 -1.21 0.27 0.0001 1 
ENSECAT00000026976; 
ENSECAT00000026981 
1278 COL1A2 collagen, type I, alpha 2 1.10 -0.48 0.17 -0.98 0.19 0.0002 1 
ENSECAT00000010653 81578 COL21A1 collagen, type XXI, alpha 1 2.10 -0.34 -0.86 -1.23 0.33 0.0000 1 
ENSECAT00000018719 84570 COL25A1 collagen, type XXV, alpha 1 0.73 -0.13 -0.33 -0.42 0.15 0.0053 1 
CX595082 1280 COL2A1 collagen, type II, alpha 1 0.57 0.15 -0.26 -0.17 -0.29 0.0090 1 
ENSECAT00000026766; 
ENSECAT00000026771 
1281 COL3A1 collagen, type III, alpha 1 1.03 -0.29 0.26 -1.26 0.26 0.0001 1 
ENSECAT00000022446 1282 COL4A1 collagen, type IV, alpha 1 0.51 -0.43 -0.15 -0.44 0.50 0.0007 1 
ENSECAT00000007919 1285 COL4A3 collagen, type IV, alpha 3 (Goodpasture antigen) 0.39 -0.70 0.35 -0.43 0.40 0.0071 1 
ENSECAT00000000945 1287 COL4A5 collagen, type IV, alpha 5 0.97 -0.10 -0.32 -0.56 0.01 0.0001 1 
ENSECAT00000023228 1288 COL4A6 collagen, type IV, alpha 6 0.82 -0.17 -0.15 -0.32 -0.18 0.0024 1 
CX602562; ENSECAT00000013712 1289 COL5A1 collagen, type V, alpha 1 0.77 -0.38 0.03 -0.62 0.21 0.0018 1 
ENSECAT00000011989 1290 COL5A2 collagen, type V, alpha 2 0.42 -0.32 0.24 -0.47 0.14 0.0057 1 
CX603428 1291 COL6A1 collagen, type VI, alpha 1 0.89 -0.01 -0.27 -0.47 -0.15 0.0003 1 
CX605460 1292 COL6A2 collagen, type VI, alpha 2 0.81 0.14 -0.42 -0.25 -0.28 0.0016 1 
ENSECAT00000022862 1293 COL6A3 collagen, type VI, alpha 3 1.06 0.18 -0.71 -0.82 0.30 0.0002 1 
ENSECAT00000012001 646300 COL6A4P2 collagen, type VI, alpha 4 pseudogene 2 1.37 -0.17 -0.65 -0.40 -0.16 0.0001 1 
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ENSECAT00000013001 1294 COL7A1 collagen, type VII, alpha 1 0.82 -0.13 -0.39 -0.24 -0.06 0.0023 1 
CX594651; ENSECAT00000025116 1299 COL9A3 collagen, type IX, alpha 3 0.96 -0.25 0.20 -0.58 -0.33 0.0008 1 
ENSECAT00000012809 2919 CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth 
stimulating activity, alpha) 
1.87 -0.15 -1.30 -1.47 1.05 0.0001 1 
NM_001081886 6374 CXCL5 chemokine (C-X-C motif) ligand 5 1.98 -0.70 -1.20 -1.27 1.19 0.0000 1 
BI961602 6372 CXCL6 chemokine (C-X-C motif) ligand 6 (granulocyte 
chemotactic protein 2) 
2.84 -0.61 -1.88 -2.33 1.99 0.0000 1 
EU438776 4283 CXCL9 chemokine (C-X-C motif) ligand 9 0.93 -0.31 -0.05 -0.40 -0.17 0.0038 1 
XM_001490737 3577 CXCR1 chemokine (C-X-C motif) receptor 1 1.17 -1.24 -0.11 0.26 -0.07 0.0098 1 
ENSECAT00000003720 7852 CXCR4 chemokine (C-X-C motif) receptor 4 2.48 -0.94 -1.47 -0.37 0.30 0.0000 1 
ENSECAT00000012106 1906 EDN1 endothelin 1 0.64 -0.25 -0.23 -0.42 0.26 0.0042 1 
NM_001081823 1907 EDN2 endothelin 2 0.99 -0.31 -1.00 0.05 0.27 0.0019 1 
ENSECAT00000020976 1909 EDNRA endothelin receptor type A 0.63 -0.06 -0.58 -0.31 0.31 0.0011 1 
ENSECAT00000012792 146433 IL34 interleukin 34 0.49 0.06 -0.51 -0.02 -0.02 0.0054 1 
BI961791; NM_001083951 3576 IL8 interleukin 8 0.89 -0.22 -0.60 -1.07 1.00 0.0019 1 
ENSECAT00000004954 79148 MMP28 matrix metallopeptidase 28 0.40 -0.14 -0.31 0.24 -0.19 0.0075 1 
NM_001082495 4314 MMP3 matrix metallopeptidase 3 (stromelysin 1, 
progelatinase) 
2.24 -0.73 -1.22 -1.29 1.01 0.0000 1 
NM_001111302 4318 MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa 
gelatinase, 92kDa type IV collagenase) 
1.38 0.11 -0.97 -0.36 -0.17 0.0004 1 
ENSECAT00000024697 4856 NOV nephroblastoma overexpressed gene 0.76 0.09 -0.78 -0.18 0.11 0.0007 1 
AF076673 5020 OXT oxytocin, prepropeptide 0.47 -0.15 0.21 0.11 -0.64 0.0089 1 
ENSECAT00000014888 5733 PTGER3 prostaglandin E receptor 3 (subtype EP3) 0.98 -0.27 -1.12 -0.22 0.63 0.0002 1 
ENSECAT00000015356 5265 SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 1 
1.57 -0.13 -1.73 -1.77 2.06 0.0001 1 
NM_001114533 5265 SERPINA1 serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 1 
1.69 -0.07 -1.96 -1.88 2.21 0.0001 1 
ENSECAT00000026755 5104 SERPINA5 serpin peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 5 
0.48 0.17 -0.43 -0.34 0.12 0.0062 1 
DN510302 6678 SPARC secreted protein, acidic, cysteine-rich (osteonectin) 0.77 -0.42 -0.17 -0.48 0.29 0.0001 1 
ENSECAT00000019034 3371 TNC tenascin C 1.61 -0.35 -1.47 -1.48 1.69 0.0000 1 
NM_001081772 2099 ESR1 estrogen receptor 1 0.18 0.69 -0.22 -0.93 0.28 0.0054 2 
ENSECAT00000019888 2254 FGF9 fibroblast growth factor 9 (glia-activating factor) 0.83 0.36 -0.30 -1.06 0.17 0.0008 2 
AF053141; ENSECAT00000012266 5241 PGR progesterone receptor 0.62 0.39 -0.04 -0.74 -0.24 0.0043 2 
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ENSECAT00000027031 1019 CDK4 cyclin-dependent kinase 4 -0.10 0.69 0.03 -0.38 -0.23 0.0061 3 
ENSECAT00000001020 2852 GPER G protein-coupled estrogen receptor 1 0.07 0.73 -0.30 -0.63 0.13 0.0020 3 
NM_001081806 5737 PTGFR prostaglandin F receptor (FP) -0.03 0.70 0.39 -0.20 -0.85 0.0007 4 
ENSECAT00000016007 33 ACADL acyl-CoA dehydrogenase, long chain -0.68 -0.04 0.91 0.02 -0.22 0.0010 5 
ENSECAT00000009814 51094 ADIPOR1 adiponectin receptor 1 -0.84 0.14 0.37 0.47 -0.13 0.0002 5 
ENSECAT00000016893 79602 ADIPOR2 adiponectin receptor 2 -1.00 0.05 0.88 0.76 -0.69 0.0001 5 
ENSECAT00000015567 60481 ELOVL5 ELOVL fatty acid elongase 5 -0.78 0.09 0.61 0.39 -0.31 0.0015 5 
ENSECAT00000016651 2101 ESRRA estrogen-related receptor alpha -0.48 -0.17 0.56 -0.13 0.22 0.0055 5 
DN509190; ENSECAT00000009911 10857 PGRMC1 progesterone receptor membrane component 1 -0.63 0.16 0.82 0.05 -0.41 0.0003 5 
ENSECAT00000020544 10449 ACAA2 acetyl-CoA acyltransferase 2 -0.37 -0.28 0.18 0.49 -0.02 0.0018 6 
ENSECAT00000018172 32 ACACB acetyl-CoA carboxylase beta -0.62 -0.28 0.76 0.11 0.03 0.0090 6 
ENSECAT00000000590 10455 ECI2 enoyl-CoA delta isomerase 2 -0.92 -0.34 1.21 0.63 -0.56 0.0000 6 
DN511229 3032 HADHB hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA 
thiolase/enoyl-CoA hydratase (trifunctional protein), 
beta subunit 
-0.11 -0.25 0.54 0.13 -0.31 0.0029 6 
NM_001082509 *100034213 *P19 *P19 lipocalin -2.54 -0.61 1.61 1.34 0.20 0.0000 6 
NM_001081908 1645 AKR1C1 aldo-keto reductase family 1, member C1 (dihydrodiol 
dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid 
dehydrogenase) 
-0.56 -0.47 -0.65 1.46 0.22 0.0014 7 
ENSECAT00000018317 6696 SPP1 secreted phosphoprotein 1 -1.46 -2.02 1.18 1.62 0.68 0.0000 7 
ENSECAT00000017044 285 ANGPT2 angiopoietin 2 0.15 -0.04 -0.60 0.13 0.36 0.0075 8 
ENSECAT00000019790 306 ANXA3 annexin A3 0.17 0.10 -0.77 -0.38 0.88 0.0010 8 
ENSECAT00000023112 715 C1R complement component 1, r subcomponent 0.05 -0.52 -0.38 0.32 0.53 0.0052 8 
ENSECAT00000007684; 
ENSECAT00000008036 
718 C3 complement component 3 1.01 -0.46 -1.46 -0.05 0.95 0.0015 8 
ENSECAT00000014288 722 C4BPA complement component 4 binding protein, alpha -0.48 -1.26 -0.68 -0.09 2.51 0.0001 8 
ENSECAT00000023700 722 C4BPA complement component 4 binding protein, alpha -0.11 -0.78 -0.26 -0.12 1.28 0.0005 8 
XM_001492512 725 C4BPB complement component 4 binding protein, beta -0.36 -1.24 -0.15 -0.21 1.95 0.0004 8 
ENSECAT00000013161 730 C7 complement component 7 -0.18 -0.73 -0.63 0.11 1.42 0.0003 8 
ENSECAT00000025665 6357 CCL13 chemokine (C-C motif) ligand 13 0.24 -0.69 -0.38 0.74 0.09 0.0053 8 
NM_001081931 6347 CCL2 chemokine (C-C motif) ligand 2 0.02 -0.59 -0.24 -0.50 1.31 0.0005 8 
ENSECAT00000014867 6366 CCL21 chemokine (C-C motif) ligand 21 0.56 -0.53 -0.29 -0.29 0.54 0.0050 8 
NM_001081863 6352 CCL5 chemokine (C-C motif) ligand 5 0.31 -0.17 -0.64 0.28 0.21 0.0029 8 
NM_001081864 6355 CCL8 chemokine (C-C motif) ligand 8 -0.06 -0.28 -0.56 0.23 0.66 0.0070 8 
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ENSECAT00000027086 1303 COL12A1 collagen, type XII, alpha 1 0.27 -1.09 -0.23 0.09 0.95 0.0001 8 
ENSECAT00000019794 1305 COL13A1 collagen, type XIII, alpha 1 0.10 -0.09 -0.48 -0.27 0.74 0.0075 8 
ENSECAT00000008760 1308 COL17A1 collagen, type XVII, alpha 1 0.54 -0.91 -0.61 0.74 0.25 0.0020 8 
ENSECAT00000020647 1295 COL8A1 collagen, type VIII, alpha 1 0.56 -0.94 -0.91 -0.33 1.62 0.0000 8 
ENSECAT00000019475 58191 CXCL16 chemokine (C-X-C motif) ligand 16 0.48 -0.06 -0.87 -0.35 0.80 0.0004 8 
ENSECAT00000000643 284340 CXCL17 chemokine (C-X-C motif) ligand 17 0.03 -0.48 -0.81 -0.03 1.29 0.0004 8 
CX605159 57007 CXCR7 chemokine (C-X-C motif) receptor 7 0.30 -0.53 -0.59 0.27 0.56 0.0015 8 
ENSECAT00000018689 641700 ECSCR endothelial cell-specific chemotaxis regulator 0.12 -0.26 -0.59 0.23 0.49 0.0014 8 
XM_001489561 2104 ESRRG estrogen-related receptor gamma 0.70 -0.73 -0.58 0.15 0.45 0.0010 8 
ENSECAT00000015464 2247 FGF2 fibroblast growth factor 2 (basic) 0.68 -1.04 -0.38 -0.14 0.89 0.0005 8 
ENSECAT00000015025 3600 IL15 interleukin 15 0.52 -0.96 -0.52 0.28 0.68 0.0001 8 
NM_001081794 3554 IL1R1 interleukin 1 receptor, type I 0.16 -0.54 -0.38 -0.05 0.81 0.0062 8 
XM_001499705 9235 IL32 interleukin 32 0.50 -0.49 -0.45 -0.18 0.61 0.0011 8 
AY246709 3791 KDR kinase insert domain receptor (a type III receptor 
tyrosine kinase) 
-0.16 -0.07 -0.45 0.05 0.63 0.0073 8 
NM_001081843 5321 PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-
dependent) 
0.70 0.21 -1.35 -0.78 1.22 0.0000 8 
ENSECAT00000011519 5734 PTGER4 prostaglandin E receptor 4 (subtype EP4) 0.39 -0.54 -0.59 0.07 0.67 0.0003 8 
NM_001081775 5743 PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin 
G/H synthase and cyclooxygenase) 
-0.15 -0.74 -0.57 0.26 1.19 0.0073 8 
ENSECAT00000011379 710 SERPING1 serpin peptidase inhibitor, clade G (C1 inhibitor), 
member 1 
0.24 -0.46 -0.82 0.39 0.65 0.0002 8 
ENSECAT00000010346 5274 SERPINI1 serpin peptidase inhibitor, clade I (neuroserpin), 
member 1 
0.68 -0.29 -1.44 -0.40 1.45 0.0000 8 
DN507993 6578 SLCO2A1 solute carrier organic anion transporter family, member 
2A1 
0.16 -0.44 -0.40 -0.16 0.84 0.0010 8 
ENSECAT00000018137 7010 TEK TEK tyrosine kinase, endothelial -0.05 0.01 -0.58 0.14 0.48 0.0055 8 
Table VIII-I: List of differentially expreseed genes in equine endmetrium (only genes that are mentioned in this study are shown).1 Target Accession number supplied by 
databases 2 Gene Identifier supplied by NCBI ,3 Official Gene Symbol, 4 Gene descrition supplied by databases), analyzed days during the cycle, 5q-value achieved from 
microarray analysis and 6SOTA clustering number.* no official human orthologous gene (Eca Entrez gene ID, Eca Gene symbol and Eca gene description are shown). 
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Day in 
cycle 
Date Animal-
ID 
CL (shape and number) Time additional comments 
left right left right  
Day 0 08.05.2007 D0S19 8 larger follicles 5 7:27-7:35 7:39-7:45 oedematized mucosa, no liquid right side 
D0S20 5 smaller follicles 10 7:48-7:53 7:57-8:02 1 Ovulation right side 
D0S21 6 4 8:04-8:10 8:16-8:22 oedematized mucosa, 
D0S22 11 relatively large 6 8:28-8:33 8:38-8:44 oedematized mucosa 
D0S23 11 relatively large 14 8:49-8:54 8:59-9:04 oedematized mucosa, 
D0S24 5 2 large, many smaller 9:08-9:14 9:18-9:23 oedematized m 
Day 3 10.04.2007 D3S07 7 4 7:30-7:48 7:40-7:50 Very, very small 
D3S08 8 5 7:58-8:08 8:10-8:18 Very, very small 
D3S09 11 very bloody 4 8:22-8:34 8:37-8:41 Very, very small, endometrium extremely 
blooded 
D3S10 8 7 8:45-8:51 8:57-9:03 Very, very small, endometrium extremely 
blooded 
D3S11 11 10 9:14-9:20 9:29-9:34 Very, very small 
D3S12 3 7 9:38-9:43 9:52-9:56 Very, very small 
Day 6 01.05.2007 D6S13 5 7 very small (1 extreme large 
Follicle) 
7:23-7:31 7:36 -7:41 very small uterus, extremely blooded, not 
sure if day 0 
D6S14 5 6 7:50-7:57 8:04-8:10 very small uterus, extremely blooded, not 
sure if day 0 
D6S15 4 7 8:15-8:22 8:24-8:30 uterus extremely good blooded 
D6S16 6 9 8:35-8:43 8:46-8:51 - 
D6S17 6 5 8:57-9:02; 9:06-9:12 Ok 
D6S18 5 6 9:14-9:19 9:24-9:30 Ok 
Day 12 03.04.2007 D12S1 21 23 7:42-7:45 7:50-8:00 Ok 
D12S2 9 11 8:12-8:15 8:25-8:30 Ok 
D12S3 13 6 8:40-8:43 8:50-8:56 Ok 
D12S4 5(0.5cm) - 9:05-9:07 9:15-9:23 100 small follicles (1mm) 5 large Follicles 
left side (2cm), many follicles right 
D12S5 9 (1 extreme large 
Follicle) 
ca. 100 small follicles (2-3mm) 9:32-9:35; 9:45-9:48 Endometrium extremely blooded 
D12S6 Data missing Data missing 9:56-10:02 10:05-10:12 OK 
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Day 18 03.07.2007 D18S25 3 large, many 
smaller 
10, many smaller 7:28-7:32 7:42-7:44 liquid pink, oedematized mucosa 
D18S26 8 C.L.(little bit 
larger) 
7 7:58-8:02 8:12-8:15 liquid pink, oedematized mucosa 
D18S27 9 large _ 8:27- 8:29 8:288:41 liquid pink, oedematized mucosa 
D18S28 22 _ 8:53-8:50 9:01-9:04 liquid pink, oedematized mucosa 
D18S30 5 7 9:35-9:38 9:42-9:45 liquid pink, oedematized mucosa 
Table VIII-II: Sample collection protocol for porcine endometrium tissue samples. Three samples (front, middle and back) of each unterine horn (left and right) were collected 
from six sows (S07-S30) on five times during the cycle (D0, D3, D6, D12, D18). Protocol shows CL (shape and number) in left and right ovaries, the time (beginning and end) 
of sample collection and includes all comments (sample condition and collection procedure). S-Saw, D-days, CL-corpus luteum. 
Target accession 
number1 
Hsa 
Entrez 
Gene ID2 
Hsa 
Gene 
symbol3 
Hsa Gene description4 D0 D3 D6 D12 D18 
q.valu
e5 
SOTA-
Cluster
6 
NM_214181 330 BIRC3 baculoviral IAP repeat containing 3 0.72 0.02 -0.38 -0.48 0.12 0.0007 1 
NM_001161640 843 CASP10 caspase 10,apoptosis-related cysteine peptidase 1.02 0.12 -0.58 -0.28 -0.28 0.0000 1 
TC467326 843 CASP10 caspase 10, apoptosis-related cysteine peptidase 1.08 0.38 -0.82 -0.42 -0.22 0.0000 1 
NM_001001621 1230 CCR1 chemokine (C-C motif) receptor 1 1.58 -0.22 -0.67 -0.52 -0.17 0.0000 1 
NM_001001618 1234 CCR5 chemokine (C-C motif) receptor 5 0.92 0.02 -0.28 -0.98 0.32 0.0001 1 
ENSSSCT00000004952 1303 COL12A1 collagen,type XII,alpha 1 2.22 -0.28 -0.98 -1.88 0.92 0.0000 1 
ENSSSCT00000004955 1303 COL12A1 collagen, type XII, alpha 1 2.08 -1.12 -0.92 -0.82 0.78 0.0000 1 
XM_001927036 1303 COL12A1 collagen,type XII,alpha 1 2.00 -0.15 -1.05 -1.20 0.40 0.0000 1 
XM_001929444 1308 COL17A1 collagen,type XVII,alpha 1 2.88 -0.22 -3.42 -0.12 0.88 0.0000 1 
ENSSSCT00000019137 1277 COL1A1 collagen,type I,alpha 1 1.13 -0.42 -0.42 -0.02 -0.27 0.0000 1 
ENSSSCT00000019139 1277 COL1A1 uncharacterized LOC100738213 1.30 -0.80 -0.40 -0.40 0.30 0.0000 1 
ENSSSCT00000016699 1278 COL1A2 collagen,type I,alpha 2 1.40 -0.70 -0.50 -0.40 0.20 0.0000 1 
CK450104 85301 COL27A1 collagen,type XXVII,alpha 1 1.60 -0.10 -0.30 -0.80 -0.40 0.0000 1 
EW423756 85301 COL27A1 collagen alpha-1(XXVII) chain-like;collagen, type XXVII, alpha 1 1.54 -0.16 -0.66 0.34 -1.06 0.0006 1 
TC407931 1281 COL3A1 collagen, type III, alpha 1 1.08 -1.02 -0.12 -0.22 0.28 0.0000 1 
CK453450 1282 COL4A1 collagen alpha-1(IV) chain-like 0.98 -0.72 -0.12 -0.82 0.68 0.0006 1 
XM_001925656 1282 COL4A1 collagen alpha-1(IV) chain-like 0.96 -0.58 -0.60 -0.28 0.48 0.0001 1 
NM_001014971 1289 COL5A1 collagen,type V,alpha 1 1.43 -0.54 -0.54 -0.21 -0.14 0.0000 1 
NM_001009580 6387 CXCL12 chemokine (C-X-C motif) ligand 12 0.94 -0.26 -0.66 -0.06 0.04 0.0008 1 
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ENSSSCT00000003385 284340 CXCL17 chemokine (C-X-C motif) ligand 17 3.98 0.58 -2.22 -2.62 0.28 0.0000 1 
NM_001001861 2920 CXCL2 chemokine (C-X-C motif) ligand 2 2.42 -0.08 -1.98 0.27 -0.63 0.0001 1 
NM_213876 6372 CXCL6 alveolar macrophage-derived chemotactic factor-II 5.24 -0.46 -1.56 -1.86 -1.36 0.0000 1 
TC444818 6372 CXCL6 alveolar macrophage-derived chemotactic factor-II 3.94 -0.56 -1.06 -1.26 -1.06 0.0000 1 
NM_214017 2028 ENPEP glutamyl aminopeptidase (aminopeptidase A) 1.58 -1.32 0.68 -1.12 0.18 0.0001 1 
NM_214220 2099 ESR1 estrogen receptor 1 0.94 0.27 -0.56 -0.26 -0.39 0.0000 1 
CO987406 2099 ESR1 estrogen receptor 1 0.98 0.18 -0.82 0.18 -0.52 0.0005 1 
TC497409 2099 ESR1 estrogen receptor 1 1.04 0.14 -0.66 -0.36 -0.16 0.0000 1 
NM_214041 3586 IL10 interleukin 10 0.78 -0.12 -0.62 -0.52 0.48 0.0000 1 
NM_214390 3600 IL15 interleukin 15 1.76 -0.34 -0.59 -0.69 -0.14 0.0000 1 
AK233260 3600 IL15 interleukin 15 2.48 -0.72 -0.62 -1.62 0.48 0.0000 1 
NM_213997 3606 IL18 interleukin 18 (interferon-gamma-inducing factor) 0.85 -0.05 -0.65 -0.40 0.25 0.0001 1 
NM_214055 3553 IL1B interleukin 1,beta 1.44 0.44 -1.46 -0.46 0.04 0.0002 1 
TC465413 3566 IL4R interleukin 4 receptor 0.40 0.10 -0.70 -0.30 0.50 0.0001 1 
NM_001083932 3685 ITGAV integrin,alpha V (vitronectin receptor,alpha polypeptide,antigen CD51) 0.66 -0.54 -0.04 -0.44 0.36 0.0006 1 
CK453646 4012 LNPEP leucyl/cystinyl aminopeptidase 0.62 -0.38 -0.48 -0.38 0.62 0.0002 1 
NM_001099938 4321 MMP12 matrix metallopeptidase 12 (macrophage elastase) 3.56 -0.74 -0.84 -1.04 -0.94 0.0000 1 
NM_214239 4323 MMP14 matrix metallopeptidase 14 (membrane-inserted) 1.10 -0.30 -0.60 -0.30 0.10 0.0000 1 
NM_214192 4313 MMP2 matrix metallopeptidase 2 (gelatinase A,72kDa gelatinase,72kDa type IV 
collagenase) 
0.64 -0.51 -0.41 0.09 0.19 0.0001 1 
TC454140 4313 MMP2 matrix metallopeptidase 2 (gelatinase A; 72kDa gelatinase; 72kDa type IV 
collagenase) 
0.74 -0.56 -0.46 0.04 0.24 0.0000 1 
TC438862 8829 NRP1 neuropilin 1 0.82 -0.58 -0.28 -0.88 0.92 0.0002 1 
NM_214023 6696 SPP1 secreted phosphoprotein 1 3.56 -1.99 -1.07 -0.32 -0.19 0.0000 1 
TC512863 6696 SPP1 secreted phosphoprotein 1 1.62 -0.98 -0.48 -0.78 0.62 0.0001 1 
BI338261 6696 SPP1 secreted phosphoprotein 1 2.86 -1.14 -1.44 -0.04 -0.24 0.0000 1 
BF441912 7064 THOP1 thimet oligopeptidase 1 0.20 0.30 0.40 -0.90 0.00 0.0008 1 
DV229960 7124 TNF tumor necrosis factor 1.12 -0.18 -0.38 -0.48 -0.08 0.0000 1 
NM_001024696 8743 TNFSF10 tumor necrosis factor (ligand) superfamily,member 10 1.51 -0.79 -0.64 -0.49 0.41 0.0000 1 
TC445342 8743 TNFSF10 tumor necrosis factor ligand superfamily member 10-like 1.24 -1.06 -0.36 0.04 0.14 0.0001 1 
*16724 8743 TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 1.28 -0.32 -0.52 -0.32 -0.12 0.0000 1 
NM_001129946 6352 CCL5 chemokine (C-C motif) ligand 5 0.96 0.61 -0.24 -0.49 -0.84 0.0000 2 
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AK233548 6352 CCL5 chemokine (C-C motif) ligand 5 1.08 0.48 -0.22 -0.52 -0.82 0.0002 2 
ENSSSCT00000019288 6355 CCL8 chemokine (C-C motif) ligand 8 0.78 0.78 0.28 -1.32 -0.52 0.0000 2 
NM_001164515 6355 CCL8 chemokine (C-C motif) ligand 8 0.60 0.50 0.30 -0.80 -0.60 0.0001 2 
DN100836 898 CCNE1 cyclin E1 0.58 1.08 -0.52 -0.72 -0.42 0.0001 2 
AJ945293 729230 CCR2 chemokine (C-C motif) receptor 2 1.02 0.52 -0.38 -0.58 -0.58 0.0000 2 
ES445357 1233 CCR4 chemokine (C-C motif) receptor 4 1.60 0.60 -0.40 -0.80 -1.00 0.0000 2 
NM_001001532 1236 CCR7 chemokine (C-C motif) receptor 7 1.22 -0.28 0.32 -0.48 -0.78 0.0000 2 
ENSSSCT00000006580 7373 COL14A1 collagen,type XIV,alpha 1 0.30 0.10 0.28 0.27 -0.94 0.0005 2 
XM_001925576 1306 COL15A1 collagen; type XV; alpha 1 1.15 0.31 0.27 -0.71 -1.03 0.0000 2 
ENSSSCT00000005921 1306 COL15A1 collagen,type XV,alpha 1 1.15 0.08 0.31 -0.52 -1.02 0.0001 2 
TC456033 1287 COL4A5 collagen,type IV,alpha 5 0.80 -0.50 0.40 -0.30 -0.40 0.0000 2 
ENSSSCT00000013747 1287 COL4A5 collagen,type IV,alpha 5 0.98 -0.32 0.18 -0.12 -0.72 0.0000 2 
ENSSSCT00000013746 1288 COL4A6 collagen alpha-6(IV) chain-like 1.06 -0.04 -0.14 -0.24 -0.64 0.0000 2 
NM_001105289 1290 COL5A2 collagen,type V,alpha 2 1.19 -0.01 -0.01 -0.46 -0.71 0.0000 2 
BG383121 1290 COL5A2 collagen, type V, alpha 2 1.08 -0.12 0.08 -0.42 -0.62 0.0000 2 
AY368623 1290 COL5A2 collagen, type V, alpha 2 0.96 0.06 -0.14 -0.24 -0.64 0.0000 2 
XM_001928087 1293 COL6A3 collagen,type VI,alpha 3 1.27 -0.25 -0.32 0.04 -0.74 0.0001 2 
ENSSSCT00000017779 1293 COL6A3 collagen,type VI,alpha 3 0.96 -0.14 0.06 -0.04 -0.84 0.0002 2 
ENSSSCT00000017780 1293 COL6A3 collagen,type VI,alpha 3 1.20 0.00 -0.20 0.10 -1.10 0.0005 2 
TC483186 1294 COL7A1 collagen, type VII, alpha 1 1.20 0.10 0.20 -0.90 -0.60 0.0000 2 
ENSSSCT00000012432 1294 COL7A1 similar to alpha 1 type VII collagen 1.19 0.09 0.25 -1.01 -0.51 0.0000 2 
NM_001008691 3627 CXCL10 chemokine (C-X-C motif) ligand 10 1.69 0.19 -0.56 -0.21 -1.11 0.0000 2 
NM_001128491 6373 CXCL11 chemokine (C-X-C motif) ligand 11 3.06 0.56 -0.74 -1.04 -1.84 0.0000 2 
ENSSSCT00000015634 9547 CXCL14 chemokine (C-X-C motif) ligand 14 0.90 1.50 -0.50 -1.20 -0.70 0.0007 2 
NM_001114289 4283 CXCL9 chemokine (C-X-C motif) ligand 9 1.96 0.36 -0.54 -0.64 -1.14 0.0000 2 
NM_001001623 10663 CXCR6 chemokine (C-X-C motif) receptor 6 1.54 0.54 -0.36 -1.06 -0.66 0.0000 2 
NM_001098582 1908 EDN3 endothelin 3 0.64 -0.26 1.04 -0.36 -1.06 0.0001 2 
XM_001928678 2260 FGFR1 fibroblast growth factor receptor 1 1.22 0.42 -0.28 -0.68 -0.68 0.0000 2 
TC439806 2260 FGFR1 fibroblast growth factor receptor 1 1.18 0.48 -0.32 -0.72 -0.62 0.0000 2 
ENSSSCT00000017223 2260 FGFR1 fibroblast growth factor receptor 1 0.81 0.46 0.01 -0.39 -0.89 0.0002 2 
CF359055 50615 IL21R interleukin-21 receptor-like 1.10 0.40 0.50 -1.60 -0.40 0.0001 2 
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XM_001929445 4320 MMP11 matrix metallopeptidase 11 (stromelysin 3) 0.44 -0.06 0.14 0.04 -0.56 0.0007 2 
ENSSSCT00000011032 4320 MMP11 matrix metallopeptidase 11 (stromelysin 3) 0.72 0.12 -0.28 -0.28 -0.28 0.0002 2 
BI338397 4326 MMP17 matrix metallopeptidase 17 (membrane-inserted) 1.00 -0.20 0.30 -0.40 -0.70 0.0003 2 
TC504067 64386 MMP25 matrix metalloproteinase-25-like 1.18 0.38 0.08 -1.02 -0.62 0.0000 2 
CF792385 5241 PGR progesterone receptor 1.16 1.16 -0.44 -0.14 -1.74 0.0001 2 
NM_001166488 5241 PGR progesterone receptor 1.60 1.00 -0.50 -1.10 -1.00 0.0000 2 
TC492417 5241 PGR progesterone receptor 1.28 1.18 -0.52 -0.92 -1.02 0.0000 2 
DB792958 5734 PTGER4 prostaglandin E2 receptor EP4 subtype-like 0.48 0.48 0.18 -0.62 -0.52 0.0003 2 
NM_213900 5973 RENBP renin binding protein 0.74 -0.36 0.44 -0.06 -0.76 0.0000 2 
EU681268 6366 CCL21 chemokine (C-C motif) ligand 21 0.00 1.70 0.70 -0.70 -1.70 0.0004 3 
*12017 414062 CCL3L3 chemokine (C-C motif) ligand 3-like 1 0.18 0.58 -0.32 -0.02 -0.42 0.0008 3 
XM_001924034 2826 CCR10 chemokine (C-C motif) receptor 10 0.28 0.78 0.28 -0.42 -0.92 0.0000 3 
ENSSSCT00000006725 1019 CDK4 cyclin-dependent kinase 4 0.26 0.76 -0.24 -0.34 -0.44 0.0002 3 
ENSSSCT00000004588 2254 FGF9 fibroblast growth factor 9 (glia-activating factor) 0.26 0.76 0.26 -1.44 0.16 0.0004 3 
TC498977 6626 SNRPA small nuclear ribonucleoprotein polypeptide A -0.08 1.32 -0.08 -0.38 -0.78 0.0000 3 
AK236306 7064 THOP1 thimet oligopeptidase 1 0.13 0.93 -0.07 -0.57 -0.42 0.0000 3 
NM_001033015 1636 ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 -0.78 0.52 0.82 0.52 -1.08 0.0001 4 
BW967338 6356 CCL11 CCL11 -0.66 1.04 0.74 0.14 -1.26 0.0000 4 
DB794536 6361 CCL17 chemokine (C-C motif) ligand 17 -0.60 0.60 0.60 0.40 -1.00 0.0000 4 
NM_001003922 10850 CCL27 chemokine (C-C motif) ligand 27 -0.26 0.24 0.54 0.14 -0.66 0.0001 4 
NM_001024695 56477 CCL28 chemokine (C-C motif) ligand 28 -0.94 1.86 2.76 -0.14 -3.54 0.0000 4 
NM_001001619 729230 CCR2 chemokine (C-C motif) receptor 2 0.30 0.50 0.20 0.00 -1.00 0.0001 4 
NM_001001624 10803 CCR9 chemokine (C-C motif) receptor 9 -0.52 0.58 0.78 0.58 -1.42 0.0000 4 
AK238923 7852 CXCR4 chemokine (C-X-C motif) receptor 4 0.04 -0.06 0.84 -0.26 -0.56 0.0009 4 
TC499070 400935 IL17REL putative interleukin-17 receptor E-like -1.58 -0.28 2.72 0.42 -1.28 0.0001 4 
NM_214399 3569 IL6 interleukin 6 (interferon,beta 2) -0.92 2.28 -0.02 -1.12 -0.22 0.0010 4 
CF359271 5179 PENK proenkephalin -1.72 0.58 0.68 2.48 -2.02 0.0004 4 
NM_213882 1906 EDN1 endothelin 1 -0.22 -0.92 1.28 -0.62 0.48 0.0003 5 
ENSSSCT00000000163 7078 TIMP3 tissue inhibitor of metalloproteinase-3 -0.68 -0.78 0.12 1.22 0.12 0.0005 6 
CF367219 185 AGTR1 type-1 angiotensin II receptor-like -0.22 -0.52 -0.62 0.08 1.28 0.0002 7 
NM_214020 1950 EGF epidermal growth factor -0.98 -1.15 -0.95 3.25 -0.18 0.0000 7 
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TC414631 2066 ERBB4 receptor tyrosine-protein kinase erbB-4-like -0.22 -0.92 -0.92 0.78 1.28 0.0001 7 
EH009240 2252 FGF7 fibroblast growth factor 7 -1.36 -3.36 -2.66 3.04 4.34 0.0000 7 
ENSSSCT00000005134 2252 FGF7 fibroblast growth factor 7;keratinocyte growth factor-like -1.44 -3.24 -2.34 2.96 4.06 0.0000 7 
NM_001099924 2263 FGFR2 fibroblast growth factor receptor 2 -0.98 -1.45 -0.45 2.02 0.85 0.0000 7 
BX924155 2261 FGFR3 fibroblast growth factor receptor 3-like 0.18 -0.52 -1.62 1.78 0.18 0.0001 7 
NM_214027 5021 OXTR oxytocin receptor -0.64 -1.94 -2.54 0.86 4.26 0.0000 7 
TC415136 5021 OXTR oxytocin receptor 0.04 -0.86 -0.56 1.14 0.24 0.0007 7 
TC444315 5321 PLA2G4A cytosolic phospholipase A2-like -0.16 -0.16 -0.76 0.44 0.64 0.0006 7 
TC429092 5321 PLA2G4A cytosolic phospholipase A2-like -0.22 -0.72 -1.12 0.98 1.08 0.0000 7 
ENSSSCT00000005548 5732 PTGER2 prostaglandin E receptor 2 subtype EP2 -0.98 -1.18 -0.28 0.02 2.42 0.0002 7 
XM_001928689 5732 PTGER2 prostaglandin E receptor 2 subtype EP2 -1.56 -1.11 -1.11 0.49 3.29 0.0000 7 
FJ750950 5737 PTGFR prostaglandin F receptor (FP) -0.10 -1.40 -0.80 1.45 0.85 0.0000 7 
TC469578 5737 PTGFR prostaglandin F receptor (FP) -0.24 -1.04 -0.24 0.26 1.26 0.0003 7 
NM_214059 5737 PTGFR prostaglandin F receptor (FP) -0.10 -1.40 -0.10 1.20 0.40 0.0003 7 
DY437619 5743 PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and 
cyclooxygenase) 
-0.28 -1.38 -2.18 1.12 2.72 0.0000 7 
NM_214321 5743 PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and 
cyclooxygenase) 
-0.88 -1.73 -3.28 2.07 3.82 0.0000 7 
NM_001145985 7077 TIMP2 TIMP metallopeptidase inhibitor 2 -1.22 -1.92 -2.12 1.68 3.58 0.0000 7 
TC450358 7077 TIMP2 TIMP metallopeptidase inhibitor 2 -1.10 -1.80 -1.90 1.80 3.00 0.0000 7 
XM_001924659 183 AGT angiotensinogen-like 0.31 -0.97 -2.34 -0.67 3.66 0.0000 8 
ENSSSCT00000011150 183 AGT angiotensinogen-like -0.22 -0.32 -1.62 -0.02 2.18 0.0002 8 
ENSSSCT00000012803 185 AGTR1 type-1 angiotensin II receptor-like -0.08 -0.48 -0.58 0.02 1.12 0.0002 8 
ENSSSCT00000000733 715 C1R complement component 1,r subcomponent 0.60 -0.30 -1.00 -0.50 1.20 0.0001 8 
NM_001005349 716 C1S complement component 1,s subcomponent 0.66 -0.34 -1.09 -0.54 1.31 0.0002 8 
ENSSSCT00000000735 716 C1S complement component 1,s subcomponent 0.92 -0.58 -1.28 -0.78 1.72 0.0000 8 
TC413063 716 C1S complement component 1,s subcomponent 1.06 -0.44 -1.34 -0.74 1.46 0.0000 8 
NM_001097449 729 C6 complement component 6;complement component C6-like 1.32 -1.78 -0.58 0.82 0.22 0.0000 8 
NM_213971 1191 CLU clusterin 1.94 -1.46 -2.06 -0.16 1.74 0.0000 8 
ENSSSCT00000008134 5476 CTSA cathepsin A 0.50 -0.70 -0.60 -0.10 0.90 0.0000 8 
XM_001927652 2065 ERBB3 erb-b2 receptor tyrosine kinase 3 -0.18 -1.08 -0.88 0.02 2.12 0.0000 8 
NM_213839 355 FAS Fas (TNF receptor superfamily,member 6) 0.56 -0.74 -0.14 -0.14 0.46 0.0001 8 
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NM_001105291 4012 LNPEP leucyl/cystinyl aminopeptidase 0.56 -0.64 -0.44 -0.34 0.86 0.0001 8 
CF790427 4012 LNPEP leucyl/cystinyl aminopeptidase 0.52 -1.08 -0.38 0.02 0.92 0.0000 8 
ENSSSCT00000007146 4582 MUC1 mucin 1,cell surface associated 1.31 -1.84 -1.49 1.21 0.81 0.0000 8 
NM_214295 4846 NOS3 nitric oxide synthase 3 (endothelial cell) 0.44 -0.56 -0.66 -0.46 1.24 0.0000 8 
TC475132 4846 NOS3 nitric oxide synthase 1 (neuronal) 1.48 -2.42 -7.32 3.68 4.58 0.0000 8 
BG610210 4846 NOS3 nitric oxide synthase 1 (neuronal) 0.30 -2.70 -4.10 3.00 3.50 0.0000 8 
TC410747 8828 NRP2 neuropilin-2-like 0.98 -0.82 -1.12 0.58 0.38 0.0000 8 
NM_001123194 710 SERPING1 serpin peptidase inhibitor,clade G (C1 inhibitor),member 1 0.37 -0.26 -0.86 -0.49 1.24 0.0004 8 
TC407865 710 SERPING1 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 0.58 -0.52 -1.02 -0.52 1.48 0.0001 8 
AJ961798 6578 SLCO2A1 solute carrier organic anion transporter family, member 2A1 -0.04 -0.24 -1.14 0.26 1.16 0.0000 8 
ENSSSCT00000005647 7010 TEK TEK tyrosine kinase,endothelial 0.12 -0.71 -0.45 0.19 0.85 0.0000 8 
DY424396 7010 TEK TEK tyrosine kinase, endothelial 0.10 -1.20 -0.40 0.30 1.20 0.0000 8 
Table VIII-III: List of differentially expressed genes in the porcine endometrium (only genes that are discussed in this study are shown). List provides; Target Accession 
Number from Agilent mircoarray software, Hsa Entrez Gene ID, Hsa Gene symbol, Hsa Gene description; relative gene expression levels (normalized value of one time point 
minus mean of normalized values of all 5 time points (D0, D3, D6, D12, D18); q-value, SOTA cluster (Self-organizing tree algorithm of MeV software (version 4.8.1) was used 
to obtain groups of genes with similar expression profiles. D-day, Ssc-Sus scorfa, Hsa-Homo sapiens, ID-identifier. 
Hsa Entrez 
Gene ID1 
Hsa Gene 
symbol2 
Sus scrofa Equus caballus positive 
correlation 
r4 p-value5 D0 D3 D6 D12 D18 
SOTA 
cluster3 D0 D3 D8 D12 D16 
SOTA 
cluster3 
8038 ADAM12 0.68 -0.72 -0.12 -0.12 0.28 1 1.16 -0.10 -0.61 -0.86 0.41 1 0.68 0.030 
1278 COL1A2 1.40 -0.70 -0.50 -0.40 0.20 1 1.10 -0.48 0.17 -0.98 0.19 1 0.83 0.003 
1281 COL3A1 1.08 -1.02 -0.12 -0.22 0.28 1 1.03 -0.29 0.26 -1.26 0.26 1 0.67 0.036 
1282 COL4A1 0.98 -0.72 -0.12 -0.82 0.68 1 0.51 -0.43 -0.15 -0.44 0.50 1 0.99 0.000 
1289 COL5A1 1.43 -0.54 -0.54 -0.21 -0.14 1 0.77 -0.38 0.03 -0.62 0.21 1 0.78 0.008 
6372 CXCL6 5.24 -0.46 -1.56 -1.86 -1.36 1 2.84 -0.61 -1.88 -2.33 1.99 1 0.72 0.020 
3206 HOXA10 0.94 -0.36 -0.06 -0.36 -0.16 1 0.75 -0.17 -0.33 -0.58 0.33 1 0.81 0.004 
171019 ADAMTS19 2.02 -0.58 0.12 -0.88 -0.68 1 1.23 0.00 -0.57 -0.77 0.12 2 0.81 0.005 
1287 COL4A5 0.80 -0.50 0.40 -0.30 -0.40 2 0.97 -0.10 -0.32 -0.56 0.01 1 0.65 0.043 
1288 COL4A6 1.06 -0.04 -0.14 -0.24 -0.64 2 0.82 -0.17 -0.15 -0.32 -0.18 1 0.93 0.000 
1294 COL7A1 1.20 0.10 0.20 -0.90 -0.60 2 0.82 -0.13 -0.39 -0.24 -0.06 1 0.74 0.015 
4283 CXCL9 1.96 0.36 -0.54 -0.64 -1.14 2 0.93 -0.31 -0.05 -0.40 -0.17 1 0.83 0.003 
367 AR 0.64 -0.03 0.07 -0.26 -0.43 2 0.51 0.00 -0.02 -0.56 0.07 2 0.71 0.021 
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5241 PGR 1.16 1.16 -0.44 -0.14 -1.74 2 0.62 0.39 -0.04 -0.74 -0.24 2 0.65 0.040 
6132 RPL8 0.46 0.46 0.06 -0.64 -0.34 2 0.45 0.26 -0.12 -0.30 -0.29 2 0.92 0.000 
4172 MCM3 1.54 1.94 -0.96 -1.06 -1.46 2 0.17 1.01 -0.52 -0.46 -0.21 3 0.87 0.001 
6147 RPL23A 0.21 0.31 0.46 -0.54 -0.44 3 0.54 0.03 0.03 -0.17 -0.43 1 0.64 0.048 
4175 MCM6 0.46 1.06 0.16 -0.64 -1.04 3 0.49 1.50 -1.03 -0.74 -0.21 2 0.68 0.030 
6141 RPL18 0.25 0.49 0.52 -0.65 -0.61 3 0.45 0.34 0.03 -0.37 -0.45 2 0.85 0.002 
6146 RPL22 0.11 0.65 0.45 -0.52 -0.69 3 0.41 0.30 -0.03 -0.41 -0.27 2 0.76 0.012 
6159 RPL29 0.22 0.59 0.45 -0.58 -0.68 3 0.54 0.40 -0.01 -0.45 -0.48 2 0.84 0.002 
6166 RPL36AL 0.06 0.76 0.36 -0.44 -0.74 3 0.63 0.11 0.14 -0.44 -0.45 2 0.64 0.047 
6181 RPLP2 0.32 0.42 0.22 -0.68 -0.28 3 0.48 0.09 0.07 -0.38 -0.26 2 0.85 0.002 
6204 RPS10 0.23 0.73 0.59 -0.65 -0.89 3 0.58 0.05 0.02 -0.27 -0.39 2 0.64 0.045 
6209 RPS15 0.04 0.64 0.64 -0.56 -0.76 3 0.36 0.45 0.02 -0.31 -0.52 2 0.81 0.005 
3921 RPSA 0.44 0.84 0.14 -0.96 -0.46 3 0.55 0.47 -0.28 -0.54 -0.20 2 0.87 0.001 
388524 RPSAP58 0.31 0.82 0.26 -0.76 -0.63 3 0.52 0.62 -0.40 -0.56 -0.17 2 0.76 0.011 
891 CCNB1 1.52 3.02 -0.08 -1.98 -2.48 3 0.39 2.20 -0.54 -1.52 -0.52 3 0.89 0.001 
9133 CCNB2 1.30 2.50 -0.20 -1.40 -2.20 3 0.47 2.65 -0.38 -1.83 -0.91 3 0.91 0.000 
595 CCND1 0.18 1.08 -0.22 -0.72 -0.32 3 0.05 0.93 -0.45 -0.52 0.00 3 0.94 0.000 
991 CDC20 1.44 3.14 0.14 -1.36 -3.36 3 0.47 2.58 -0.50 -1.28 -1.26 3 0.91 0.000 
8318 CDC45 0.15 1.20 -0.70 -0.40 -0.25 3 0.17 2.72 -1.03 -1.56 -0.31 3 0.96 0.000 
990 CDC6 0.40 1.40 -0.40 -0.50 -0.90 3 -0.51 2.11 -0.44 -0.93 -0.25 3 0.82 0.004 
83461 CDCA3 1.58 2.78 -0.12 -1.72 -2.52 3 0.42 2.59 -0.46 -1.72 -0.84 3 0.90 0.000 
983 CDK1 1.39 2.89 -0.21 -1.41 -2.66 3 0.41 2.64 -0.48 -2.03 -0.54 3 0.83 0.003 
1019 CDK4 0.26 0.76 -0.24 -0.34 -0.44 3 -0.10 0.69 0.03 -0.38 -0.23 3 0.87 0.001 
1062 CENPE -0.58 1.52 0.37 0.02 -1.33 3 0.23 1.72 -0.34 -1.12 -0.49 3 0.65 0.042 
1063 CENPF 0.34 1.34 0.54 -1.26 -0.96 3 -0.05 2.39 -0.24 -1.49 -0.60 3 0.88 0.001 
91687 CENPL 0.56 1.26 -0.44 -0.54 -0.84 3 0.20 1.58 -0.73 -0.65 -0.41 3 0.93 0.000 
79019 CENPM 0.24 1.24 -0.46 0.04 -1.06 3 0.11 1.64 -0.63 -0.83 -0.29 3 0.78 0.008 
55839 CENPN 0.90 2.70 -0.50 -0.90 -2.20 3 0.19 1.74 -0.38 -1.05 -0.51 3 0.89 0.001 
4173 MCM4 1.02 2.22 -0.88 -1.08 -1.28 3 0.23 1.32 -0.68 -0.69 -0.19 3 0.92 0.000 
795 S100G 0.70 2.55 -0.25 -0.35 -2.65 3 -0.04 1.26 0.65 -0.88 -0.99 3 0.81 0.004 
6626 SNRPA -0.08 1.32 -0.08 -0.38 -0.78 3 -0.12 1.11 -0.30 -0.62 -0.06 3 0.86 0.002 
55388 MCM10 -0.14 0.86 0.16 -0.14 -0.74 4 -0.09 1.53 -0.50 -0.89 -0.05 3 0.66 0.039 
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2194 FASN -0.25 1.00 0.90 -0.85 -0.80 4 -0.98 1.10 0.64 -0.34 -0.43 4 0.84 0.003 
10857 PGRMC1 -1.36 -0.43 0.87 0.61 0.31 5 -0.63 0.16 0.82 0.05 -0.41 5 0.70 0.025 
5743 PTGS2 -0.9 -1.7 -3.3 2.1 3.8 7 -0.15 -0.74 -0.57 0.26 1.19 7 0.94 0.000 
55503 TRPV6 -1.42 -1.42 -0.02 -0.22 3.08 7 -2.02 -0.98 0.66 1.27 1.07 7 0.69 0.028 
7422 VEGFA -0.03 -0.83 -0.73 0.52 1.07 7 -0.65 -0.35 -0.06 0.26 0.80 7 0.74 0.014 
715 C1R 0.60 -0.30 -1.00 -0.50 1.20 8 0.05 -0.52 -0.38 0.32 0.53 8 0.66 0.037 
687 KLF9 0.49 -0.73 -0.72 -0.02 0.98 8 0.13 -0.31 -0.40 0.12 0.46 8 0.97 0.000 
710 SERPING1 0.37 -0.26 -0.86 -0.49 1.24 8 0.24 -0.46 -0.82 0.39 0.65 8 0.75 0.012 
5733 PTGER3 -0.26 0.24 0.64 -0.06 -0.56 4 0.98 -0.27 -1.12 -0.22 0.63 1 -0.90 0.000 
718 C3 -1.02 0.58 1.18 0.48 -1.22 4 1.01 -0.46 -1.46 -0.05 0.95 8 -0.96 0.000 
5737 PTGFR -0.10 -1.40 -0.80 1.45 0.85 7 -0.03 0.70 0.39 -0.20 -0.85 4 -0.83 0.003 
Table VIII-IV: List of differentially expressed genes in equine and porcine endometrium (ony genes that are discussed int his study). Calculation of correlation coefficience 
(correl r), t-value and p-value of positive and negative correlated genes is demontrated in list. 
Hsa Entrez 
Gene ID 
Hsa Gene 
symbol 
Sus scrofa Equus caballus Bos taurus 
D0 D3 D6 D12 D18 
SOTA-
Cluster 
D0 D3 D8 D12 D16 
SOTA 
cluster 
D18P4L D0 D3.5 D12 D18P4H 
715 C1R 0,60 -0,30 -1,00 -0,50 1,20 2 0,05 -0,52 -0,38 0,32 0,53 1 -0,21 -0,75 0,15 0,22 0,59 
1278 COL1A2 1,40 -0,70 -0,50 -0,40 0,20 2 1,10 -0,48 0,17 -0,98 0,19 1 0,11 0,7 0,23 -0,38 -0,66 
1281 COL3A1 1,08 -1,02 -0,12 -0,22 0,28 3 1,03 -0,29 0,26 -1,26 0,26 1 0,26 0,68 -0,01 -0,27 -0,66 
1282 COL4A1 0,98 -0,72 -0,12 -0,82 0,68 3 0,51 -0,43 -0,15 -0,44 0,50 3 0,45 0,33 -0,17 -0,21 -0,41 
2099 ESR1 0,94 0,27 -0,56 -0,26 -0,39 4 0,18 0,69 -0,22 -0,93 0,28 7 0,14 -0,04 0,69 -0,48 -0,31 
10769 PLK2 0,86 -1,64 -1,14 0,46 1,46 1 -0,02 0,03 -0,59 -0,05 0,63 3 0,61 0,71 0,26 -0,95 -0,63 
710 SERPING1 0,37 -0,26 -0,86 -0,49 1,24 3 0,24 -0,46 -0,82 0,39 0,65 3 -0,27 -0,77 -0,28 0,78 0,54 
Table VIII-V: List of differentially expressed genes in all three species (only genes are shown that are discussed in this study . Comparison of significant positive and negative 
correlated genes from equine and porcine endometrium were compared to the list of differentially expressed genes in bovine estrous cycle (Mitko, 2008).P4L-low levels of 
progesterone, P4H-higher level of progesterone. 
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